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HIV-1 was first diagnosed within South Africa in 1982. In the 1980’s 
homosexual transmission dominated the HIV-1 epidemic within the country. In 
the late 1980’s the second HIV-1 epidemic was recognized amongst 
heterosexual individuals. Today heterosexual transmission of HIV-1 
dominates the epidemic in South Africa. Subtype C HIV-1 is responsible for 
the overwhelming majority of heterosexual infections. An estimated 95% of all 
infections in the country are thought to be subtype C related. To date only a 
few papers have been published on non-subtype C HIV within the country. 
This study characterized subgenomic and near full-length sequences of non-
subtype C HIV-1 viruses from the Cape Town area.  
The gag p24, pol-integrase, and env gp41 regions of 11 of the 12 samples 
were characterized by amplification and direct sequencing. Phylogenetic 
analysis of the sequenced data, with online subtyping tools (REGA and 
jpHMM) and the drawing of NJ-trees revealed the presence of subtype A1, B, 
F1 and recombinant viral forms such as AD, AG and AC. One of the isolates 
was classified as a subtype C and was included for control purposes.   
Near full-length characterization of four of the samples were attempted, 
through full genome PCR amplification and sequencing. Analysis of 
sequenced data with the use of subtyping-, recombination identification, and 
tree drawing tools revealed a subtype B, and A1 isolate. The other two 
isolates were identified as possible AC and AD recombinants.  
The data that was generated will greatly improve our knowledge of non-
subtype C isolates circulating within South Africa. Due to the possible impact 
that the high degree of genetic variation that HIV may have on vaccine design 
and development and ARV treatment and HIV diagnosis, ongoing research of 




MIV was in 1982 vir die eerste keer in Suid Afrika gediagnoseer en was 
hoofsaaklik deur homoseksuele kontak oorgedra. Aan die begin van die 
1990’s is `n tweede MIV epidemie gewaar onder heteroseksuele individue. 
Heteroseksuele oordrag van die virus domineer tans die MIV epidemie in Suid 
Afrika en is meestal subtipe C verwant. Subtipe C, MIV-1 is verantwoordelik 
vir 95 persent van alle infeksies in die land. Tot hede  is slegs `n paar 
publikasies oor die nie-subtipe C epidemie in die land gepubliseer. Die huidige 
studie was gemik op die karakterisering van subgenomiese en vollengte  
genome van nie-subtipe C MIV isolate van die Kaapstad omgewing.  
Die gag p24, pol-integrase en env gp41 subgenomiese fragmente van 12 
monsters was gekarakteriseer deur amplifikasie en DNS nukleotied volgorde 
bepaling. Filogenetiese analise deur middel van subtipering (REGA en jpHMM 
aanlyn subtiperings programme) asook NJ-filogenetiese bome van die data 
het die teenwoordigheid van subtipe A1, B, en F1, asook verskeie 
rekombinante viruse insluitende AG, AD en AC vorme aangedui. Een van die 
isolate was geklassifiseer as `n subtipe C maar is in die studie ingevoeg vir 
kontrole doeleindes.  
Vollengte karakterisering van 4 uit die 12 isolate was ook gedoen deur 
vollengte genoom amplifikasie en DNS nukleotied volgorde bepaling. Tydens 
die analisering van die DNS volgorde data, deur middel van aanlyn 
subtipering, rekombinasie identifikasie (Simplot en RIP), en filogenetiese 
boom konstruksie programme is twee isolate geidentifiseer as subtipe B en 
A1 MIV-1 viruse. Die ander twee isolate was as moontlike AC en AD 
rekombinante geklassifiseer.  
Die data van nie-subtipe C MIV isolate sal ons kennis van die nie-subtipe C 
epidemie in Suid Afrika versterk. As gevolg van die impak wat die hoë graad 
van genetisie variasie van MIV op die ontwikkeling van entstowwe, sowel as 
die diagnose en behandeling van pasiente kan hê, is verdere navorsing in die 
epidemiologie van die MI-virus in Suid Afrika nodig.  
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The clinical condition known as acquired immunodeficiency syndrome (AIDS) 
is caused by the human immunodeficiency virus (HIV). The virus exists in two 
distinct forms, HIV-type 1 (HIV-1) and HIV-type 2 (HIV-2). With the help of 
epidemiological and molecular tools closer analysis has revealed that HIV-1 
has spread all over the world, whereas HIV-2 is mostly confined to areas of 
West Africa [Essex and Mboup, 2002; Levy, 2007]. HIV-1 can be divided into 
three groups: group M (major), group N (non-M or non-O) and group O 
(outlier) [Peeters, 2001]. Group M HIV-1 is responsible for the majority of 
infections worldwide and can be subdivided into a large variety of subtypes 
and circulating recombinant forms (CRF’s) [http://www.hiv.lanl.gov/]. The 
genetic similarity between HIV-1 and other closely related viruses, such as 
HIV-2 and SIV, can be used as genetic markers in the study of the virus with 
the help of molecular and phylogenetic techniques.  
 
The July 2008 UNAIDS report, estimates that 34 million adults and 2.3 million 
children are living with HIV/AIDS, with 2.7 million new infections each year. 
The report also estimates that 2 million people die, due to AIDS related deaths 
each year [UNAIDS, 2008].  Although HIV and AIDS are found in all parts of 
the world, some areas are more severely affected than others. Of the 36 
million people infected worldwide, an estimated 24.1 million infected 
individuals live in sub-Saharan Africa where, in some places, more than one in 
five adults can be infected [UNAIDS, 2008]. Though sub-Saharan Africa is 
most severally affected, the epidemic is spreading more rapidly in Eastern 
Europe and Central Asia, where the rate of new infections increased by as 
much as 50% between 2004 and 2008 [UNAIDS, 2008].  
In South Africa (SA) the HIV-I epidemic was initially associated with the 
homosexual population [Sher, 1989]. In the 1980’s, HIV-1 was isolated form 
homosexual men, who introduced the virus into SA from other countries 
[Becker et al, 1985]. These initial isolates were later identified as HIV-1 
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subtype B and D viruses [Becker et al, 1995; Engelbrecht et al, 1995]. Today 
the HIV-1 epidemic has spread widely amongst the heterosexual population of 
the region with as many as 6.2 million infected people in SA alone [UNAIDS, 
2008]. Subtype C HIV-1 is responsible for nearly 52% of HIV infections 
worldwide and is commonly found in parts of the Indian subcontinent and 
eastern and southern Africa.  In SA, it can account for as much as 95% of all 
infections [Ariën et al, 2007]. Though HIV-I subtype C still holds a dominant 
position within southern Africa, non-subtype C HIV-I infections have been 
growing in importance over the past couple of years, which may impact a wide 
spectrum of fields e.g. antiretroviral treatment [Spira et al, 2003], diagnostics 
and the development of an effective vaccine [Buonaguro et al, 2007; Peeters 
et al, 2003]. In the following section the history of the HIV pandemic, the 
genetic diversity, the virus structure, as well as phylogenetic methods used in 
analysis of HIV will be reviewed. 
LITERATURE REVIEW 
1.1. History 
 1.1.1 The HIV pandemic 
Kaposi’s Sarcoma (KS) was a very rare form of a relatively benign cancer that 
mostly affected the elderly [Gange and Jones, 1978; Penn, 1979]. By March 
1981 eight cases of a more aggressive form of KS was reported amongst 
young homosexual men from New York [Hymes et al, 1981, Friedman-Kien et 
al, 1981]. At this time there were increases all over the United States (US) in 
the number of cases of a rare lung infection, Pneumocystis carinii pneumonia 
(PCP) [Gottlieb et al, 1981; Masur et al, 1981]. In April of 1981 these 
increases were noticed by a young drug technician working at the Center of 
Disease Control and Prevention (CDC) in Atlanta, when a doctor treating a 
young patient with PCP requested a refill for the drug used in the treatment of 
PCP patients [CDC, 1981]. This was very unusual as most patients responded 
to medication within 10 days of treatment or they passed away. Afterwards a 
number of theories were developed about the possible cause of these 
opportunistic infections and cancers. 
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By the end of 1981 it was clear that the disease was affecting other population 
groups, when the first cases of PCP infection were reported in intravenous 
drug users [Shilts, 1987]. Shortly afterwards, the first reported cases of these 
opportunistic infections were documented in continental Europe and the UK. 
By the beginning of the next year the disease still did not have a name. By 
June 1982 a report suggested that the disease might be caused by an 
infectious agent that was sexually transmitted, after a small cluster of cases 
amongst homosexual men in southern California was reported. By October 
1982, 452 cases from 23 states had been reported to the CDC [CDC, 1982]. It 
soon became apparent that the disease was also occurring amongst 
heterosexuals. By this time reported cases had been observed in homosexual 
and heterosexual people, intravenous drug users, certain blood transfusion 
recipients [Curran et al, 1984; Jaffe et al, 1984], some organ transplant 
recipients [Curran et al, 1984], a few newborn infants [Rubinstein et al, 1983; 
Oleske et al, 1983] and international travelers from African decent [Clumeck et 
al, 1983].  
The acronym AIDS was beginning to be used on government level, the press 
and in scientific journals. Doctors thought AIDS was an appropriate name 
because people acquired the condition rather than inherited it, resulting in a 
deficiency within the immune system, with a number of manifestations. By this 
time still very little was known about the transmission of the infectious agent 
and public anxiety started to grow. By the end of 1982 a 20-month old child 
who received multiple transfusions of blood and blood products died from 
infections related to AIDS [Curran et al, 1984]. Meanwhile in Uganda, doctors 
were beginning to see the first cases of a new, fatal wasting disease which 
came to be known locally as “slimming-disease” [Serwadda et al, 1985].  
In May 1983 doctors and scientist at the Pasteur Institute in France reported 
the isolation of a new retrovirus from the lymph node of a man with persistent 
Lymphadenopathy Syndrome (LAS), which they suggested might be the 
causative agent of AIDS and was subsequently named Lymphadenopathy 
virus (LAV) [Barre-Sinoussi et al, 1983]. At the same time, reports from 
Europe suggested that two rather separate AIDS epidemics were occurring. In 
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the UK, Germany and Denmark, the majority of people with AIDS were 
homosexual men with a history of sexual encounters with American nationals. 
In France and Belgium however, AIDS occurred mainly in migrants from 
former African colonies or those with links to areas in Africa [Clumeck et al, 
1983]. Due to the fact that these patients had no history of blood transfusion, 
homosexuality or intravenous drug use, European and American scientists set 
out to discover more about the occurrence of AIDS in Africa [Weller et al, 
1984]. By the end of 1983 the World Health Organization (WHO) reported that 
the disease were present in the United States, Canada, fifteen European 
countries, Haiti, Zaire (now the Democratic Republic of the Congo), seven 
Latin American countries, Australia and Japan [WHO, 1983]. 
A year after the team of Barre-Sinoussi [Barre-Sinoussi et al, 1983] isolated 
the Lymphadenopathy virus at the Pasteur Institute, Robert Gallo and his 
colleagues postulated that a variant T-lymphotropic retrovirus, which they 
called HTLV-III, might be the causative agent of AIDS [Gallo et al, 1984].  By 
1984, Levy and co-workers, found the same viral agent that Barre-Sinoussi 
[Barre-Sinoussi et al, 1983] discovered an year earlier in one of the samples 
of an infected patient [Levy et al, 1984]. Ratner and co-workers independently 
confirmed that the new variant of HTLV-III was the causative agent of AIDS 
and also published the first full sequenced genome of the virus [Ratner et al, 
1985a; Ratner et al, 1985b]. Medical data and records of patients suffering 
from opportunistic infections, from Central African countries, suggested that 
the disease was already present within the region in the 1970’s and asserted 
the claims that it might have arisen from the region [Quinn et al, 1986]. 
Though HIV/AIDS was initially associated with people from particular risk 
groups, such as homosexuals and intravenous drug users, heterosexual 
transmission is now responsible for the majority of new infections [Osmanov 
et al, 2002; Esparza and Bhamaraparvati, 2000].  
By 1986 two new retroviruses were isolated from patients with AIDS like 
symptoms from West Africa. Closer analysis of these viruses (LAV-2 or later 
called HIV-2), showed that although both caused immunodeficiency and AIDS 
in infected individuals, HIV-1 and HIV-2 differ in their natural history of 
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infection and pathogenicity [De Cock et al, 1993; Pepin et al, 1991]. Since 
then it has been shown that both HIV-1 and HIV-2 shares structural, genetic 
and biological properties and cause CD4 cell depletion in infected individuals 
[Markovitz, 1993]. 
 1.1.2 The origin of HIV 
HIV is a member of the Lentivirus subfamily of retroviruses (Retroviridae). 
Since HIV was established as the etiological agent of AIDS an estimated 60 
million people have been infected with HIV-1 worldwide [UNAIDS, 2008]. 
Though HIV/AIDS only came under the attention of humans in the early 
1980’s recent scientific discoveries dates the existence of the virus in humans 
as far back as the 1930’s [Hahn et al, 2000; Korber et al, 2000]. A plasma 
sample from 1959 that was taken from a patient from the Central African 
country of Zairë (now the DRC), gives credible evidence that the disease has 
been in humans for some time longer than we first thought and also suggests 
that the epidemic might have originated in Africa [Nahmias et al, 1986].  
Considerable evidence for a simian ancestor for HIV exists today. Simian 
immunodeficiency virus (SIV), which is also a member of the lentivirus family, 
is found in a large group of species of non-human primates and is related to 
HIV on a genomic level (Figure 1.1) [Myers et al, 1992]. All factors indicate 
that HIV originated through cross-species transmission from naturally infected 
primates to humans in Africa, a process commonly known as zoonosis [Hahn 
et al, 2000]. Phylogenetic analysis indicated that multiple zoonotic events, 
from simian species to humans, lead to the formation of two genetically 
distinct types of HIV (HIV-1 and HIV-2) and three main groups of HIV-1 [Gao 
et al, 1999; Papathanasopoulos et al, 2003a].  
Molecular studies showed that HIV-1 is more closely related to primate 
lentiviruses from chimpanzees (SIVcpz), mainly from the subspecies Pan 
troglodytes troglodytes [Gao et al, 1999]. Similarly HIV-2 is more closely 
related to SIV sequences commonly found in sooty mangabeys, Caeoceus 
atys, [Gao et al, 1992; Hirsch et al, 1989]. Chimpanzees and other non-human 
primates are commonly hunted for food in certain regions in Central and 
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Western Africa and represent an easy source for zoonotic transmission of SIV 
to humans [Hahn et al, 2000; Papathanasopoulos et al, 2003a; Essex and 
Kanki, 1998]. Sooty mangabeys are also commonly used as a food source 
and in some cases domesticated as house pets in parts of Western Africa 
[Peeters et al, 2003]. Further support for the zoonotic infections of humans is 
that natural SIV infections in their simian hosts fail to induce a state of 
disease, which indicates that the virus has adapted itself to the host or that 
they co-exist in a symbiotic way [Cichutek and Norley, 1993; Rey-Cuille et al, 
1998; Silvestri et al, 2003]. 
 
Figure 1.1: A phylogenetic tree depicting the evolutionary relationship 
between: HIV-1 and its major groups; HIV-2; and several different SI-viruses 
isolated from different primates on the African continent. Bootstrap values greater 
than 90 percent are included in the tree [Adapted from Buonaguro et al, 2007].  
The timing of the zoonotic events leading to the rise of HIV in man has been a 
question for debate. Advanced phylogenetic methods have estimated 1930 as 
the time of the last common ancestor of the HIV-1 group of viruses [Korber et 
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al, 2000; Salemi et al, 2001]. These estimations are based on the assumption 
of a molecular clock, with genetic change in a linear function and substitution 
occurring according to a Poisson distribution. Similarly the best estimate of the 
most recent ancestor of the HIV-2 group was estimated to be 1940 for HIV-2 
group A and 1945 for HIV-2 group B, plus or minus 16 years [Lemey et al, 
2003]. 
1.2 The HIV-1 virus 
 1.2.1 Retroviruses 
The first discovery of a retrovirus was made as far back as 1910 at the 
Rockefeller Institute of Medical Research in New York.  It was called avian 
sarcoma virus and induced tumors in muscle, bone and other tissues of 
chickens [Huebner and Todaro, 1969]. Later other retroviruses were identified 
that could induce the same symptoms in mice and other mammals [Essex et 
al, 1975; Hardy et al, 1973]. Retroviruses possess a unique enzyme called 
reverse transcriptase (RT), which uses the viral RNA as a template for making 
a DNA copy, which is then integrated into the host cell nucleic acid [Bebenek 
et al, 1989; Boyer et al, 1992]. The discovery of reverse transcriptase were 
profound in the field of biology as it overturned the central belief of molecular 
biology, that genetic information flows only in one direction (which is from 
DNA to RNA and on to protein synthesis). Retroviruses are also diploid, which 
means that there is a constant opportunity for recombination to occur when 
different parental genomes are packaged in the same virus particle 
[Robertson et al, 1995]. Initially these retroviruses were regarded to be of little 
importance because they were only associated with organisms other than 
humans. That all changed with the discovery of human associated 
retroviruses.  
To date several different human retroviruses have been identified which can 
be divided into three families including; Lentivirinae (HIV-1 and HIV-2), 
Oncovirinae (HTLV-I and HTLV-II) and Spumavirinae. The human spumavirus 
(HSRV) was the first isolated human retrovirus [Achong et al, 1971]. 
Spumaviruses are found worldwide and can be isolated from a wide range of 
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species, from monkeys to cattle [Flügel, 1991]. To date no known form of 
pathology of HSRV in humans has been found. The Oncovirinae family all 
shares the ability to induce cancerous conditions in its hosts, including 
lymphomas, leukemia, carcinoma and other forms of cancer.  Two species of 
this family of retroviruses have been identified in humans to date, HTLV-I and 
HTLV-II. In 1976 a retrovirus was isolated from the lymph node of an ATL-
patient (adult T-cell leukemia-lymphoma patient) in Japan [Uchiyama et al, 
1977]. The etiological agent of ATL was named human T-cell leukemia virus 
Type - I or HTLV-I [Ammann et al, 1983; Fahey et al, 1984]. HTLV-I proved to 
be endemic in Japan, Central and South America, the Caribbean and Africa. 
The origin and the transmission of HTLV-I are thought to be the same as for 
HIV-1. Later a second virus, HTLV-II was isolated from the cells of a patient 
with a rare form of leukemia [Gallo, 2005]. An Africa origin was later 
hypothesized for HTLV-II, which then spread to other areas of the world where 
it is mostly associated with intravenous drug users [Vandamme et al, 1998]. 
The Lentivirinae family of retroviruses includes HIV-1, HIV-2 and other 
lentiviruses commonly found in non-human primates which are termed SIV. 
Later the fifth human retrovirus, HIV-2, was isolated from mildly immune 
suppressed patients in West Africa which appeared to be less pathogenic 
[Marlink et al, 1994; Kanki et al, 1994].  
 1.2.2 The Virion Structure 
HIV-1 and HIV-2 belong to the group of lentiviruses [http://www.hiv.lanl.gov/] 
which can be distinguished from other retroviruses (such as HTLV-I and -II) by 
the presence of a cone-shaped nucleoid, absence of oncogenicity and the 
length and slow onset of clinical symptoms. The HIV particle is approximately 
100 nm in size with an outer envelope of a lipid bilayer, which arises from the 
virus budding from the host cell. This lipid bilayer is penetrated by 72 
glycoprotein spikes, the envelope (env) protein. The env polypeptide is 
composed of two subunits: the outer glycoprotein knob (gp120) and a 
transmembrane portion (gp41) which connects the knob to the virus lipid 
envelope [Levy, 2007] (Figure 1.2). 
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On the inside of the lipid bilayer the envelope is lined with a matrix protein 
(p17). Also present within the lipid envelope are cellular proteins such as MHC 
class 1 and class 2 antigens. In HIV-1 the lipid envelope encloses an 
icosahedral shell of protein (p24) which in turn encloses a cone-shaped 
protein core (p7 and p9 proteins). Within the cone-shaped core are two 
molecules of ssRNA in the form of a ribonucleoprotein. Bound to the diploid, 
positive-sense ssRNA are multiple copies of reverse transcriptase (RT), 
integrase (for genome integration into the host cell nucleic acid) and protease 
enzymes [Levy, 2007].  
 
 
Figure 1.2: A schematic diagram of the HIV virion. The diagram displays all the 
major proteins and the ssRNA [http://en.wikipedia.org/wiki/HIV]. 
 1.2.3 Genomic organization of HIV-1 
The genome of the HIV-1 virus is approximately 9.7 kb long with long terminal 
repeats (LTR’s) on both sides (Figure 1.3).  Within the 9.7 kb fragment of the 
genome there are several open reading frames coding for a multitude of 
functional virus proteins namely; structural genes (gag, pol, and env), 
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regulatory genes (tat, and rev), and accessory genes (vif, vpr, nef, and vpu). 
The gag gene provides the structural elements of the virus. The p24 part of 
the gene makes up the viral capsid whereas the p6 and p7 parts provide the 
nucleocapsid and p17 provides a protective matrix. The pol gene is a common 
feature of all retroviruses. It encodes for the reverse transcriptase enzyme that 
is responsible for the transcription of viral RNA into double-stranded DNA 
[Levy, 2007]. 
 
Figure 1.3: A diagrammatical representation of the genome layout of HIV-1. All 
three reading frames with all the most important genes are shown. All start and stop 
coordinates of genes on the diagram corresponds to that of the HXB2 reference strain. Exons 
1 and 2 of tat and rev are indicated on the diagram with dark and light gray respectively 
[Adapted from http://www.hiv.lanl.gov/]. 
The pol gene also codes for the integrase and protease enzymes. Integrase is 
responsible for the integration of the double-stranded DNA into the host cells 
genome [Dicker et al, 2007]. The gag and pol genes do not produce their 
proteins in their final form, but as a large polypeptide. HIV protease then 
cleaves these large protein segments into separate functional units. The env 
gene encodes for a precursor protein of gp120 and gp41 called gp160, which 
is cleaved into the two functional proteins by the host cell’s own enzymes. Env 
gp120 is exposed on the surface of the viral envelope and binds the virus to 
the CD4 receptors on the surface of any target cells. The glycoprotein gp41 is 
non-covalently bound to gp120, and facilitates the second step of viral 
entering into the target cells. The gp41 is originally found inside the viral 
envelope, but when gp120 binds to the CD4 receptor, gp120 undergoes a 
conformational change causing gp41 to become exposed on the viral 
envelope, where it can assist in the fusion of the virus with the host cell [Chan 
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et al, 1997]. A summary of all the HIV genes and proteins are listed in Table 
1.1.  
Table 1.1: The HIV-1 genes and proteins with their functions. [Adapted from Levy, 
2007]                                
HIV proteins and their function 
Proteins Size (kDa) Function Abbreviation
p24 Capsid (CA), structural protein CA 
p17 Matrix (MA) protein, myristoylated MA 
p7 Nucleocapsid (NC) protein, helps in reverse transcription NC 
Gag 
p6 Role in viral budding (L domain) - 
Polymerase  p66, p51 Reverse Transcription (RT): RNase H - inside core RT 
Protease  p10 Gag/Pol cleavage and maturation PR 
Integrase  p32 Viral cDNA integration IN 
gp120 Envelope surface protein SU 
Env 
gp41 Envelope transmembrane protein TM 
Tat p14 Transactivation Tat 
Rev p19 Regulation of viral mRNA expression Rev 
Nef p27 Pleiotropic, can increase or decrease virus replication Nef 
Vif p23 Promotes virion maturation and infectivity Vif 
Vpr p15 Helps in virus replication, transactivation Vpr 
Vpu p16 Helps in virus release, disrupts gp160:CD4 complexes Vpu 
Vpx p15 Helps in entry and infectivity (Only in HIV-2 and SIV) Vpx 
Key: p (protein), gp (glycoprotein), - (no abbreviation), cDNA (complimentary DNA), RT 
(Reverse Transcriptase), mRNA (messenger RNA), and CD4 (cluster of differentiation 4) 
Unlike certain oncogenic retroviruses, such as HTLV-I and -II in the retrovirus 
family, HIV-1 has no onc gene, but possess other unique genes such as; rev 
(facilitates the exportation of mRNA from the nucleus to the cytoplasm), tat 
(transactivation of HIV gene expression), vif (inhibits the cellular protein, 
APOBEC3G, from entering the virion at the time of budding), vpr (plays an 
important role in regulating nuclear importation of the HIV-1 pre-integrated 
complex and is required for virus replication in non-dividing cells), vpu 
(facilitates viral budding), and nef (ensuring T cell activation and the 
establishment of a persistent state of infection) [Levy, 2007]. 
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 1.2.4 The life cycle of HIV-1 (Replication) 
The human immunodeficiency virus (HIV) can infect a variety of immune cells 
such as CD4+ T-cells, Cytotoxic T-lymphocytes (CTLs), CD4+ monocytes, 
macrophages and CD4+ dendritic cells of the host’s immune system [Chan et 
al, 1998]. The virus life cycle can be divided into two distinctive stages: the 
early establishment of infection and the later viral replication stage (Figure 
1.4).  
 
Successful infection of a target cell is accomplished through a series of virus-
host cell interactions. These include the binding of the virus to the cell surface, 
the fusion of the virus and the cell membrane, entry of the virus capsid into the 
cytoplasm of the host cell, the reverse transcription of RNA to DNA and the 
incorporation of the viral DNA into the nucleus of the host cell [Chan et al, 
1998]. Briefly, entry to the cell begins through interaction of the trimeric 
envelope complex (gp160 spike) and both CD4 and a chemokine receptor 
(generally either CCR5 or CXCR4) on the cell surface [Levy, 2007].  The first 
step in fusion involves the high-affinity attachment of the CD4 binding 
domains of gp120 to CD4. Once gp120 is bound with the CD4 protein, the 
envelope complex undergoes a structural change, exposing the chemokine 
binding domains of gp120 and allowing them to interact with the target 
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chemokine receptor. This allows for a more stable two-pronged attachment, 
which allows the N-terminal fusion peptide gp41 to penetrate the cell 
membrane [Wyatt and Sodroski, 1998].  
After successful fusion p24 is released into the cytoplasm, which uncoats to 
release the viral RNA into the host cells cytoplasm.  The RNA is then reverse 
transcribed using the host cells reverse transcriptase enzyme to synthesis a 
double-stranded DNA copy of its RNA. With the help of the viral integrase the 
newly synthesized double-stranded copy of DNA is then incorporated into the 
host cells genome. 
Once integration has occurred in a host cell the cells progeny will also be 
infected [Levy, 2007]. The provirus establishes latency in the infected cell. 
New virions are then synthesized from the integrated provirus. When a host 
cell is infected by two or more viruses there is a possibility that two different 
genomes may be transcribed into the same virion. The successful infection, 
integration and translation, of these virions into new host cells will then lead to 
the production of proviral genomes that are recombinants of the two viral 
genomes [Rodrigo and Learn, 2000]. Viral recombination in HIV-1 is made 
possible by the diploid (two RNA molecules) nature of the viral genome. Viral 
recombination of HIV-1 occurs during the reverse-transcription step, before 
viral integration and dependence on the co-packaging of two different viral 
genomes.  This requires simultaneous infection of the same cell by two 
different strains and subsequent integration of two different parental-
generation proviruses in the same nucleus (Figure1.5) [Taylor et al, 2008].  
The later viral replication stage starts as soon as the viral DNA is transcribed 
into RNA by the host cells DNA polymerase. Spliced and unspliced viral 
mRNA is then exported to the cytoplasm of the host cell for translation and 
virus formation. Spliced viral mRNA is translated into viral proteins in the 
cytoplasm of the host cell.  The virus capsid incorporates an unspliced copy of 
viral mRNA into a newly formed particle on the inner surface of the host 
membrane [Gelderblom, 1997]. New virions are produced as the virus buds 
through a region of the host’s cell membrane. As the virion buds through the 
host cells membrane, outer surface proteins of the host cell become 
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associated with the virus. The host cell dies from the effect of continuous 
immune activation that occurs in HIV-1 infected patients [Goldberg and 
Stricker, 1999]. Today it is widely hypothesized that the apoptosis of immune 
cells in infected patients is the major cause of the severe depletion of CD4+ T-
cells and the eventual paralysis of an individual’s immune system.  
The intense study of the viral life cycle of HIV has been a key to developing 
valuable antiretroviral drugs against HIV-1. Today a wide range of 
antiretroviral drugs can be used to target up to six different stages of the viral 
life cycle including viral entry, reverse transcription, integration, expression of 
viral proteins, viral assembly and viral release [van Rossum AMC et al, 2002]. 
1.3 Diversity of HIV-1 
HIV-1 is characterized by a high degree of genetic variation driven by a wide 
range of factors, such as the lack of a proofreading ability by its relatively 
weak reverse transcriptase [Op de Coul et al, 1997; Roberts et al, 1988], the 
rapid turnover time of HIV-1 in vivo [Ho et al, 1995], host selective pressures 
[Michael, 1999], and recombination events in dually infected patients [Temin, 
1993]. The rate of sequence variation across the genome of HIV varies, with 
the highest degree of sequence variation in the env gene, intermediate 
amounts in the gag and a low degree in the pol gene [Shankarappa et al, 
1999]. Thus, no two strains are identical and even in infected individuals; HIV 
is present in a swarm of micro variants (quasispecies) that are highly related, 
but genetically distinct.  
The family of human immunodeficiency viruses consists of groups of 
genetically distinct retroviruses. The most basic division of the viruses that 
cause AIDS in humans is the human immunodeficiency virus type 1 (HIV-1) 
and type 2 (HIV-2). HIV-1 can be divided into three subgroups; Group M, N 
and O and each of them have arisen due to a single zoonotic transmission 
from non-human primates. Group M in itself is made up of nine subtypes, 
several sub-subtypes and 43 circulating recombinant forms (CRF’s) [De Leys 
et al, 1990; Gurtler et al, 1994]. New data also support the idea that a subtype 
pattern can be found within group O sequences [Lemey et al, 2004].  
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The subtype classification that is used for HIV is based on a phylogenetic 
system, which means that subtypes are grouped on their inferred evolutionary 
relationship, rather than on other characteristics such as serological reactivity, 
phenotype, co-receptor usage and many other possible biological 
characteristics. This sets HIV viral subtype classification apart from other older 
viral pathogens where serological subtyping is the norm. HIV was discovered 
during the times in which PCR and sequencing technologies were discovered, 
which lead to the use of such techniques for the subtype classification instead 
of the older method of serology which was widely used for other older viral 
pathogens [Rodrigo and Learn, 2000]. The HIV-1 classification system was 
first used in 1992. By the end of 1992, five subtypes were known for env (A 
through E) and four for gag (A through D) [Myers et al, 1992; Louwagie et al, 
1993]. Since then the classification system has been continually updated as 
new viral isolates were sequenced and new data became available. In 1993, 
subtypes F, G and H were added. Since then there has been many additions 
to the classification system [http://www.hiv.lanl.gov./].  
Due to all these changes in the field of subtype classification, new criteria for 
assigning a sequence to an existing subtype and for creating new subtypes or 
sub-subtypes were decided on in September of 1999. These criteria set out to 
give more order to the classification system and set out strict rules for the 
creation of new groups, subtypes and sub-subtypes [Robertson et al, 2000]. 
The classification scheme of HIV-1 into subtypes has proven useful in the 
phylogenetic analysis for clarifying epidemiological relationships and possible 
ancestry of HIV and the classification of new sequences. It has given us a 
clear picture of the worldwide spread of the epidemic and provided us with 
information on how HIV has entered different countries, where patterns differ 
depending on epidemiological factors. In some cases there have been 
isolates that did not fit the subtype classification system very well. Some were 
found to be part of newly discovered subtypes, such as the subtype F which 
was then sub-divided into sub-subtypes [Potts et al, 1993]. Others were later 
found to be recombinants that could not be assigned to a subtype 
unambiguously, but were more likely a mix of a wide variety of subtypes [Carr 
et al, 1996; Gao et al, 1996].  
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Advances in full-genome amplification and sequencing of HIV made the 
identification of circulating and unique recombinant forms (CRFs and URFs 
respectively) much easier. These isolates are the result of recombination 
between subtypes within a dually infected person (Figure 1.5), from which the 
recombinant forms are then passed on to other people. The progeny of such a 
recombinant virus are classified as a CRF if they have been identified in three 
or more epidemiologically unlinked people.  If a particular recombinant form 
has only been identified in one or two cases and thus are of little 
epidemiological value then such viruses are classified as unique recombinant 
forms [Rodrigo and Learn, 2000].  
 
Figure 1.5: Creation of a URF in a coinfected individual. The individual is 
coinfected with two different subtypes X and Y, where the genome of the URF represents part 
of both parental strands [Taylor et al, 2008]. 
 1.3.1 Global diversity of HIV-1 
Globally group M is the predominant circulating HIV-1 group. Group M HIV-1 
can be divided into 9 subtypes (A, B, C, D, F, G, H, J and K), sub-subtypes 
(A1-A3 and F1-F2), circulating recombinant forms (a total of 43 have been 
identified to date) and several unique recombinant forms [Gurtler et al, 1994; 
Janssens et al, 1994; Taylor et al, 2008]. In some cases, subtypes can be 
linked to a specific geographical region or epidemiological group [Hemelaar et 
al, 2006]. These distribution patterns are either the consequence of accidental 
trafficking (due to international travel) or due to a prevalent route of 
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transmission, which results in a strong advantage for a specific subtype to 
become dominant within a specific region or country [Myers, 1994]. Recent 
academic data indicates that the most prevalent HIV-1 genetic forms are 
subtypes A, B, and C, with subtype C accounting for as much as 50% of all 
infections worldwide [Ariën et al, 2007]. 
 
Molecular epidemiology studies have shown that, with the exception of sub-
Saharan Africa where most subtypes and circulating recombinant forms can 
be found, there is a specific geographic distribution pattern for HIV-1 subtypes 
(Figure 1.6).  
 
 
Figure 1.6: Global distribution of different HIV-1 subtypes and circulating     
recombinant forms. [Adapted from Ariën et al, 2007] 
 
Subtype A viruses are most prevalent in areas of central and eastern Africa 
(Kenya & Tanzania) and in the East European countries formerly part of the 
Soviet Union [Buonaguro et al, 2007]. These areas where subtype A viruses 
co-circulate with other viral subtypes have also seen the rise of recombinant 
viruses. Some areas have seen the rise of A recombinant viral forms due to 
the co-circulation of other viral subtypes in the same geographical area e.g. 
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the prevalence of subtypes A and B which lead to the rise of AB recombinant 
viruses in Eastern Europe [Liitsola et al, 1998] and the co-circulating of 
subtype A and D viruses in East African countries such as Kenya which lead 
to the rise of AD recombinants [Songok et al, 2004; Dowling et al, 2002]. 
Subtype B is the major genetic clade in the rest of Europe, the Americas, 
Japan and Australia, but is also found in large numbers in the countries of 
Southeast Asia, Northern Africa and the Middle East and amongst 
homosexual men from South Africa and Russia. Subtype C HIV-1 is 
predominant in the countries of Southern Africa and the Indian subcontinent 
[Buonaguro et al, 2007].  
Of the 43 CRF’s known to us, some 20 reports have been made of CRF’s 
been isolated in areas where the parental strains of the recombinant viral 
forms are cocirculating. The existence of multiple subtypes and CRF’s within 
the same region increases the probability that individuals will become infected 
with different HIV-1 genetic forms, which can exchange parts of their genetic 
material, and result in the formation of recombinant viruses [McCutchan, 
2006]. The role that circulating recombinant forms or CRF’s are playing in the 
global HIV-1 pandemic is increasingly being recognized, with CRF’s 
accounting for more than 18% of global infections [Osmanov et al, 2002; 
Hemelaar et al, 2006; Peeters, 2000]. In some areas of the world, CRF’s 
represent the dominant form of HIV-1 such as in Southeast Asia (CRF01_AE) 
[Menu et al, 1996] and in West and West Central Africa (CRF02_AG) 
[McCutchan et al, 1999; Njai et al, 2006]. 
 
CRF01_AE (Figure 1.7) plays a major role in the HIV-1 epidemic in Southeast 
Asia. This subtype is responsible for more than 75% of the infections within 
the region and accounts for an estimated 4.7% worldwide infections 
[Hemelaar et al, 2006]. This subtype was first identified in Thailand in the late 
1980’s [McCutchan et al, 1992; Carr et al, 1996]. It was first classified as a 
new clade called subtype “E” but after full-length sequence analysis of these 
isolates it became apparent that the virus appeared to have a mosaic-like 
structure, with the gag gene clustering with other subtype A isolates and the 
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env genes from clade E [Leitner et al, 2005; Carr et al, 1996; Gao et al, 1996]. 
To date the parental clade E strain has not been found. Extensive studies of 
CRF01_AE have shown that the isolate was introduced into Thailand from 
Africa and from there the isolate has spread to other counties in Southeast 
Asia where it has become the most prevalent form of HIV-I where it is linked 
to heterosexual sex workers and intravenous drug users within the region 
[Anderson et al, 2000]. 
 
Figure 1.7: The genomic structure of a CRF01_AE isolate. The yellow areas 
correspond with HIV-I subtype E and the red areas with HIV-1 subtype A. The breakpoints of 
the recombination events are also shown (breakpoint coordinates relative to the reference 
strain HXB2) [Adapted from LANL database, http://www.hiv.lanl.gov/].  
 1.3.2 HIV-1 diversity in Africa 
The African continent is home to the largest portion of all HIV infections in the 
world with as many as 23.6 million people living with HIV/AIDS [UNAIDS, 
2008]. A multitude of subtypes and circulating recombinant forms can be 
found in Africa which is possibly due to the African origin of HIV-1 [Torques et 
al, 1999; Vidal et al, 2000]. The distribution and occurrence of different 
subtypes within African populations are not generally linked to a particular 
lifestyle habit as it would be in other parts of the world. In Central and Eastern 
Africa subtype A1 and D HIV-1 is the most prevalent form of HIV. Subtype C 
is dominating the epidemic in Southern Africa where it can account for as 
many as 95 percent of all HIV infections (Figure 1.8). Due to the importance of 
subtype C HIV within the Southern African region this subtype has been 
extensively studied in the past [Bell et al, 2007; Engelbrecht et al, 2001; 
Scriba et al, 2002; Bessong et al, 2005; Hunt et al, 2003; Papathanasopoulos 





Figure 1.8: Subtype distribution of HIV-1 in a handful of sub-Sahara African 
countries [Adapted from: http:www.hiv.lanl.gov./]. 
CRF02_AG (Figure 1.9) which is the dominant form of HIV in Western and 
Central Africa also contributes considerably to the global epidemiology of the 
virus accounting for an estimated 4.6% of worldwide infections [Hemelaar et 
al, 2006].  
Initially the CRF02_AG viral subtype was described as a divergent lineage 
within HIV-1 subtype A, based on partial gag and env sequences [Howard and 
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Rasheed, 1996]. After full length sequences of these isolates were obtained, it 
was recognized as a complex mosaic virus of alternating subtype A and 
subtype G regions [Carr et al, 1998]. This viral form of HIV-1 have been 
isolated in various regions ranging from West Africa to East African countries 
and a CRF02_AG isolate have also been identified in South Africa. [Bredell et 
al, 2002, Jacobs et al, submitted] In countries of West and Central Africa, 
such as Nigeria and Cameroon, this recombinant form is responsible for 
between 50 – 70% of new infections [Andersson et al, 1999; McCutchan et al, 
1999; Fischetti et al, 2004]. 
Figure 1.9: The genomic structure of CRF02_AG. The green areas correspond with 
HIV-I subtype G and the red areas with HIV-1 subtype A. The breakpoints of the 
recombination events are also shown (breakpoint coordinates relative to the reference strain 
HXB2) [Adapted from LANL database, http://www.hiv.lanl.gov/].  
 1.3.3 HIV-1 diversity in South Africa 
South Africa is currently in the grip of one of the most devastating AIDS 
epidemics in the world. By the end of 2007, 6.2 million people were living with 
HIV in South Africa, with countless more being affected by the lost of family 
and loved ones. UNAIDS estimated that there were 1.4 million South African 
children orphaned by AIDS in 2007 [UNAIDS, 2008]. The UNAIDS report of 
2008 estimate that almost 1,000 AIDS related deaths occurring every day 
within the country [UNAIDS, 2008].  
In 1982 the first reported case of AIDS in South Africa was documented, with 
the first virus isolation done in 1984 [Ras et al, 1983; Becker et al, 1985]. 
Initially HIV infections seemed to be occurring mainly amongst homosexual 
white men [Sher, 1989]. By the start of the 1990’s it became apparent that a 
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second HIV pandemic, amongst the heterosexual indigenous black 
population, was occurring within the country [Williamson et al, 1995]. By 1990 
an estimated 74,000 people were living with HIV in South Africa [Department 
of Health, 2005]. The following year the number of diagnosed heterosexually-
transmitted HIV infections equaled the number of infections transmitted 
through men having sex with other men. Since then heterosexual 
transmission has dominated the epidemic in the country.  The most rapid 
increase in South Africa’s HIV prevalence took place between 1993 and 2000, 
during which time the country was distracted by major political changes. While 
the attention of the South African people and the world's media was focused 
on the political and social changes occurring in the country, HIV was rapidly 
becoming more widespread. Subtype C HIV-1 is responsible for nearly 95 
percent of all infections within the country.  
Over the past years subtype C HIV-1 has been extensively studied in South 
Africa due to its immense importance [Jacobs et al, 2006; Hunt et al, 2003; 
Papathanasopoulos et al, 2002; Rousseau et al, 2006; de Oliveira et al, 2003; 
Gordon et al, 2003; zur Megede et al, 2002]. To date only a few papers have 
been published on complete genomes of non-subtype C HIV-1 isolates in 
South Africa [Papathanasopoulos et al, 2001; Loxton et al, 2005]. A lot of 
research has been conducted on HIV-1 over the years within the country. To 
date several papers on a wide range of HIV-1 subtypes have been published 
on subgenomic fragments (Table 1.2) or near full-length sequences (Table 
1.3). These viruses were isolated from several geographical locations within 
the country. The majority of HIV research has been conducted within the three 
biggest urban areas, Johannesburg, Cape Town, and Durban, but smaller 
studies has also been conducted in other areas of the country, such as 




Table 1.2: Summary of published data of subgenomic fragments of HIV-1 isolates from South Africa.  
Characterization of subgenomic regions 
Publication Number of samples Method of Subtyping Region of Genome Subtypes 
Subtype B 
Subtype D 










Subtype D (n = 1) 
van Harmelen et al, 
1997 
61 Samples HMA & partial sequencing V3 - V5 or gag 
CRF01_AE (n = 1) 
Bredell et al, 1998 44 Samples HMA & sequencing V3 - V5 env region All subtype C 
Subtype C Engelbrecht et al, 1999 81 Samples Serology (cPEIA) and 
Phylogenetics 
V3 region of env 
Subtype B 
Subtype A (n = 2) 
Subtype B (n = 28) 
Subtype C (n = 56) 
van Harmelen et al, 
1999 
87 Samples RFLP gag 
Subtype D (n = 1) 
Subtype C (n = 43) 
Subtype A (n = 2) 
Subtype B (n = 3) 
Hunt et al, 2001 60 Samples  HMA & Phylogenetics gag & env 
Several Recombinants 
Engelbrecht et al, 2001 13 Samples Phylogenetics gag & env All subtype C 
Subtype A (n = 2) Bredell et al, 2002 10 Samples HMA & partial sequencing gag & env 
C CA, CD, G, AG and D  
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Characterization of subgenomic regions - Continued 
Publication Number of samples Method of Subtyping Region of Genome Subtypes 
Scriba et al, 2002 14 Samples Phylogenetics 5' LTR, nef, tat and rev All subtype C 
Subtype C (n = 71) Gordon et al, 2003 72 Samples Phylogenetics pol and env C2V5 
CD Recombinants (n = 1) 
Bessong et al, 2005 42 Samples HMA & sequencing gag & env All Subtype C 
Bell et al, 2007 20 Samples Phylogenetics vif, vpr & vpu All subtype C 
Subtype C (n = 48) Jacobs et al, 2008a 50 Samples Phylogenetics vif 
Subtype B (n = 2) 
Subtype C (n = 133) 
Subtype B (n = 5) 
CRF02_AG (n = 1) 
Jacobs et al, 2008b 140 
Samples 
Phylogenetics pol sequences 
Subtype G (n = 1) 
Subtype C (n = 341) 
Subtype B (n = 36) 
Subtype A (n = 7) 
Subtype D (n = 3) 
Jacobs et al, submitted 410 
Samples 
Serology (cPEIA) and 
Phylogenetics 
V3 region of env 
Several Recombinants 
Key: n (number) 
Table 1.3: Published data of near-full length HIV-1 sequences from South Africa.  
Full length-genome characterization 
Publication Number of samples Method of Subtyping Subtypes 
van Harmelen et al, 2001 4 Samples Sequencing and Phylogenetics Subtype C (n = 4) 
Subtype C (n = 2) 
A2C Recombinant (n = 1) 
Papathanasopoulos et al, 2002 
4 Samples 
Sequencing and Phylogenetics 
ACDGK Recombinant (n = 1) 
zur Megede et al, 2002 3 Samples Sequencing and Phylogenetics All subtype C 
Papathanasopoulos et al, 2003b 2 Samples Sequencing and Phylogenetics All subtype C 
Hunt et al, 2003 3 Samples Sequencing and Phylogenetics All subtype C 
Loxton et al, 2005 4 Samples Sequencing and Phylogenetics All subtype D 
Subtype C (n = 241) 
Subtype B (n = 1) 
Rousseau et al, 2006 
244 Samples 
Sequencing and Phylogenetics 
CA Recombinants (n = 2) 
Jacobs et al, 2007 1 Sample Sequencing and Phylogenetics Subtype D (n = 1) 
Key: n (number) 
1.4 Diversity within the HIV – 2 genome 
Since the discovery of HIV-2 in Western Africa in the mid-1980’s a great deal 
has been learned about the epidemiology, spread and pathogenesis of the 
virus [Markovitz, 1993]. Unlike HIV-1, HIV-2 has not spread all over the world, 
but is mostly confined to areas of West Africa. Analyses of HIV-2 have 
revealed the existence of five major lineages within the cluster, which are 
termed HIV-2 groups A – E [Gao et al, 1994; Hasegawa et al, 1989].   
1.5 Methods used in the phylogenetic analysis of HIV 
Phylogenetics is the science of estimating the evolutionary relationship, which 
is based on the comparison of DNA or protein sequences with the phylogeny 
ultimately depicted in the form of an evolutionary tree [Graur and Li, 1999; 
Salemi and Vandamme, 2003]. The use of trees to depict such hypotheses 
goes back to the start of the field of evolution in Charles Darwin’s days. It is 
only until recently that methods have been developed to numerically calculate 
trees through quantitative methods. In the modern age of rapid gene 
sequencing, digitization of sequences and creation of sequence databases, 
molecular phylogeny has become a powerful tool for making sense of these 
vast amounts of data.  
Before one can start with phylogenetic analysis of data, one needs to 
generate DNA sequence data. These procedures include the designing and 
testing of primers, the amplification of target genes or genomes, and the 
sequencing of amplified products [McCormack and Clewley, 2002]. These 
processes include a wide range of procedures and technical expertise on its 
own. The following section will take a look at some of the methods commonly 
used in modern phylogenetic analysis.    
 1.5.1 Searching for homologous sequences  
The ultimate goal of phylogenetic analysis is to compare the evolutionary 
relationship between new sequences and other known sequences. One of the 
first things to do before starting analysis of data is to obtain homologous 
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sequences. Today most genetic data, either in nucleic acid or amino acid 
formats, is stored in online accessible sequence databases with the three 
largest of these being; EMBL (European Molecular Biology Laboratory), 
GenBank (at NCBI), and the DDBJ (DNA Data Bank of Japan) [Salemi and 
Vandamme, 2003]. The BLAST (Basic Local Alignment Search Tool) is the 
most widely used method in modern molecular evolutionary biology to search 
for homologous sequences and can be performed on most of the genetic 
databases [Altschul et al, 1990]. Some databases were developed for specific 
uses such as the LANL (Los Alamos National Laboratory, Los Alamos, New 
Mexico, USA) which only contains HIV and SIV related sequences 
[http://www.hiv.lanl.gov/].  
The HIV sequence database at Los Alamos was created in 1986 under the 
guidance of the AIDS Program of the US National Institute of Allergy and 
Infectious Diseases (NIAID) in association with the US Department of Energy 
(DOE) [Rodrigo and Learn, 2000]. It is a specialized molecular-sequence 
database that provides a wide range of services, free of charge to the global 
HIV research community. The HIV database, unlike other more general 
genetic databases such as Genbank, contains only sequences that relate to 
primate lentiviruses and a few primate genes and proteins that interact with 
HIV. Any data in the database is shared with the general databases, so that 
all the data also appears in the GenBank, EMBL, and DDBJ databases [Learn 
et al, 1996]. The HIV database also contains useful tools for working with 
sequences. One can search the database of sequences in a number ways: by 
genome region, country of origin, subtype, viral phenotype, year of sampling, 
similarity to a given sequence (BLAST) and health of patients (with respect to 
ARV therapies, CD4 counts and several other factors) [Holmes, 2000]. The 
database also contains several pre-built sequence alignments of nucleotides 
or amino acids of partial fragments or complete genomes. Other tools include 
the jpHMM (for subtype and recombinant identification) [Zhang et al, 2006; 
Schultz et al, 2006], sequence locator (useful for assigning a DNA fragment to 
a particular region of the HIV genome relative to HXB2) 
[http://www.hiv.lanl.gov/], RIP or Recombinant Identification Program (for 
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recombinant virus identification) [Siepel et al, 1995] and gene cutter 
[http://www.hiv.lanl.gov/]. 
 1.5.2 Aligning homologous sequences 
Before phylogenetic trees can be draw one must first construct a multiple 
alignment containing the sequences of interest with homologous sequences 
that were obtained from a specific sequence database [Hogeweg and Hesper, 
1984]. Accurate alignment of sequences is extremely important in the analysis 
of datasets. Only homologous sequences can be aligned with one another. 
Homologous sequences are any two sequences that share a common recent 
ancestor. One should distinguish between sequence similarity and sequence 
homology. Any sequences have some measurable similarity, but homology 
implies that this similarity is the result of a share common recent ancestor 
[Abecasis et al, 2007].  
The most common method of constructing multiple alignments is by 
progressive alignment such as Clustal W or Clustal X [Salemi and 
Vandamme, 2003]. When a multiple alignment can be used to construct a 
phylogenetic tree then the converse is also true. With progressive alignment 
methods sequences are aligned in pairs to create a distance matrix based on 
their alignment scores. These scores are then downweighted according to 
how closely related the sequences are. This distance matrix is used to 
construct a Neighbor Joining (NJ) guide tree. The guide tree is used to cluster 
the sequences during the stepwise alignment, with the isolates that were 
clustered closest together being aligned with one another first. For further 
alignment these two sequences are treated as one with other sequences 
being aligned to them one by one. Clustal W [Thompson et al, 1994] and 
Clustal X [Thompson et al, 1997] are the most widely used programs for 
carrying out multiple alignments. These two programs are identical in terms of 
alignment methods, but Clustal W offers a simple text-based interface 
whereas Clustal X has a more graphical interface which might be more user 
friendly [Salemi and Vandamme, 2003]. Before proceeding with further 
analysis one should always manually check the alignment with a sequence 
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editing program such as BioEdit [Hall, 2001]. Often one can easily improve the 
alignment and in some cases it might be required to delete blocks containing 
gaps [Abecasis et al, 2007].  
 1.5.3 Choosing a model of evolution 
Genetic sequences are not very informative regarding their evolutionary 
history. When we compare homologous sites in sequences, we only observe 
that the sequences are the same or different [Page and Holmes, 1998]. 
Evolution is caused by mutations which spread through populations by genetic 
drift or natural selection. These mutations can be caused by a number of 
events such as nucleotide substitutions, insertions, deletions or recombination 
events [Graur and Li, 1999]. Phylogenetic analysis makes certain 
assumptions about the process and rate of DNA substitutions or amino acid 
replacements in the model of evolution they employ [Salemi and Vandamme, 
2003]. Point mutations can either by be due to transitions, when a purine 
nucleic base (A, G) replaces another purine base or a pyrimidine base (C, T) 
replaces another pyrimidine base, or transversions, when a purine is replaced 
by a pyrimidine base or vice versa [Graur and Li, 1999].  
To study the dynamics of these changes in the sequences, one needs to use 
mathematical models that take into account different rates of nucleotide 
substitution. To date, a vast array of these models has been developed over 
the years by scientists [Li, 1997; Graur and Li, 1999; Salemi and Vandamme, 
2003]. The first of these models, the Jukes and Cantor method, was 
developed as far back as the late 1960’s [Jukes and Cantor, 1969]. The three 
most commonly used methods for the analysis of HIV datasets are the Kimura 
two-parameter model [Kimura, 1980]; the Hasegawa, Kishino, Yano (HKY) 
method [Hasegawa et al, 1985] and the General time-reversible (GTR) model 
[Rodriguez et al, 1990; Yang et al, 1994].    
In most cases, as for HIV, the number of transitions is often higher than the 
rate of transversions. In 1980, Kimura developed an algorithm for estimating 
the number of nucleotide substitutions per site, which took into account the 
higher probability of transitional change [Kimura, 1980]. The model assumes a 
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total rate of nucleotide substitution of: α + 2β, where rate of transitions per site 
is α and the rate of transversions is β. At any particular site the nucleotide 
base can undergo three possible changes, one being a transition and the 
other two being transversions [Li, 1997].  
The Hasegawa, Kishino, Yano (HKY) model was first described in 1985 by 
Hasegawa and co-workers [Hasegawa et al, 1985]. As in the case of the 
Kimura 2-parameter model, the HKY-model also allows for a 
transition/transversion bias, but unlike the Kimura 2-parameter model that 
estimates equal base frequencies, the HKY-model allows base frequencies to 
vary. Theoretically in a given sequence each nucleotide base (Adenine, 
Cytosine, Guanine, or Thymine) has an equal probability (0.25) of appearing, 
however it often does not hold true. Some organisms have a higher 
composition of guanine and cytosine which makes their DNA much more 
thermodynamically stable due to the higher concentration of triple hydrogen 
bonds in the DNA molecules. Thus it is clear when working with sequences 
that the use of a model which allows for base frequencies to vary would be 
much more useful and accurate than other models that do not allow for this 
[Page and Holmes, 1998].  
The GTR or general time-reversible model is the most general, unbiased, 
independent, finite-sites, time-reversible model possible, and was first 
described in 1986 by Simon Tavaré [Tavaré, 1986]. The probability matrix of 
the GTR-model has six parameters so that each possible substitution has its 
own probability [Page and Holmes, 1998]. Thus this model allows not only for 
different base frequencies, but also for different rates for all six substitutions. 
For a time-reversible model, there is no assumption that substitutions 
preferentially change in a certain direction over time. 
 1.5.4 Drawing phylogenetic trees 
A phylogenetic tree, much like a real tree, is made up of branches and nodes. 
The branches are connected to the nodes and the nodes are the point of 
branch divergence. Nodes can also be internal or external. External nodes 
represent the sequences from which the tree was constructed or operational 
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taxonomic units (OUT’s) whereas the internal nodes represent a common 
ancestor between two or more taxa (Figure 1.10). 
Phylogenetic trees are usually drawn so that the branch lengths correspond to 
the amount of evolution between the two nodes they connect and such trees 
are termed additive trees. That means the longer the branches, the more 
divergent the sequences are. At the base of a phylogenetic tree is normally a 
root, which represents the oldest common ancestor of all the sequences in the 
tree [Hall, 2004]. Trees are rooted by using outgroups or an external point of 
reference. An outgroup may be anything that is not a natural member of the 
sequences or group of interest [Baldauf 2003; Salemi and Vandamme 2003].  
Two main methods of calculating phylogenetic trees exist today: the distance-
matrix method, also known as clustering or the algorithmic method (e.g. 
UPGMA, neighbor-joining, or Fitch - Margoliash) and the discrete data method 
which is also known as the tree searching method (e.g. parsimony, maximum 
likelihood, or the Bayesian method) [Baldauf 2003].  
The distance method is extremely easy and fast to use, but does not involve 
an evolutionary model. The distance (or percentage sequence difference 
calculated by pairing up two sequences in a matrix), is calculated for all 
pairwise combinations of all OTU’s and then the distances are assembled into 
a tree [Baldauf 2003]. Thus sequences with the closest distances are grouped 
close together on the representative tree. The UPGMA or Unweighted Pair 
Group Method with Armetric Means, searches for the smallest value in the 
pairwise distance matrix to construct a phylogenetic tree [Sneath and Sokal, 
1973] The neighbor-joining method sequentially finds its closest neighbors 
based on the internal branch lengths of the tree [Saitou and Nei, 1987], and 
the Fitch-Margoliash method evaluates all possible trees to find the one with 
the shortest overall branch lengths [Fitch and Margoliash, 1967].  
The discrete data method, such as the maximum parsimony, maximum 
likelihood and Bayesian methods, examines each column of the multiple 
alignments separately and then searches for the tree that best accommodates 
all of this information. Discrete data analyses are rich in information because it 
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creates a hypothesis for every column in the alignment and one can thus trace 
the evolution at a specific site in a DNA molecule (e.g. regulatory regions) 
[Baldauf 2003].  
 
Figure 1.10: A simplistic representation of a phylogenetic tree. The tree indicates 
the root, branches, and nodes of the tree. A clade of are shown as well as a taxon (OTU) 
[Adapted from: http://www.talkorigins.org/]. 
The maximum parsimony and maximum likelihood methods use the theory of 
stepwise addition and branch swapping to search for the most representative 
phylogenetic tree. Through stepwise addition, branches are added in 
succession at different levels on the tree. Each level is then evaluated and the 
best tree is chosen before the addition of the next branch. Branch swapping 
techniques allow for the pre-defined rearrangement of the branches. The most 
common branch swapping techniques are tree bisection and reconstruction; 
nearest-neighbour interchange; and subtree pruning and regrafting [Salemi 
and Vandamme, 2003]. Maximum parsimony and maximum likelihood can 
both be performed with the PHYLIP software package [Felsenstein, 1982]. 
Baysian analysis is very much like that of maximum likelihood [Mau et al, 
1999; Rannala and Yang, 1996]. Instead of seeking the tree that maximizes 
the likelihood of observing data, Bayesian analysis seeks those trees with the 
greatest likelihood of the given data. Baysian models search for the best tree 
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which is consistent with both the evolutionary model of choice and the data in 
an alignment. Baysian analysis of datasets is the most commonly used 
method today, with new software, such as BEAST (Bayesian Evolutionary 
Analysis Sampling Trees) [Drummond and Rambaut, 2007].  
 1.5.5 Detection of recombinant viruses 
Recombination within viral genomes, and especially within HIV’s genome, is 
extremely common. Recombination within the HIV genome occurs when an 
individual is co-infected with multiple strains of the virus. To date, several 
methods have been developed for the identification of recombinant viruses. In 
some cases one can characterize several small subgenomic regions 
throughout the viral genome [Swanson et al, 2003]. This method, though 
widely used does have some drawbacks. One can miss small regions of 
recombination in-between the regions that were characterized. Recent 
advances in the field of viral DNA or RNA amplification (Figure 1.11), which 
makes the amplification of large fragments (6 – 36 kbp) possible, has made 
the identification of viral recombinants much easier [Salminen et al, 1995a; 
Nadai et al, 2008].  
 
The importance of full genome characterization of samples has been 
described on several occasions in the past [Choi et al, 1997; Carr et al, 1996; 
Gao et al, 1996]. To successfully identify viral recombinants there must be 
enough genetic variation between the different lineages of the particular virus 
in order to confirm that genetic exchange has occurred. The basic strategy of 
recombination identification is to construct a multiple alignment containing the 
query sequence and several different isolates from the different lineages. 
When these alignments of full or near full-length genome sequences are 
analyzed with the use of software packages such as; Simplot (Similarity Plot) 
[Lole et al, 1999; Salminen et al, 1995b], RIP (Recombination Identification 
Program) [Siepel et al, 1995], or RDP3 (Recombination Detection Program) 





Figure 1.11: A graphical representation of a full-length amplification assay, for 
the characterization of a near full-length HIV-1 genome. Viral RNA is reverse 
transcribed into cDNA. PCR’s are then performed in four overlapping fragments to amplify a 
near full-length genome of the virus. The methodology that was used here was developed as 
a standard protocol for the characterization of near full-length HIV-1 genomes from RNA 
[Nadai et al, 2008]. 
Simplot uses a sliding window approach moving across a multiple alignment 
in small increment steps to generate a similarity plot [Lole et al, 1999; 
Salminen et al, 1995b]. The program allows the user to query any sequence 
within the alignment and adjust the window and step sizes. The program is 
based on the Kimura 2-parameter substitution model. The recombination 
identification program (RIP) is one of the many online tools which are 
accessible from the LANL database [http://www.hiv.lanl.gov/; Siepel et al, 
1995]. The program gives the user the opportunity to compare the query 
sequence against their own alignment or the pre-made alignment of the 
program itself. The pre-made alignment consists of several isolates from the 
most prominent viral subtypes (A1, B, C, D, F1, F2, G, H and CRF01_AE). 
Other subtypes such as A2, J and K are only represented by a single 
sequence in the alignment. The large size of the pre-made alignment makes 
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the identification of recombination events much easier. The program also 
allows the user to define the appropriate window size. It further allows for the 
simplifying of the results, with the use of the rerun application, and exports the 
graphs in a convenient manner [http://www.hiv.lanl.gov/]. 
AIM OF THE STUDY 
The large variety of subtypes, sub-subtypes and circulating recombinant forms 
of HIV-1 complicates the development of effective vaccination strategies and 
has major implications for diagnostic assays and the effective treatment of 
infected people with anti-retroviral drugs. It is thus of the utmost importance 
that we continue monitoring the epidemiology of the HIV-1 epidemic. To date 
very few papers have been published on near full-length non-subtype C HIV 
type 1 viruses in South Africa [Papathanasopoulos et al, 2001; Loxton et al, 
2005]. This study was aimed at characterizing non-subtype C HIV type 1 
viruses from Cape Town, South Africa. This will greatly enrich our knowledge 
of other viral subtypes that are becoming more and more important in the 
South African setting.  
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CHAPTER TWO – MATERIALS AND METHODS 
The experimental procedures used in this study are illustrated in this chapter. 
The materials and sampling methodology used will be described, followed by 
the experimental procedures used for the characterization of subgenomic and 
near full-length sequences (Figure 2.1). 
Subtyping of subgenomic 
regions and tree construction 
 
Experimental Methodology
Tygerberg Virology Databank 
(400 V3 sequences) 
12 Samples were chosen [11 
non-subtype C and 1 subtype C 
isolate] 
Four samples were chosen for 
near full-length characterization 
Amplification and sequencing (ABI 
3130xl automated DNA sequencer) of 
near-full length genomes  
Phylogenetic analysis of near full-
length sequences Amplification and sequencing of 
gag p24, pol-integrase and env 
gp41 regions 
- Subtyping 
- Tree construction 
- Recombination identification 
- Analysis of non recombinant 
isolates 
 
Figure 2.1: A flow diagram summarizing the methodology used in the study. 
Briefly, twelve samples were selected based on previous data that was 
generated within the department. Subgenomic regions of these 12 samples 
were amplified and directly sequenced. HIV subtyping and phylogenetic 
analysis was then performed on the sequenced data. From the data that was 
gathered, four samples were chosen for full or near full-length genomic 
characterization. After amplification and sequencing the sequenced data were 
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analyzed with the use of phylogenetic methods, such as tree construction, 
subtyping, and recombination identification.  
2.1 Reagents and equipment used in the study 
All the materials and equipment that were used for the characterization of 
samples are described. A brief summary of all the equipment that was used 
are summarized in Table 2.1. The symbols ® and TM indicate that the particular 
product are either a registered trademark or trademark of the suppliers.  
Table 2.1: Equipment used to perform sample analysis. 
Equipment Supplier Location 
Eppendorf Centrifuge 5417C Eppendorf Hamburg, Germany  
Eppendorf Centrifuge 5415D Eppendorf Hamburg, Germany  
GeneAMP® 9700 PCR system  Applied BioSystems California, USA 
Hoefer EPS 2 A 200, Power Pack Pharmacla Biotechnologies San Francisco, CA, USA  
NanodropTM ND 1000 Nanodrop Technologies Inc. Delaware, USA 
SyngeneTM GeneGenius Computer System Synoptics Ltd. Cambridge, UK  
Vortex Mixer VM 300 Gemmy Industrial Corp. Taipei, Taiwan  
ABI 3130 xl Automated DNA sequencer Applied BioSystems California, USA 
 
The chemicals and commercial products used in the study, and the various 
software packages used for sequence analysis are summarized in Tables 2.2 











Table 2.2: List of chemicals and commercial products used in the study. 
Product Company Location Catalogue Number 
Big Dye® Terminator v 3.1 Cycle 
Sequencing Kit Applied BioSystems Foster City, CA, USA  0 211 005 
Half Dye Mix Bioline London, UK  BIO-36026 
GoTaq® DNA Polymerase  Promega Madison, WI, USA  M 8305 
Expand dNTP pack Roche Diagnostics Mannheim, Germany  11 681 834 001 
Wizard SV Gel & PCR Clean-up kit Promega Madison, WI, USA  A 9281 
dNTP's Roche Diagnostics Mannheim, Germany  11 636 103 001 
Ethidium bromide Promega Madison, WI, USA  H 5041 
Nuclease Free Water Promega Madison, WI, USA  P 1193 
Molecular grade Agarose Whitehead Scientific (Pty) Ltd. Brackenfell, Cape Town, RSA # D1 - LE 
I kbp DNA Bench Top Ladder Promega Madison, WI, USA  G7541 
Blue/Orange Loading Dye Promega Madison, WI, USA  G1881 
PCR Product Pre-Sequencing Kit USB Corporation Cleveland, Ohio, USA   70995 
 Table 2.3: Software packages used in the analysis of sequenced data.  
Software package Reference / Licensed Company 
Sequencher 4.8 Gene Codes Corporation, Ann Arbor, MI, USA 
Sequence Scanner v 1.0 Applied Biosystems, Foster City, CA, USA  
Clustal X Thompson© et al, 1997 
DNAMAN v 4.0 Lynnon BioSoft© 1994 – 1997 
BioEdit v 5.0.9 Hall©, 2001 
Tree view 1.6.6 Page©, 2001 
MEGA v 4.1 Tamura et al, 2007 
Simplot v 3.5.1 Stuart C Ray, Copyright© 1997 - 2003 
PAUP* 4.0b10 Swofford, 2002 
PhyML 3.0 Guindon and Gascuel, 2003 
Geneious 4 Biomatters Ltd., Auckland, New Zealand 
FigTree v 1.1.2 Rambaut A, Institute of Evolutionary Biology, University of Edinburgh 
2.2 Patient samples 
From the data of a previous study that was done within the department, that 
characterized the V3 region of 410 samples [Jacobs et al, submitted], 11 
samples were chosen. The study identified 36 out of 410 samples (8.8%) as 
non-subtype C HIV-1 isolates but due to the limited amount of DNA available 
only 12 samples were chosen for further characterization. Ten of these 
samples were suspected to be non-subtype C HIV-1. The other sample was a 
known subtype C viral isolate, which was included for control purposes. A 
known subtype B isolate which was isolated from a homosexual male in the 
mid 1980’s was also included for control purposes. A brief summary of the 
patient information are listed in Table 2.4.   
 
Table 2.4: Patient samples and demographics. 









R 84 Caucasian male ND SA Asymptomatic NA No 
TV 86 African Male 1965 SA Cryptococcal meningitis 207 No 
TV 101 African Female  1977 SA  Asymptomatic 2,000 No 
TV 218 African Female  1975 SA Asymptomatic NA ND 
TV 239 African Male  1973 SA TB 64 No 
TV 314 African Male 1965 SA Asymptomatic 229 No 
TV 340 African Male 1963 DRC TB abdomen severe thrush 3 No 
TV 412 African Male  1955 Kenya Chronic staph skin sepses 71 No 
TV 441 African Female  1976 SA Asymptomatic 178 Yes 
TV 480 Coloured Female 1968 SA Pheumonia NA No 
TV 515 Coloured Female 1970 SA NA NA No 
TV 546 African Female  1970 SA NA NA ND 
Key: SA (South Africa), DRC (Democratic Republic of the Congo), TV (Tygerberg Virology), 
NA (Not available), TB (Tuberculosis), staph (staphylococcal), and ND (No data) 
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For DNA isolation, EDTA blood was centrifuged at 2,500 x g for 10 min, to 
separate blood plasma and buffy coat cells. The buffy coat cells were then 
used to extract DNA with the use of the QIAamp® DNA Mini Kit (QIAGEN, 
Hilden, Germany), according to manufacturer’s specifications. The DNA was 
eluted in AE buffer and the concentrations were determined with the 
NanodropTM ND 1000 (Nanodrop Technologies Inc., Delaware, USA) 
 
2.3 Amplification and sequencing of partial gag, pol and env 
      fragments 
          2.3.1 PCR amplification of partial gag, pol and env fragments  
PCR’s were performed on the gag p24, pol-integrase and env gp41 regions of 
the 12 samples. All the primers used and other relevant data are summarized 
in Table 2.5. All PCR’s that was used for the amplification of subgenomic 
regions were performed with the GeneAmp PCR System 9700 thermal cycler 
(Applied BioSystems, CA, USA) with GoTaq DNA polymerase (Promega, 
Madison, WI, USA). 
Briefly, the PCR methods and primers were adapted from Swanson et al, 
2003. Both the prenested and nested PCR reactions for the gag, pol and env 
regions contained 0.2mM of dNTP’s, 20 µM of each primer, 1.5 mM of MgCl2, 
and 1U of Taq polymerase in a total volume of 50 µl. The following cycling 
conditions were used for both the gag, pol and env PCR’s: One cycle of 
denaturation at 94oC for 2 minutes; followed by 40 cycles of: denaturing at 
94oC for 30 seconds, primer annealing for 30 seconds (Table 2.5), and 
elongation at 68oC for 1 minute; one final step of elongation at 68oC for 10 
minutes and afterwards the samples were cooled down to 4oC until the PCR 
tubes were removed and stored at 4oC. Two and a half micro liters of the 





2.3.2 Gel electrophoresis and sample clean-up of PCR  
         fragments 
PCR products of the gag p24, pol-integrase and env gp41 PCR’s were run on 
0.8% agarose gels (10 cm long) at 50 Volts for 45 minutes in TAE buffer (0.04 
M TRIS-acetate & 0.001 M EDTA). After the samples migrated through the 
gels, the gels were stained with Ethidium Bromide (0.5µg/ml) and exposed to 
UV light and photographs were taken.  
Samples were then cleaned up with the use of the PCR Product Pre-
Sequencing Kit (USB Corporation, Cleveland, Ohio, USA). The kit uses two 
enzymes, Exonuclease I, which is responsible for removing any residual 
single-stranded primers or any other extraneous single-stranded DNA, and 
Shrimp Alkaline Phosphatase, which is responsible for the removing of any 
remaining dNTP’s. The two enzymes were added to 8 µl of amplified product 
and incubated at 37oC for 15 minutes. Samples were then heated at 80oC for 
15 min to inactivate the enzymes.  
The concentrations of the cleaned up DNA products were determined with the 
NanodropTM ND 1000 (Nanodrop Technologies Inc., Delaware, USA).   
Table 2.5: List of different primers used in the amplification of the gag (p24), pol-integrase and the env (gp41) fragments. 
 Primers Oligonucleotide sequences TA (
oC) HXB2 Position F/R [MgCl2] Size 
p24-1 AGYCAAAATTAYCCYATAGT 45 1174 - 1194 F 1.5 mM 
PN gag p24 
p24-7 CCCTGRCATGCTGTCATCA 45 1844 - 1826 R 1.5 mM 
671 bp 
p24-2 AGRACYTTRAAYGCATGGGT 50 1237 - 1256 F 1.5 mM 
N gag p24 
p24-6 TGTGWAGCTTGYTCRGCTC 50 1721 - 1703 R 1.5 mM 
485 bp 
poli 5 CACACAAAGGRATTGGAGGAAATG 50 4162 - 4185 F 1.5 mM 
PN pol-IN 
poli 8 TAGTGGGATGTGTACTTCTGAAC 50 5217 - 5195 R 1.5 mM 
1056 
bp 
poli 6 ATACATATGRTGTTTTACTAARCT 45 5130 - 5107 R 1.5 mM 
N pol-IN 
poli 7 AACAAGTAGATAAATTAGTCAGT 45 4186 - 4208 F 1.5 mM 
945 bp 
JH38 GGTGARTATCCCTKCCTAAC 50 8365 - 8346 R 1.5 mM 
PN env gp41 
JH41 TTATATAATTCACTTCTCCAATT 50 7775 - 7797 F 1.5 mM 
568 bp 
env 27F CTGGYATAGTGCARCARCA 45 7861 - 7879 F 1.5 mM 
N env gp41 
Menv 19R AARCCTCCTACTATCATTATRA 45 8299 - 8278 R 1.5 mM 
439 bp 
Key: PN (Prenested PCR), N (Nested PCR), TA (annealing temperature), F (Forward primer), R (Reverse primer), oC (degrees Celsius), bp (base pairs), IN 
(Integrase), and mM (millimoles per liter) 
2.3.3 Sequencing of partial gag, pol and env PCR fragments 
Amplified gag p24, pol-integrase and env gp41 fragments were all directly 
sequenced with the use of the primers listed in Table 2.6. All primers were 
described by Swanson et al, 2003 except for primer FGF 46 [Fong et al, 
1996]. Samples TV101 and TV218 have already been characterized and was 
not sequenced with the other samples [Personal Communication, S 
Engelbrecht]. The BigDyeTM Terminator cycle sequencing ready reaction kit 
(Applied Biosystems, Foster City, California, USA) was used for the 
sequencing reactions.   
Every sequencing reaction contained: approximately 50 ng of the purified 
PCR product, 5 pmol of sequencing primer, 1.3 µl of Big Dye terminator 
enzyme mix, and 2.7 µl of Half Dye (Bioline, London, United Kingdom). 
Nuclease free water was added to the reaction mix to give a final volume of 10 
µl. Each sequencing reaction was performed under the following conditions: 
25 cycles of denaturation at 96oC for 10 seconds, primer annealing for 5 
seconds and an elongation step at 60oC for 4 minutes. Afterwards the 
samples were cooled down to 4oC and sent to the Central Analytical Facility of 
the University of Stellenbosch where they could be cleaned-up and run on the 
ABI 3130xl automated DNA sequencer. 
The trace data files were received from the Central Analytical Facility and 
were imported into Sequencer 4.7 (Gene Codes Corporation, Ann Arbor., 
Michigan, USA) and assembled into contiguous fragments. After the 
assembled fragments were proofread they were exported in a text file (.txt) 
and labeled for later use.    
Table 2.6: List of different sequencing primers for the gag p24, pol-integrase and the env gp41 fragments.  
gag p24 Sequences 
Primer Oligo nucleotide sequence Bases F / R HXB2  Position TA (oC) 
p24-2 AGRACYTTRAAYGCATGGGT 20 F 1237 - 1257 50 
p24-6 TGTGWAGCTTGYTCRGCTC 19 R 1703 - 1721 50 
pol-integrase Sequences 
Primer Oligo nucleotide sequence Bases F / R HXB2  Position TA (oC) 
poli7 AACAAGTAGATAAATTAGTCAGT 23 F 4186 - 4209 45 
FGF-46 GCATTCCCTACAATCCCCAAAG 22 F 4648 - 4670 55 
poli10b TATTCATAGATTCYACTACTCCTTG 25 R 4695 - 4670 45 
poli6 ATACATATGRTGTTTTACTAARCT 24 R 5130 - 5106 45 
env gp41 Sequences 
Primer Oligo nucleotide sequence Bases F / R HXB2  Position TA (oC) 
env 27 F CTGGYATAGTGCARCARCA 19 F 7861 - 7880 50 
Menv19R AARCCTCCTACTATCATTATRA 22 R 8299 - 8277 45 
Key: TA (annealing temperature), F (Forward primer), R (Reverse Primer), and oC (degrees Celsius)  
2.4 HIV-1 subtyping of partial gag, pol and env sequences using  
      REGA and jpHMM online tools 
HIV subtyping was performed on all the sequenced samples to establish the 
genomic variation of our cohort of 12 samples. Two different online subtyping 
tools were used for this purpose: the REGA subtyping tool 
(http://www.bioafrica.net/virus-genotype/html/subtyping.html) and the jumping 
profile Hidden Markov Model or jpHMM (http://jphmm.gobics.de/) which is also 
accessible form the LANL webpage (http://www.hiv.lanl.gov/). The REGA 
subtyping tool is an easy online method of subtyping full-length or subgenomic 
fragments by combining different phylogenetic analytical approaches with 
bootscanning methods [de Oliveira et al, 2005].  
The jpHMM method uses a jumping alignment approach, first proposed by 
Spang and co-workers [Spang et al, 2002], for the subtyping of sequence 
fragments or the identification of recombinant viruses. Instead of a query 
sequence (X) being compared with a multiple alignment (Y), the query 
sequence (X) is compared and aligned to individual sequences from the 
alignment. In the case of recombination events the query sequence (X) can 
then jump between different sequences of the multiple alignment as a sliding 
window moves over the alignment. This approach also makes the 
identification of particular breakpoint within a recombinant isolate much easier 
[Schultz et al, 2006; Zhang et al, 2006]. 
2.5 Multiple alignments of the partial gag, pol and env sequences 
Before multiple alignments could be constructed, reference sequences were 
obtained from the LANL database (http://www.hiv.lanl.gov/). For the alignment 
of gag p24 fragments, sequences of 485 bp and stretching from 1237 – 1721 
(relative to HXB2) were obtained. Reference sequences corresponding to the 
same length and location of the pol-integrase and env gp41 PCR fragments, 
stretching from 4186 – 5130 (944 bp) and 7861 – 8299 (438 bp) relative to 
HXB2 respectively, were acquired. After the reference sequences were 
obtained multiple alignments were constructed with the use of Clustal X v 1.81 
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[Thompson© et al, 1997]. All alignments were manually checked and 
improved, where possible, with BioEdit v 5.09 [Hall©, 2001].  
The isolate N.CM.95.YBF30.AJ006022 was included as an outgroup in the 
alignments. Every name in the LANL database is specifically classified and 
annotated. For example in strain N.CM.95.YBF30.AJ006022, the N stands 
for Group N, CM the country of origin (Cameroon), 95 the year the sample was 
collected (1995), YBF30 is the name of the virus strain and AJ006022 is the 
GenBank Accession number.   
2.6 Construction of NJ phylogenetic trees using MEGA 
After the alignments were done and manually inspected, Neighbor-Joining 
phylogenetic trees were constructed. Adjusted multiple alignment files were 
imported into MEGA v 4.1 [Tamura et al, 2007] where the alignment files (.aln 
or .pir) were converted into MEGA format (.meg). The MEGA files (.meg) were 
then opened in MEGA and NJ-trees [Saitou and Nei, 1987] were constructed 
with the use of the Kimura 2 parameter method of nucleotide substitution 
[Kimura, 1980]. Bootstrap analysis [Felsenstein, 1985] was also performed on 
the trees to confer statistical significance, with a total of a 1,000 bootstrap 
replicates for each dataset. 
2.7 Amplification and sequencing of NFLG’s from 4 samples 
After data analysis of the gag pol and env regions, full- or near full-length 
genome characterization of four of the twelve samples (R84, TV239, TV314 
and TV412) were attempted. The entire genomes of the four different samples 
were first amplified in a single amplification assay to obtain 9.2 kbp products.  
2.7.1 PCR amplification of the 9.2 kbp HIV-1 genome 
Briefly, a prenested and nested PCR were carried out with the Expand long 
range dNTP pack (Roche Diagnostics, Mannheim, Germany) to obtain near-
full length genome amplification of HIV samples (Figure 2.2).  
 
Figure 2.2: Schematic diagrams of the full genome amplification of an HIV isolate using a long PCR amplification assay.  The 







Nested PCR                   F: Up1A [634 - 650]                                                                                R: Low 2 [506 – 527] 
Prenested PCR               F: MSF 12 [623 - 649]                                                                         R: MSR 5 [521 - 547]     
HXB2 
Each PCR reaction contained 0.2mM of dNTP’s, 20 µM of each primer, 12 % 
DMSO solution and 5U of DNA polymerase in a total volume of 50 µl. The 
buffer that was used already contained MgCl2. The rest of the volume was 
made up to 50 µl with nuclease free water (Promega, Madison, WI, USA). 
The following cycling conditions were used for the prenested and nested 
amplification assays: one cycle of denaturation at 92oC for 2 minutes; followed 
by 10 cycles of denaturation at 92oC for 10 seconds, primer annealing for 30 
seconds (Table 2.7), and elongation at 68oC for 10 minutes; which was 
followed by 30 cycles of; denaturation at 92oC for 10 seconds, primer 
annealing for 30 seconds, and elongation at 68oC for 10 minutes plus 20 
seconds for each consecutive cycle, final elongation at 68oC for 10 minutes 
and afterwards the samples were cooled down to 4oC until the PCR reactions 
were collected.  Five micro liters of the prenested product were carried over to 
the nested reaction.  
Table 2.7: Primers that were used for the amplification of 9.2 kbp fragments. 
Full genome Primers 
  
Primer  Oligo nucleotide sequence F / R HXB2 Position TA (oC) Size 
MSF12A AAATCTCTAGCAGTGGCGCCCCGAACAG F 623 - 649 55 
PN 
MSR5A GCACTCAAGGCAAGCTTTATTGAGGCT R 9797- 9823 55 
9.17  
kbp 
UP1AB AGTGGCGCCCGAACAGG F 634 - 650 60 
N 
LOW2B TGAGGCTTAAGCAGTGGGTTTC R 9706 - 9727 60 
9.09 
kbp 
Key: PN (Prenested PCR), N (Nested PCR), F (Forward primer), R (Reverse primer), oC 
(degrees Celsius), and kbp (kilo base pairs) [A Rodenburg et al, 2001; B Mwaengo and 
Novembre, 1998].  
The following cycling conditions were used for the prenested and nested 
amplification assays: one cycle of denaturation at 92oC for 2 minutes; followed 
by 10 cycles of denaturation at 92oC for 10 seconds, primer annealing for 30 
seconds (Table 2.7), and elongation at 68oC for 10 minutes; which was 
followed by 30 cycles of; denaturation at 92oC for 10 seconds, primer 
annealing for 30 seconds, and elongation at 68oC for 10 minutes plus 20 
seconds for each consecutive cycle, final elongation at 68oC for 10 minutes 
and afterwards the samples were cooled down to 4oC until the PCR reactions 
 66
were collected.  Five micro liters of the prenested product were carried over to 
the nested reaction.  
2.7.2 Amplification of the HIV genome in four overlapping   
         fragments 
The original proviral DNA was then used for the amplification of a near-full 
length genome consisting of four overlapping PCR fragments (Figure 2.3) 



















Figure 2.3: Schematic diagrams of the full genome amplification of an HIV 
isolate in four overlapping fragments. The prenested and nested amplifications and 
their approximate location (relative to HXB2) are indicated. All dotted lines indicate prenested 





Prenested LTR – gag     
623 – 1844 
Nested LTR – gag       
634 - 1721 
Nested gag – pol          
1237 – 5130      
Prenested gag – pol       
1174 - 5217 
Prenested pol – env 
4186 - 8299 
Nested pol – env 
8281 – 8222 
Prenested env – LTR  
7964 - 489 
Nested env – LTR  
8010 - 447 
Table 2.8: Primers that were used to PCR the overlapping fragments (LTR-gag, gag-pol, pol-env, and env-LTR). 
LTR-gag Primers 
  
Primer Oligo nucleotide sequence F / R HXB2 Position TA (oC) Size Ref 
MSF12 AAATCTCTAGCAGTGGCGCCCCGAACAG F 623 - 649 52 Rodenburg et al, 2001 
PN 
P24-7 CCCTGRCATGCTGTCATCA R 1826 - 1844 52 
1.21 
kbp Swanson et al, 2003 
UP1A AGTGGCGCCCGAACAGG F 634 - 650 50 Mwaengo and Novembre, 1998 
N 
P24-6 TGTGWAGCTTGYTCRGCTC R 1703 - 1721 50 
1.09 
kbp Swanson et al, 2003 
gag-pol Primers 
  
Primer Oligo nucleotide sequence F / R HXB2 Position TA (oC) Size Ref 
p24-1 AGYCAAAATTAYCCYATAGT F 1174 - 1193 45 
PN 
poli 8 TAGTGGGATGTGTACTTCTGAAC R 5195 - 5217 45 
4.04 
kbp 
p24-2 AGRACYTTRAAYGCATGGGT F 1237 - 1256 50 
N 
poli 6 ATACATATGRTGTTTTACTAARCT R 5107 - 5130 50 
3.89 
kbp 
Swanson et al, 2003 
Key: PN (Prenested PCR), N (Nested PCR), LTR (Long terminal repeat), oC (degrees Celsius), TA (annealing temperature), F (Forward primer), R (Reverse 
primer), Ref (Reference) and kbp (kilo base pairs) 
Table 2.8 continued: Primers that were used to PCR the overlapping fragments (LTR-gag, gag-pol, pol-env, and env-LTR). 
pol-env Primers 
 
Primer Oligo nucleotide sequence F / R HXB2 Position TA (oC) Size Ref 
poli 7 AACAAGTAGATAAATTAGTCAGT F 4186 - 4208 45 
PN 
Menv 19  AARCCTCCTACTATCATTATRA R 8278 - 8299 45 
4.11 
kbp 
PPF17 AATTGGAGAGCAATGGCTAGTGA F 4281 - 4303 50 
N 
LP 7728 CCACTTGTCCAATGCCAATAAGTCTTGT R 8195 - 8222 50 
3.94 
kbp 
Swanson et al, 2003 
env-LTR Primers 
  
Primer Oligo nucleotide sequence F / R HXB2 Position TA (oC) Size Ref 
7496 F CCTKGCYCTGGAAAGATACCTA F 7964 - 7985  52 
PN 
9131R-2 CTCYCAGGCTCARATCTGGTC R 468 - 489  52 
1.70 
kbp 
7542 F TGGGGCTGCTCTGGAAAACT F 8010 - 8029  50 
N 
9110R-2 CAAGAGAGACCCAGTACAG  R 447 - 465  50 
1.64 
kbp 
Personal Communication John 
Hackett 
Key: PN (Prenested PCR), N (Nested PCR), LTR (Long terminal repeat), oC (degrees Celsius), TA (annealing temperature), F (Forward primer), R (Reverse 
primer), Ref (Reference) and kbp (kilo base pairs) 
Table 2.9: PCR cycling condition of the four overlapping fragments. 
Temperatures and Time 

















1 x Template denaturing 94
oC, 2 m  94oC, 2 m  94oC, 2 m 94oC, 2 m 94oC, 2 m 94oC, 2 m 94oC, 2 m 94oC, 2 m 
Template 
denaturing 94
oC , 30 s 94oC , 30 s 94oC , 30 s 94oC , 30 s 94oC , 30 s 94oC , 30 s 94oC , 30 s 94oC , 30 s 
Primer 
Annealing 52
oC, 30 s 51oC, 30 s 45oC, 30 s 45oC, 30 s 45oC, 30 s 50oC, 30s 52oC, 30 s 50oC, 30 s 
40 x 
Elongation 68oC, 90 s 68oC, 90 s 68oC, 4 m 68oC, 4 m 68oC, 4 m 68oC, 4 m 68oC, 2 m 68oC, 2 m 
1 x Final Elongation 68oC, 10 m 68oC, 10 m 68oC, 10 m 68oC, 10 m 68oC, 10 m 68oC, 10 m 68oC, 10 m 68oC, 10 m 
1 x Storing 4oC, Indef 4oC, Indef 4oC, Indef 4oC, Indef 4oC, Indef 4oC, Indef 4oC, Indef 4oC, Indef 
Key: x (times), PCR (polymerase chain reaction),oC (degrees Celsius), m (minutes), s (seconds), and Indef (indefinitely).  
 Each PCR reaction contained 0.2mM of dNTP’s, 20 µM of each primer, 1.5 
mM of MgCl2, and 1U of Taq polymerase in a total volume of 50 µl. Five micro 
liters of the prenested product (ranging between 10 and 50 µg/µl) was carried 
over to each of the nested reaction. Table 2.9 gives a brief summary of the 
cycling conditions that was used.  
2.7.3 Gel electrophoresis and clean-up of NFLG PCR   
         fragments 
PCR products were run on 0.8% agarose gels (10 cm in length) at 50 Volts for 
45 minutes in TAE buffer (0.04 M TRIS-acetate & 0.001 M EDTA). A 1kbp 
molecular marker was run in parallel with all samples. After the samples 
migrated through the gels, the gels were stained with Ethidium Bromide (0.5 
µg/ml) and exposed to UV light before photographs were taken.  
The Wizard SV gel and PCR clean-up kit from Promega, Madison, Wisconsin, 
USA were used to purify the amplified products of any unwanted dNTP’s or 
oligonucleotides. The concentrations of the cleaned up products were 
determined with the NanodropTM ND 1000 (Nanodrop Technologies Inc., 
Delaware, USA) after they were eluted from the spin column.  
2.7.4 Sequencing of NFLG PCR fragments 
The various amplified products were directly sequenced by employing primer 
walking techniques. Appropriate primers were chosen for every 400 – 500 
base pairs in both the forward and reverse directions (John Hackettt, personal 
communication). All the sequencing primers use in the sequencing of each 
isolate is listed in Tables 6.4 – 6.7 in Appendix C, Chapter 6.  
 
The BigDyeTM Terminator cycle sequencing ready reaction kit (Applied 
Biosystems, Foster City, California, USA) was used for the PCR based 
sequencing reactions. Approximately 50 ng of the purified PCR product were 
used with, 5 pmol of sequencing primer, 1.3 µl of Big Dye terminator enzyme 
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mix, and 2.7 µl of Half Dye (Bioline, London, United Kingdom). Nuclease free 
water was added to the mix to give a final volume of 10 µl of reaction mix. 
Each sequencing reaction were performed under the following sequencing 
cycling reaction conditions: 25 cycles of denaturization at 96oC for 10 
seconds, primer annealing for 5 seconds and an elongation step at 60oC for 4 
minutes. Afterwards the samples were cooled down to 4oC and sequenced at 
the Central Analytical Facility at the University of Stellenbosch, as described 
before. After the trace data files were recovered from the Central Analytical 
Facility they were imported into Sequencer 4.7 (Gene Codes Corporation, Ann 
Arbor., Michigan, USA) were they were assembled into contiguous fragments. 
After the assembled fragments were proofread they were exported as text 
files (.txt).  
The contiguous fragments were also analyzed with the use of sequence tools 
such as the Gene Cutter tool of the LANL database [http://www.hiv.lanl.gov/]. 
The Gene Cutter tool [Goldman and Yang, 1994] is an online tool from the Los 
Alamos National Laboratory which can be used to identify the different genes 
within sequences, produce information on the amino acid sequence, and 
identify premature stop codons and sites with multi-state characters. 
Sequences can be submitted in an aligned or unaligned format. 
2.8 Phylogenetic analysis of near full-length genome sequences 
After all sequences were proof-read, quality controlled phylogenetic analysis 
could be conducted. Briefly, the DNA sequence fragments were used to 
perform subtyping to establish viral subtypes and/or recombinants. Multiple 
alignments were constructed and phylogenetic trees were drawn. Bootstrap 
analysis was performed on all trees for statistical purposes. Recombination 
identification was also performed to identify recombination events within 
isolates. Non-recombinant HIV isolates were also compared against samples 




2.8.1 Subtyping with REGA and jpHMM tools  
All the near full-length fragments were submitted to two online subtyping tools; 
the jpHMM (http://jphmm.gobics.de/ which is also accessible at the LANL 
website http://hiv.lanl.gov./) and the REGA subtyping tools 
(http://www.bioafrica.net/virus-genotype/html/subtyping.html). 
2.8.2 Construction of a multiple alignment of NFLG  
         sequences  
Reference sequences were obtained from the LANL database before multiple 
alignments could be constructed. All non-recombinant subtypes of the 
reference set, as well as the most prominent recombinant viruses, were 
included in the datasets that was used for the various alignments. Due to the 
varying length of the different fragments reference sequences ranging from 
1230 - 8700 (relative to the coordinates of the reference strain HXB2) were 
downloaded. Because no contiguous fragment could be obtained for TV239, 
reference sequences in two fragments stretching from 1246 - 5534 and 5908 - 
9106 (relative to the coordinates of the reference strain HXB2) were 
downloaded. The reference strain N.CM.95.YBF30.AJ006022 was included in 
each dataset for the use as an outgroup.  
Multiple alignments were then constructed with the use of Clustal X v 1.81 
[Thompson© et al, 1997]. The three isolates; R84, TV314, and TV412 were all 
aligned in a single alignment. Due to a gap of nearly 660 bp in between the 
two fragments of TV239, a separate alignment was performed for each of 
these fragments. After the alignments were created in Clustal X, they were 
manually checked with BioEdit v 5.09 [Hall©, 2001]. 
2.8.3 Construction of phylogenetic trees 
Neighbor-Joining trees [Saitou and Nei, 1987] were drawn with MEGA v 4.1 
[Tamura et al, 2007] of all the data. Three trees were drawn in total, one 
containing the NFLG fragments of R84, TV314 and TV412 with reference 
sequences, and two trees for the two fragments (gag-pol and env-nef) of 
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TV239 also with reference sequences. The Kimura 2 parameter method of 
nucleotide substitution [Kimura, 1980] was used and a total of a 1000 
bootstrap replicates was performed on each of the trees. The datasets were 
also analyzed with PAUP* version 4.0b10 (Phylogenetic Analysis using 
Parsimony* and other methods) [Swofford, 2002] for the construction of 
maximum likelihood trees.  
The methods used by PAUP*, though far more thorough [Salemi and 
Vandamme, 2003], are extremely computationally intensive and the output 
format of the data needs far more additional work than with the use of other 
tree drawing software such as MEGA. 
2.9 Detection of recombinant viruses using RIP and Simplot 
Recombinant identification was performed with two widely used methods: 
Simplot [Lole et al, 1999] and the Recombinant Identification Program, RIP 
[Siepel et al, 1995]. The consensus alignment (excluding CRF01_AE) of RIP 
was used to query the sequences of interest. All NFLG fragments (R84, 
TV314 and TV 412) and the gag-pol and env-nef fragments of isolate TV239 
were queried. The raw text files (.txt) of each of the fragments were uploaded 
into the program and a window size of 300 bp was chosen.  
The multiple alignments were also imported into Simplot version 3.5 [Lole et 
al, 1999; Salminen et al, 1995b] to identify recombination events within the 
NFLG samples and the two fragments of TV239. For the analysis of the NFLG 
fragments all three isolates (R84, TV314 and TV 412) were queried. A window 
size of 350 bp and a step size of 50 bp were selected. The gag-pol and env-
nef fragments of isolate TV239 were also queried with the use of the same 
window and step size as with the analysis of the NFLG fragments. 
All sequences (R84, TV314 and TV 412) were first queried against all 
subtypes in the alignments for both the Simplot and the RIP analysis before 
each of the sequence analysis were rerun to simplify the output format. 
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After the recombinant identification was completed Neighbor-Joining trees of 
the different recombinant sections were drawn. Reference sequences of pure 
subtype were obtained from the LANL database. Breakpoint coordinates 
which corresponded with the breakpoints that were obtained from the subtype 
and recombination identification done by the jpHMM analysis was used to 
obtain genome segments which corresponded with the same area of 
suspected viral recombination. Only a small number (10-15) of reference 
samples, which represented the most prominent viral subtypes were included 
in these datasets. After the various reference sequences were obtained 
multiple alignments of the different recombinant fragments were constructed 
with the use of Clustal X v 1.81 [Thompson© et al, 1997]. After the alignments 
were completed and was manually checked with BioEdit v 5.09 [Hall©, 2001] 
the different alignment files (.aln) were converted to MEGA format (.meg). 
These files were imported into MEGA v 4.1 [Tamura et al, 2007] to construct 
Neighbor-joining phylogenetic trees [Saitou et al, 1987]. The Kimura 2-
parameter [Kimura, 1980] was employed for the construction of the NJ-trees.  
A 100 bootstrap replicates were performed on all these datasets to confer 
statistical significance.  
2.10 Phylogenetic analysis of non-recombinant NFLG sequences 
The two isolates of a non-recombinant nature were also compared to other 
non-recombinant subtypes of A and B. From the previous analysis it could be 
concluded that sample R84 was an HIV-1 subtype B virus and TV 314 a 
subtype A1 virus. Subtype B and A1 sequences were obtained from the LANL 
database to compare with the sequences of interest. A BLAST was performed 
with R84 and TV314 and full-length sequences which were most closely 
related to the isolates were downloaded. Because R84 was collected in the 
mid 1980’s more subtype B viruses from the 1980’s and early 1990’s were 
included in the subtype B dataset. After the full-length sequences were 
retrieved from the database, multiple alignments of the reference sequences 
with the sequences of interest were constructed with Clustal X v 1.81 
[Thompson© et al, 1997]. The isolate K.CM.96.MP535.AJ249239 was included 
for the use as an outgroup and all possible output formats were selected for 
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each of the alignments. Each alignment were manually checked with BioEdit v 
5.09 [Hall©, 2001] after the alignments were done.   
After the alignments were completed the alignment files (.aln) were converted 
to MEGA format (.meg). These files were then imported into MEGA v 4.1 
[Tamura et al, 2007] and Neighbor-Joining phylogenetic trees [Saitou et al, 
1987] were constructed with the use of the Kimura 2-parameter [Kimura, 
1980]. Bootstrap analysis, with a total of a 1000 bootstrap replicates, were 
also performed on each of the datasets to infer statistical significance. 
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CHAPTER THREE - RESULTS 
3.1 PCR amplification of partial gag, pol and env fragments 
The PCR results of the three subgenomic regions of the 12 samples are 
summarized in Table 3.1. Sample TV546 could not be amplified with the gag 
p24, pol-integrase and env gp41 amplification assays. TV546 was previously 
characterized as a subtype G sample [Personal communication, Susan 
Engelbrecht] and thus may require the use of subtype specific primer sets. 
Other than TV 546 only the env gp41 amplification of sample TV 480 was 
unsuccessful. An example of the PCR results is illustrated in Figure 3.1 
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           1 kbp 
Figure 3.1: Agarose gel electrophoresis of the nested pol-integrase PCR 
products. Lanes: Lane M – 1kb marker, Lane 1 – TV412, Lane 2 – TV314, Lane 3 – TV340, 
Lane 4 – TV218, Lane 5 – TV239, Lane 6 – TV 101, Lane 7 – TV480, Lane 8 – TV 86, Lane 9 





Table 3.1 PCR amplification of the subgenomic regions of the 12 samples.  
PCR Results  
Sample gag p24 pol-integrase  env gp41 
R84 Positive Positive Positive 
TV 86 Positive Positive Positive 
TV 101 Positive Positive Positive 
TV 218 Positive Positive Positive 
TV 239 Positive Positive Positive 
TV 314 Positive Positive Positive 
TV 340 Positive Positive Positive 
TV 412 Positive Positive Positive 
TV 441 Positive Positive Positive 
TV 480 Positive Positive Negative
TV 515 Positive Positive Positive 
TV 546 Negative Negative Negative
The sequencing of positive PCR products was successful with one exception. 
The gag p24 sequence of TV340 could not be used due to multiple peaks in 
the electropherogram. The sequencing results of the three subgenomic 
fragments are summarized in Table 3.2. The text files of the sequences are 
presented in Appendix A. The sequences were also submitted to Genbank 
with accession numbers FJ647150 - FJ647168. 
Table 3.2: Sequencing results for the subgenomic regions.  
Sequencing Results  
Sample gag p24 pol-integrase  env gp41 
R84 Positive Positive Positive 
TV 86 Positive Positive Positive 
TV 101 Previous data* Previous data* Previous data* 
TV 218 Previous data* Previous data* Previous data* 
TV 239 Positive Positive Positive 
TV 314 Positive Positive Positive 
TV 340 Negative Positive Positive 
TV 412 Positive Positive Positive 
TV 441 Positive Positive Positive 
TV 480 Positive Positive Negative
TV 515 Positive Positive Positive 
Key: * Previous data (Personal communication, Susan Engelbrecht) 
3.2 Subtyping of the partial gag, pol and env regions 
The results of the viral subtyping done with the REGA and jpHMM viral 
subtyping tools as well as the NJ-trees of the three genomic fragments are 
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presented in sections 3.3.1 (gag p24), 3.3.2 (pol integrase) and 3.3.3 (env 
gp41) respectively. The phylogenetic data and subtyping results are 
summarized in Table 3.3.  
The results of the online viral subtyping will be presented in Appendix B 
Figures 6.1– 6.3 and Tables 6.1 – 6.3, illustrates the REGA and jpHMM 
results respectively.  
3.3 NJ phylogenetic tree analysis of partial gag, pol and env  
      fragments.  
The results of the NJ phylogenetic analysis for the gag, pol and env fragments 
will be discussed in the following sections (3.3.1 – 3.3.3).  
3.3.1 The gag p24 region 
For the NJ-tree of the 10 gag p24 sequences (Figure 3.2) with the reference 
sequences from the LANL database [http://www.hiv.lanl.gov/], four samples 
(TV314, TV412, TV239, and TV101) clustered with subtype A1 sequences. 
One sample, TV515, clustered with subtype F1 sequences in the tree. Sample 
R84, clustered with other subtype B strains in the tree. The other four samples 
(TV86, TV218, TV441, and TV480) clustered amongst other subtype C 
isolates in the tree. All these subtypes were confirmed with high bootstrap 
values. The clustering pattern of the gag sequences of the 10 samples in the 
NJ-tree corresponded with the subtyping results that were obtained with the 
REGA and jpHMM analysis. 
Table 3.3: Subtyping analysis performed on the gag p24, pol-integrase and env gp41 fragments.  

























R 84 B B B B B B B B B B 
TV86 C C C C C C C C C C 
TV101 A1 A1 A1 A1D A1* Unclass  A1 A1 A1 A1 Recombinant 
TV218 C C C C C C A1 A1* A2 CA Recombinant 
TV239 A1 A1 A1 A1H A1* A1 A1 A1* A1 / A2 A1 Recombinant 
TV314 A1 A1 A1  A1J A1* A1 A1 A1* A1 / A2 A1  
TV340 - - - GB G* G A1 A1 A1 ABG Recombinant 
TV412 A1 A1 A1 A1DJ A1* A1 A1 A1 A1 A1 Recombinant 
TV441 C C C C C* C A1 A1* A2 CA Recombinant 
TV480 C C C CJ C* C - - - C Recombinant 
TV515 F1 F1 F1 F1 F1 F1 F1 F1 F1 F1 
Key: * (the bootstrap values of the analysis was not supportive or < 70%), multi state characters e.g. A1D (indicates possible recombination events), / 
(sample clustered with both the subtypes or sub-subtypes), Unclass (Unclassified), and – (PCR or sequencing reactions were not successful) 
3.3.2 The pol-integrase region 
In the pol-integrase tree (Figure 3.3), TV515 and R84, clustered with other F1 
and B sequences respectively.  Three samples (TV412, TV314, and TV239) 
clustered with other A1 isolates. These three samples were identified as A1 
recombinants with the REGA and jpHMM subtyping and recombination 
analysis (Table 3.2). TV101 did not cluster with any of the 9 subtypes in the 
tree, which indicates possible viral recombination in this sequence. jpHMM 
analysis indicated that TV101 might be an AD recombinant within the pol-
integrase sequenced fragment. Sample TV441 was an outlier of the C cluster, 
but with the online subtyping results was continuously identified as a subtype 
C isolate. TV340 was an outlier of the subtype G cluster which might indicate 
possible recombination. The REGA subtyping tool identified TV340 as an 
subtype G sample but with a very low bootstrap support. jpHMM analysis of 
TV340 however identified the sample as AG recombinant form.  
3.3.3 The env gp41 region 
In the env NJ-tree three (Figure 3.4) the following samples clustered with 
other A1 samples: TV101, TV340 and TV412 which corresponds well with the 
subtyping results of the REGA and jpHMM analysis. TV218 and TV441 
clustered with other A2 sequences, with TV239 and TV314 outliers of the 
A1/A2 cluster, indicating possible recombination. REGA and jpHMM analysis 
of these four samples revealed that all these samples (TV218, TV239, TV314 
and TV412) were subtype A1 in the env gp41 region. As with the gag and pol 
trees TV86, TV515, and R84 clustered with other C, F1, and B sequences 






































































Figure 3.2: A Neighbor-joining tree of gag sequences (485 bp) indicating 
reference sequences and TV sequences. The TV sequences are indicated with a red 
dot. In the bottom line the genetic distance, which corresponds to the length of the branches, 













































































Figure 3.3: A Neighbor-joining tree of pol sequences (944 bp) indicating 
reference sequences and TV sequences. Each TV sequences are indicated with a 
red dot. The genetic distance, which corresponds to the length of the branches, is shown in 
the bottom line.  Only bootstrap values greater than 70 percent are included. 
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Figure 3.4: A Neighbor-joining tree of env sequences (438 bp) indicating 
reference sequences and TV sequences. Each TV sequences are indicated with a 
red dot. The genetic distance, which corresponds to the length of the branches, is shown in 
the bottom line.  Only bootstrap values greater than 70 percent are included. 
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3.4 Amplification and sequencing of NFLG of four samples 
3.4.1 PCR amplification assays of 9.2 kbp fragments of four  
         samples 
The long amplification assays (9.2 kbp) of the four samples (R84, TV239, 
TV314, and TV412) were not successful.  Due to limited template DNA, a 
large amount of 9.2 kbp PCR products could not be obtained for sequencing.   































       M           1       2         3         4           5         6         7         8     
Figure 3.5: Agarose gel of the unsuccessful 9.2 kbp PCR products of sample 
R84. Lanes: lane M – 1 kbp Molecular Marker, lane 1  - Blank, lane 2 – 500 ng/µl of template 
DNA, lane 3 – 400 ng/µl of template DNA, lane 4 - 300 ng/µl of template DNA, lane 5 - 200 
ng/µl of template DNA, lane 6 – 100 ng/µl of template DNA, lanes 7 & 8 – Negative Control 
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3.4.2 PCR amplification of four overlapping fragments 
Sample R84 were amplifiable for all four fragments (LTR-gag, gag-pol, pol-
env, and env-LTR). For the other three samples (TV239, TV314, and TV412), 
only the amplification of the gag-pol, pol-env, and env-LTR fragments were 
successful (data not shown). The results of the PCR amplification assays are 
summarized in Table 3.4.  
Table 3.4: PCR amplification of the four overlapping fragments.  
Fragment Sample 
LTR-gag gag-pol pol-env env-LTR 
R 84 Positive Positive Positive Positive 
TV239 Negative Positive Positive Positive 
TV314 Negative Positive Positive Positive 
TV412 Negative Positive Positive Positive 
 
 3.4.3 Sequences results of the NFLG fragments 
A continues fragment of sample R84, stretching from the start of the gag 
region up to the 3’LTR region (position 601-9514 relative to HXB2) were 
obtain from the sequenced data. The sequencing of the other samples was 
obtained with mixed results. All attempts to sequence the 5’LTR-gag regions 
of the other three isolates (TV239, TV314, and TV412) as well as the 660 bp 
gap between the two fragments of sample TV239 from the 9.2 kbp PCR 
fragment were unsuccessful. This resulted in; two fragments for TV 239 
stretching from position 1245 - 5534 and 6195 - 9146 (relative to HXB2 
coordinates), a single continues fragment for TV314 stretching from 1235 - 
9551 and a single fragment, stretching from position 1246 – 8254, for sample 
TV412.  
Each sequence fragment was analyzed with the Gene Cutter tool from LANL 
database. No pre-mature stop codons could be found in any of the open 
reading frames of the various genes. The results of the Gene Cutter analysis 
for each of the four isolates sequences are presented in Appendix D. All the 
near full-length sequences were submitted to GenBank with accession 
numbers FJ647145 - FJ647149. 
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3.5 Subtype identification of NFLG fragments with REGA and  
      jpHMM online tools.  
The online subtyping and recombination results, which was performed with 
the jpHMM and REGA viral subtyping tools, of the three near full-length 
sequences as well as the two fragments of sample TV239 are summarized in 
Table 3.5. For the full results of the analysis please refer to Appendix E, 
Figure 6.4 and Table 6.8, for the REGA and jpHMM results respectively.  
Table 3.5: jpHMM and REGA subtyping tools. 
Sample jpHMM subtyping tool REGA subtyping tool 
R 84 B B* 
TV 239 gag-pol A1 A1* 
TV 239 env-nef C / A1 / C / A1 / C C / A1 / C * 
TV314 A1 A1* 
TV 412 A1 / D / A1 / D / A1 A1 / D / A1* 
Key: * (The REGA reports of each of the analysis were checked and all subtyping and 
recombination patterns are with bootstrap support - >70 percent), and / (indicate possible 
recombination events). 
From the analysis of the four isolates with the two different subtyping and 
recombination tools one can conclude that: R84 is subtype B isolate, TV239 is 
a AC recombinant virus (with the gag-pol fragment belonging to subtype A1 
and the env-nef fragment showing signs of AC recombination breaking 
repeatedly throughout the fragment). Similarly, TV314 was classified as a 
subtype A1 isolate and TV412 is an AD recombinant virus (also breaking 
repeatedly throughout the fragment) by both the subtyping methods. 
Though both the REGA and the jpHMM analysis were able to correctly identify 
the four isolates, the jpHMM subtyping tool was found to be much more 
accurate due to the phylogenetic approach used by the program.  
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3.6 Construction of NFLG phylogenetic trees 
Three NJ-trees (one containing the three sequences of the NFLG fragments 
and two for each of the TV239 fragments) were constructed with the use of 
MEGA v 4.1. Data sets were also analyzed with PAUP v 4.0b10 and 
PhyML v 3.0 and maximum likelihood trees were constructed with the 
use of these programs as well as the HKY and GTR models of 
nucleotide substitution (data not shown). 
Three NJ-trees were constructed with the use of MEGA v 4.1. The Neighbor-
Joining tree of the three NFLG’s containing samples R84, TV314 and TV412 
as well as several reference strains from the LANL database can be seen in 
Figure 3.6. In the tree (Figure 3.6) two sample TV314 and R84 cluster within 
subtype clusters. R84 clustered with other subtype B viruses and was most 
closely related to B.FR.83.HXB2 LAI IIIB BRU.K034 with a strong 
bootstrap support of 94%.  TV314 clustered with A1 sequences and was more 
closely related to the reference strain A1.UG.92.92UG037.AB253429, than 
to any of the other samples in the cluster, but with a very low bootstrap 
support of only 42%. Sample TV412 was an outlier of the A1 cluster which 
possibly indicates viral recombination between subtype A1 and another HIV-1 
subtype. The outgroup, N.CM.95.YBF30.AJ006022, rooted the tree. 
Figures 3.7 and 3.8 shows the NJ-trees of sample TV239’s two fragments 
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Figure 3.6: A Neighbor-joining tree containing the NFLG sequences of the 
three TV samples and reference samples. Each TV sequences are indicated with a 
red dot. The genetic distance is shown in the bottom line and corresponds to the length of the 
branches.  Bootstrap values greater than 70 percent are shown.  
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Figure 3.7: A Neighbor-joining tree containing reference sequences and the 
sequence of the gag-pol fragment of TV239. The TV sequence is marked with a red 
dot. The genetic distance, which corresponds to the branch lengths, is shown at the bottom. 
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Figure 3.8: A Neighbor-joining tree containing reference sequences and the 
sequence of the env-nef fragment of TV239. The TV sequence is marked with a red 
dot. The genetic distance, which corresponds to the branch lengths, is shown at the bottom. 
Bootstrap values greater than 70 percent are shown.  
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Inspection of these trees revealed that out of the 71 taxa in the trees: the gag-
pol fragment clearly clustered with other subtype A1 isolates in the tree with a 
strong bootstrap support of 83% and that the env-nef fragment was an outlier 
with a bootstrap support of 53%, containing A1 isolates as well as CRF02, cpx 
19 and cpx 13 reference strains. CRF13_cpx is a complex recombinant form 
containing viral segments from subtypes A, G, and J as well as fragments of 
CRF01_AE. The CRF19_cpx sequence on the other hand contains viral 
segments from subtypes A1, D and G. From the analysis of the two fragments 
of sample TV239 it is clear that this isolate can be considered as an A1 
recombinant virus, with the gag-pol fragment as a subtype A1 and the env-nef 
fragment as the breakpoint of viral recombination. 
 
3.7 Results of recombination identification with RIP and Simplot  
The analysis of the four samples revealed recombination within two of the 
isolates genomes. TV412 and TV239 were identified by both the REGA and 
jpHMM subtype and recombination identification programs as an AD and AC 
recombinant respectively.  
Apart from the REGA and jpHMM analysis the near-full length sequences 
were also analyzed with the use of two widely used recombination 
identification programs to observe potential recombination events: RIP [Siepel 
et al, 1995] and Simplot. For the RIP analysis, the consensus alignment of the 
LANL database [http://www.hiv.lanl.gov/] was used with a window size of 300 
bp to obtain the results.  
Only two of the four isolates (TV239 and TV412) showed signs of viral 
recombination. Similarity plots for these two isolates were downloaded and 
are presented in Figures 3.9 and 3.10. The similarity plot analysis in RIP of 
samples R84 and TV314 indicated that: R84 had a high similarity with other 
subtype B viral subtypes and that TV314 had a high similarity with other 
subtype A1 isolates in the LANL reference alignment. Similarly the analysis of 
the gag-pol fragment of TV239 also showed a high similarity with other A1 
subtypes in the LANL reference alignment. Only the env-nef fragment of 
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sample TV239 (Figure 3.10) and the fragment of sample TV412 (Figure 3.11) 
showed signs of viral recombination. 
 
Figure 3.9: The analysis of the TV239 env-nef fragment with RIP. The s and the 
k symbols on the vertical and horizontal axis represent similarity and distance (in nucleotides 
or base pairs) respectively.   
The RIP similarity analysis of the env-nef fragment of TV239 indicates AC 
recombination within the fragment, with multiple breakpoints. The analysis of 
TV412 also indicated recombination within the fragment with the genome 
breaking between subtype A and D viruses throughout the fragment. The 
results of the RIP analysis roughly corresponds to the breakpoints and 
recombination pattern that was obtained from the jpHMM analysis.  
The four samples were also analyzed with Simplot v 3.5 [Lole et al, 1999; 
Salminen et al, 1995]. As with the RIP analysis samples R84, TV314 did 
not show signs of viral recombination and had high similarities with 
subtype B and A1 isolates respectively. The analysis of the TV239 
fragments showed that the gag-pol fragment was a subtype A1 isolate 
whereas the env-nef (Figure 3.11) fragment showed signs of AC 
recombination. The analysis of TV412 (Figure 3.12) indicated viral 
recombination, between subtypes A and D, within the fragment.  
Figure 3.10: The analysis of TV412 with RIP. The s and the k symbols on the vertical 
and horizontal axis represent similarity and distance (in nucleotides or base pairs) 






Figure 3.11: Simplot of TV239 env-nef fragment. The horizontal axis represents the position in the fragment and the vertical axis the similarity with 
viral subtypes against which the sequence of interest (TV239 env-nef) was queried. A window size of 350 bp and a step size of 50 bp were used. The Kimura 
2-parameter of nucleotide substitution was used for the analysis.  
Figure 3.12: Simplot of TV412. The horizontal axis represents the position in the fragment and the vertical axis the similarity with viral subtypes against 
which the sequence of interest (TV412) was queried. A window size of 350 bp and a step size of 50 bp were used. The Kimura 2-parameter of nucleotide 
substitution was used for the analysis.  
 
3.7.1 Phylogenetic analysis of recombinant breakpoints 
NJ-trees were also drawn of each of the recombinant segments 
corresponding to the jpHMM breakpoint coordinates (obtained from the 
subtyping analysis). The breakpoint coordinates of the jpHMM were used, 
instead of the REGA breakpoints, due to the higher accuracy of the jpHMM 
analysis ability to calculate breakpoints. The jpHMM uses a jumping approach 
were the queried sequence can jump between samples in a multiple 
alignment as a sliding window moves across the fragment, which makes the 
identification of breakpoints to within a few base pairs much easier. The 
jpHMM breakpoints of samples TV239 and TV412 are summarized in Table 
3.6.  
 
Table 3.6: Breakpoint coordinates of the four samples as was determined by 
jpHMM analysis. 
Sample Coordinates (Relative to HXB2) Sample coordinates Subtype 
6195 - 6335 1 - 140 C 
6336 - 8246 141 - 2050 A1 
8247 - 8532 2051 - 2337 C 
8533 - 8846 2338 - 2651 A1 
TV239 
8847 - 9146 2652 - 2951 C 
1264 - 1858 1 - 594 A1 
1859 - 2095 595 - 831 D 
2096 - 5217 832 - 3953 A1 
5218 - 6130 3954 - 4866 D 
TV412 
6131 - 8254 4867 - 6990 A1 
 
A schematic diagram was constructed for each of the recombinant fragments 
and each recombinant segment in a diagram was assigned a roman numeral 
(e.g. I, II, and III). See Figure 3.13 A and 3.13 B for the recombinant diagram 
and trees for the TV239 env-nef fragment. A total of a 100 bootstrap replicates 
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was performed on each of the trees. Only bootstrap values greater than 70 
percent was included on the trees. 
The NJ-tree analysis of the TV239 env-nef fragment revealed that there are 
five recombinant breakpoints within the sequence/fragment which clusters two 
different subtypes. The first half of the fragment (6195 – 6335) clustered with 
subtype C viruses. The second part (6336-8246) with subtype A1 and the third 
part with (8247-8532) subtype C again. The fourth (8533-8846) and fifth 
(8847-9146) segments similarly clustered with subtype A1 and C respectively. 
 
6195 9146 
V IV IIIIII A 
C C CA1 A1  
Figure 3.13A: A schematic diagram of viral recombination within the TV 239 
env-nef fragment. The Roman numerals correspond with the trees in Figure 3.13B. The 
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Figure 3.13B: NJ-trees of the different viral recombinant regions of the TV 239 
env-nef fragment. The Roman numeral in front of each of the trees corresponds with the 
numerals in the schematic diagram in Figure 3.13A. The sequence of interest is marked with 
a red dot. The genetic distance, which corresponds to the length of the branches, is shown in 
the bottom left hand corner. Only bootstrap values greater than 70 percent are shown on the 
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Figure 3.13B (continued): NJ-trees of the different viral recombinant regions of 
the TV 239 env-nef fragment. The Roman numeral in front of each of the trees 
corresponds with the numerals in the schematic diagram in Figure 3.13A. The sequences of 
interest are marked with a red dot. The genetic distance, which corresponds to the length of 
the branches, is shown in the bottom left hand corner. Only bootstrap values greater than 70 
percent are shown on the trees. Figure continued from page 89.  
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The results of the viral recombination pattern of TV412 are demonstrated in a 
similar manner (Figures 3.14A and Figure 3.14B). Similar analysis of the 
TV412 NJ-trees revealed that this fragment contained five viral segments 
within the sequenced fragment, which corresponds with two different 
subtypes. The first (1246 - 1858), third (2096 - 5217) and fifth (6131 - 8254) 
segments of TV412 clearly clustered with subtype A1 samples in the NJ-trees. 
The second (1859 - 2095) and fourth (5218 - 6130) segments on the other 
hand clustered with subtype D viruses in the tree, in particular with 
D.UG94.94UG114.U88824 from Uganda.  
1246 8254
V IIII  II IV
A1 D A1 D A1 
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Figure 3.14A: A schematic diagram of viral recombination within sample 
TV412. The Roman numerals correspond with the trees in Figure 3.15B. The coordinates on 
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Figure 3.14B: NJ-trees of the different viral recombinant regions of sample 
TV412. Each Roman numeral corresponds with the numerals in the schematic diagram in 
Figure 3.14A. Sequences of interest are indicated with a red dot. Only bootstrap values 
greater than 70 percent are shown on the trees. The genetic distance, corresponding to the 
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Figure 3.14B continued: NJ-trees of the different viral recombinant regions of 
sample TV412. Each Roman numeral corresponds with the numerals in the schematic 
diagram in Figure 3.14A. Sequences of interest are indicated with a red dot. Only bootstrap 
values greater than 70 percent are shown on the trees. The genetic distance, corresponding 




3.8 Analysis of non-recombinant isolates with reference sequences 
The two non-recombinant viral isolates (R84 and TV314) were compared with 
reference sequences of the same subtype(s). Sample R84 was compared 
with other subtype B viruses, mostly HIV-1 subtype B isolates from the 1980’s 
and early 1990’s. R 84 was aligned with these reference sequences, which 
was obtained from the LANL database, and a Neighbor-Joining tree (Figure 
3.15) was constructed in MEGA v 4.1. TV 314 was compared to other subtype 
A1 isolates from the LANL database in a similar fashion (Figure 3.16).  
Analysis of the phylogenetic analysis of the pure viral fragments revealed that 
R84 clustered with other subtype B isolates from the United States from the 
mid 1980’s, in particular with sample B.US.83.5082 83, but with a vary low 
bootstrap support of 50 percent. This sample was isolated in the mid 1980’s 
an thus are suspected to be more closely related to other subtype B viruses 
from the same period.   
The tree with TV314 contains two major clusters, one containing samples of 
African origin as well as A1 sequences from Sweden and another containing 
A1 samples that was sampled outside of Africa (mostly in the former Soviet 
countries or Australia). TV314 clustered with A1 sequences, of African origin, 
form the mid 1990’s till the year 2000. From the analysis it appears that 
TV314 is more closely related to sample A1.SE.95.UGSE8131.AF107771, 
with a very high bootstrap support of 87%. This sample was isolated from a 
patient in Sweden, but clearly clusters amongst other A1 sequences from East 
African origin, which suggests the introduction and spread of East African A1 
isolates into Northern Europe in the distant past. All these assumptions were 
made basted on the raw phylogenetic data that was obtained from the 
analysis and more in-depth phylogenetic analysis of TV314 will be needed to 


















































































Figure 3.15: A NJ tree exploring the relationship of subtype B HIV-1 isolates 
with sample R84. The TV sequence is marked with a red dot. The genetic distance, 
which corresponds to the branch lengths, is shown at the bottom. Bootstrap values greater 














































































Figure 3.16: A Neighbor-joining tree looking at the relationship between 
subtypes A1 HIV-1 isolates and sample TV314. The TV sequence is marked with a 
red dot. The genetic distance, which corresponds to the branch lengths, is shown at the 
bottom. Bootstrap values greater than 70 percent are shown. 
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CHAPTER FOUR – DISCUSSION AND CONCLUSION 
DISCUSSION  
The objective of this study was to characterize non-subtype C isolates, from 
the greater Cape Town Metropolitan area. This study indicated that non-
subtype C HIV-1 isolates, including subtypes B, A1 and A1 recombinant 
viruses, are circulating within the Cape Town area.  
4.1 HIV-1 and HIV characterization in South Africa 
The first documented cases of HIV-1 infection in South Africa occurred in 
1982 [Ras et al, 1983]. Unlike the rest of sub-Sahara Africa, the HIV-1 
epidemic in South Africa was mostly associated with the homosexual 
population [Sher, 1989]. The isolates were later characterized as subtype B 
and D viruses [Becker et al, 1995; Engelbrecht et al, 1995]. Subtype B and D 
viruses were probably introduced into the country by homosexual men 
through international travel. By the start of the 1990’s a new epidemic of HIV 
started to occur within the country amongst heterosexual individuals, which 
was largely associated with members of the indigenous black population 
[Williamson et al, 1995]. Viruses that were isolated from heterosexual 
individuals of the second epidemic mostly belonged to HIV-1 subtype C [van 
Harmelen et al, 1997]. The second epidemic quickly overtook the first initial 
epidemic in the early 1990’s and today the heterosexually transmitted 
dominates the HIV epidemic within the country [McCutchan et al, 1996], with 
as many as 6.2 million people infected [UNAIDS, 2008].  
To date several papers on a wide range of HIV-1 subtypes have been 
published within South Africa on subgenomic fragments or near full-length 
sequences (Tables 1.2 and 1.3). These viruses were isolated from several 
geographical locations within the country. The following section will take a 
look at the publications.  
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Subtype C HIV-1 accounts for nearly 95% of all infections within the country 
and subtype C viruses have been characterized on several occasions. Of the 
3884 South African full or partial sequences in the LANL database, 3706 or 
95.4% are subtype C (Figure 1.8). One should note that these figures may be 
misleading as several sequences may be from the same patient sample. The 
rest of the sequences represents subtype B and D isolates, which has been 
described in the past in association with homosexual mode of transmission 
[Engelbrecht et al, 1994; Becker et al, 1995], and other subtypes and 
recombinant forms.  
Two hundred and sixty five full-length HIV-1 sequences from 8 independent 
studies have been described within the country. The majority of these 
sequences represent subtype C isolates [van Harmelen et al, 2001; 
Papathanasopoulos et al, 2002; zur Megede et al, 2002; Papathanasopoulos 
et al, 2003; Hunt et al, 2003; Rousseau et al, 2006]. Only 11 full-length 
sequences of non-subtype C isolates have been described to date within 
South Africa. These include 5 subtype D isolates [Loxton et al, 2005; Jacobs 
et al, 2007], one subtype B [Rousseau et al, 2006], one subtype A1 
[Rousseau et al, 2006], three AC recombinants [Papathanasopoulos et al, 
2002; Rousseau et al, 2006] and one complex viral form containing subtypes 
A, C, D, G and K segments [Papathanasopoulos et al, 2002].  
As with the characterization of full-length genomes from South Africa, most 
partial sequence fragments also represents subtype C isolates [Bredell et al, 
1998; Engelbrecht et al, 2001; Scriba et al, 2002; Gordon et al, 2003; 
Bessong et al, 2005; Bell et al, 2007]. Several non subtype C viruses, apart 
from the subtype B and D viruses that was mentioned earlier [Engelbrecht et 
al, 1994; Becker et al, 1995], have been identified. These include, an 
CRF01_AE isolate [van Harmelen et al, 1997], subtype A isolates [Jacobs et 
al, submitted; Bredell et al, 2002], a G and one CRF02_AG isolate [Bredell et 
al, 2002; Jacobs et al, 2008], CD recombinants [Bredell et al, 2002; Gordon et 
al, 2003], an F1 isolate [Jacobs et al, submitted], CA recombinants [Bredell et 
al, 2002] and a CH recombinant [Jacobs et al, submitted]. Some of these 
isolates are extremely rare, such as F1, CH recombinants and subtype G, and 
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are mostly confined to areas of Central Africa e.g. the DRC (Figure 1.8) 
[Geretti, 2006]. 
4.2 Full genome characterization of HIV 
HIV sequences can be grouped into one of the 9 subtype by either 
characterization of small gene fragments throughout the genome or by 
characterizing the full HIV genome. The use of the first method has been well 
established over the years [Swanson et al, 2003]. This method does however 
have its own drawbacks as some recombination events are so small and can 
be missed in such an approach. With these limitations of partial genome 
sequencing the focus was shifted to the characterization of full-length HIV-1 
genomes. Improvements in nucleic acid amplification technology, which 
permits the amplification of large gene fragments of (9 – 36 kbp) now enables 
researchers to amplify and characterize full-genomes of HIV much easier. 
This procedure was first described in HIV-1 research by Mika Salminen and 
co-workers in 1995 [Salminen et al, 1995a]. Since then the value of full-
genome sequencing of HIV has been repeatedly demonstrated. The subtype 
E viruses, which were isolated and sequenced in the early 1990 in Southeast 
Asia, were initially termed as subtype E based on sequences from the env 
gene [Carr et al, 1996; Gao et al, 1996]. Full genome characterization of these 
isolates reveled that the isolates were recombinant in nature with subtype A in 
the gag and subtype E in the env regions. The Z321 strain from Zaire, which 
was one of the earliest identified strains HIV-1, was initially thought to have 
been subtype A based on env sequences, but with full genome amplification it 
was found to be an AG recombinant [Choi et al, 1997]. This emphasizes the 
importance of full genome amplification and sequencing of HIV isolates, 
especially when viral recombination is suspected.  
Full genome characterization of HIV-1 can either be performed on, proviral 
DNA or RNA (isolated from PBMC) or viral RNA from blood plasma. In the 
HIV database of LANL there are only 1404 HIV-1 sequences which are 
greater than 8 kbp in length (any continues HIV fragment larger than 8000 bp 
is considered to be a near full-length genome) [http://www.hiv.lanl.gov/]. The 
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majority of these near full-length sequences were generated by using proviral 
DNA from either peripheral blood mononuclear cells (PBMC) or either cultured 
cells. A standard protocol for the characterization of near full-length 
sequences from viral RNA was recently developed [Nadai et al, 2008]. Viral 
RNA represents the current replicating viral population within a patient and 
thus may offer more pathogenic and phylogenetic significance than with DNA 
isolates from PBMC’s [Wei et al, 1995].  
4.3 Success of the various amplification assays and sequencing 
      reactions 
The amplification of the near-full length genomes were all unsuccessful and 
non specific products were obtained. This might be due to un-optimized PCR 
assays, old DNA or the use of unspecific primer pairs.  
All of the other PCR’s that were performed in this study were successful, 
except for the three subgenomic fragments of TV546, the env fragments of 
TV480 and the LTR-gag amplification assays of TV239, TV314 and TV412. 
PCR failures might be due to the high degree of sequence variation in HIV-1. 
Subtype specific primers could have been design but due to sample 
limitations was abandoned. TV480 and TV546 have been identified as 
possible CJ and CG recombinant viruses in a previous study [Jacobs et al, 
submitted]. The primer sets that were used by Swanson and co-workers 
[Swanson et al, 2003] might not have been specific enough for these two 
samples. When doing PCR’s it is also important to optimize each assay for 
greater yield in product.  
The sequencing of the positive PCR products was all successful with the 
exception of TV340 gag p24 and TV239. Multiple peaks in the 
electrophenogram made it impossible to obtain a reliable sequence for TV340 
gag p24. The failure of the sequencing of TV239 which produced a 600 bp 
gap in the pol-vif region of TV239 might be due to frequent recombination 
events within this region of the genome.  
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4.4 HIV subtype results of the present study 
This section will discuss the HIV subtype results that were generated in this 
study. In the first section the results of the characterization of the various 
subgenomic regions will be discussed. The second section will discuss the 
results that were obtained in the near full-length characterization of four 
samples.  
 4.4.1 Discussion of the various subgenomic fragments  
The characterization of small subgenomic regions throughout the HIV genome 
to subtype an isolate or identify possible recombinant has been widely used in 
the past [Swanson et al, 2003]. The method that was developed by Swanson 
and co-workers targeted specific regions that is important in HIV 
antibody/antigen diagnostic assays and commercially available viral load 
assays. Theses regions are generally highly conserved and the PCR’s that 
was developed for this study was able to detect most HIV-1 groups and 
subtypes.  
In the present study subtype C, F1, A1, and B isolates were identified with this 
method of genome characterization. Several recombinant HIV viruses were 
also identified, including AD, CA, AG and other possible A1 recombinant 
forms. Sample TV546 was not amplifiable with the primer sets that were used. 
This sample was identified as a subtype G or subtype C isolate on previous 
occasion [Jacobs et al, submitted].  This illustrates the need for subtype 
specific primers when working with rare viral subtypes or recombinants forms.   
The V3 region of TV515 was characterized on a previous occasion [Jacobs et 
al, submitted]. These gag p24, pol-integrase and env gp41 sequences of 
TV515 will represent the second sequenced set of F1 sequences from South 
Africa, though from the same patient. Sample TV340 were previously 
classified [Jacobs et al, submitted] as a subtype A isolate. This sample was 
isolated from a patient in the Cape Town, which became infected in the DRC 
(Table 2.4). Through analysis of the pol and env subgenomic regions this 
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isolate was classified as an AG recombinant, with the pol fragment belonging 
to subtype G and the env fragment to subtype A1.  
Similarly analysis of TV441 was identified as a subtype A1 isolate in the same 
study. The analysis of the present study indicated that this sample is a 
possible AC recombinant with the gag p24 and pol-integrase regions 
clustering with subtype C viruses and the env gp41 region with subtype A 
viruses. It might be concluded that subgenomic characterization of isolates 
may yield more accurate results when several regions throughout the genome 
of HIV-1 is targeted.  
Though these methods of HIV genome characterization may give an 
indication of the viral subtype of a particular isolate or identify viral 
recombination, only full genome analysis of samples will allow one to make a 
safe and accurate assumption on the subtype and recombination of particular 
isolates, as recombination can occur in the regions between the three 
subgenomic fragments characterized. 
 4.4.2 Discussion of near full-length sequence results 
 4.4.2.1 R84 and other subtype B viruses in South Africa  
Subtype B HIV are typically found amongst homosexual men in North America 
and Europe. Since the outbreak of the epidemic, subtype B has also 
established itself in South America, parts of Asia, South Africa, and in 
Australia [Leitner et al, 1996]. In South Africa subtype B, along with subtype 
D, viruses were isolated and later sequenced from homosexual men in the 
mid 1980’s and early 1990’s [Becker et al, 1995; Engelbrecht et al, 1995]. To 
date only a few cases have been reported where subtype B viruses were 
isolated from heterosexual individuals [van Harmelen et al, 1997; van 
Harmelen et al, 1999]. Heterosexual transmittion of subtype B has also been 
reported in other areas of the world [Lara et al, 1997; Hayman et al, 2001; 
Cleghorn et al, 2000]. Subtype B HIV has also been reported in MTCT cohorts 
from Cape Town [Jacobs et al, submitted]. Only one full-length sequence of a 
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South African subtype B virus, which was isolated from a heterosexual 
female, have been characterized to date [Rousseau et al, 2006].  
A full-length subtype B sequence, which was isolated from a homosexual 
caucasian male in the mid 1980’s, were characterized in this study. 
Amplification and sequencing of the isolate produced an 8913 bp fragment, 
which represents the second near full-length sequence of a subtype B isolate 
from South Africa. This subtype B isolate along with the subtype D viruses, 
which has been characterized in the past [Loxton et al, 2005; Jacobs et al, 
2007], represent the only near full-length sequences of the first initial 
homosexual HIV epidemic within the country.  This near full-length sequence 
will greatly improve our knowledge and understanding of the initial HIV 
epidemic within the country. 
As was mentioned previously, heterosexual transmittion of subtype B have 
been reported in the past [van Harmelen et al, 1997; van Harmelen et al, 
1999; Jacobs et al, submitted]. It would be reasonable to assume that if the 
circulation of subtype B viruses continues to increase and co-circulate with 
subtype C amongst the heterosexual population of South Africa that this could 
create a good opportunity for viral recombination to occur and the possible 
rise of CB recombinants within the region.  
 4.4.2.2 TV239 and other HIV recombinants from South Africa 
Sample TV239 were isolated from a South African male, which presented with 
tuberculosis and a low CD4 cell count of 64. TV239 was characterized 
previously, through amplification and sequencing of a small (300 bp) fragment 
of the env gene, as a subtype A HIV-1 isolate. With the full genome analysis 
of this isolate it became apparent that the TV239 isolate was an AC 
recombinant. This only stresses the importance of full-genome 
characterization of HIV-1 isolates, as such recombination events can be 
missed with the amplification of smaller fragments.  
Only three full-length sequences of AC recombinant viruses have been 
described in South Africa to date [Papathanasopoulos et al, 2002; Rousseau 
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et al, 2006]. Through phylogenetic analysis of the two AC recombinants that 
was described by Rousseau and colleagues revealed that the A fragments of 
the two recombinants were more closely related to sub-subtype A1. The one 
AC recombinant of Papathanasopoulos and co-workers was classified with 
the A recombinant fragments clustering with subtype A2 isolates as with A1 
sub-subtypes of subtype A HIV-1 isolates. All the subtype A recombinant 
fragments as well as those of TV239 was more closely related to other 
subtype A sequences from East African. TV239 thus represents the fourth 
near full-length AC recombinant that has been described in South Africa to 
date, and only the third A1C recombinant.  
As subtype A continue to spread within the region of Southern Africa and co-
circulate with subtype C and other viral subtype one can expect and increase 
in the prevalence of these recombinant forms in the future.   
  4.4.2.3 Subtype A’s in South Africa and TV314  
TV314 was obtained from an asymptomatic South African male. Near full-
length genome characterization revealed that the isolate was subtype A1 with 
no trace of recombination within the sequenced fragment. A total of 37 
sequences of subtype A viruses from South Africa can be found in the LANL 
database, but only one full-length subtype A1 sample have been described to 
date [Rousseau et al, 2006]. The near full-length subtype A1 sequence that 
was described previously within the country was isolated form a 
heterosexually-infected female of Zulu or Xhosa ethnicity. The gag portion of 
this isolate was more closely related to the subtype A gag part that is 
characteristic of CRF01_AE isolates.  
TV314 was more closely related to an A1 sequence that was characterized 
from Sweden, A1.SE.95.UGSE8131.AF107771, but these two sequences 
were grouped together with other subtype A1 sequences from East African 
origin. The dataset that was used for the analysis contained four sequences 
from Sweden, all of whom clustered amongst the other East African 
sequences. It may be concluded that this strain was introduced into Northern 
Europe via international travel or emigration.  
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 4.4.2.4 TV412 and other AD recombinants from Kenya 
Sample TV412 were isolated from an African male, which presented with 
chronic staphylococcal skin sepses. The patient’s immune system was 
severely depleted with a CD4 count of 71. According to Hospital records the 
patient became infected with HIV in Kenya. Full-genome amplification was 
performed, but was insufficient for sequencing. Amplification was performed in 
four overlapping fragments, three of which were successful. This resulted in a 
7008 bp sequenced fragment, stretching from 1246 – 8254 (relative to HXB2 
coordinates). TV412 was classified, with the use of REGA and jpHMM 
subtyping, as a subtype A1 isolate based on the 300 bp V3 sequence that 
was characterized within the department [Jacobs et al, submitted]. In this 
study, through the characterization of a larger fragment (7 kbp) the sample 
classified as an AD recombinant. This stresses the importance of full-genome 
characterization of samples in order to make an accurate and informed 
conclusion concerning an isolates subtype status.   
Subtype A and D HIV co-circulate in large numbers within the East African 
country of Kenya. Subtype A and D respectively represents 74.4 and 10.6 
percent of the subtypes circulating within the country (Figure 1.8). This co-
circulation of these two subtype, which are also found in large numbers in 
other East African countries (e.g. Uganda and Tanzania), presents a good 
opportunity for viral recombination. Today, AD recombinant viruses comprise 
nearly 1.9% of the viruses that are sampled.  Similarly, Tanzania and Uganda 
have reported AD recombinant levels of 1.1 and 2.2 percent respectively 
(Figure 1.8). Recent data on co-infection of individuals with subtypes A and D 
showed that there are an ongoing generation and selection for A/D 
recombinant forms [Songok et al, 2004].  
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CONCLUSION 
This work represents partial gag, pol and env and near-full length sequences 
of non-subtype C HIV-1 sequences from the Tygerberg Hospital, Cape Town, 
South Africa.  Phylogenetic analysis of the sequenced data revealed the 
presence of subtype A, B, F1 as well as AC and AD recombinant viruses 
within the region. The two near full-length sequences of the recombinant 
viruses constitute two new unique recombinant HIV-1 forms. The data that 
was gathered in this study will greatly improve our knowledge of subtype 
distributions within the country. Due to the impact that HIV genetic diversity 
might have on vaccine design and development, as well as HIV diagnosis and 
the treatment of patients with antiretroviral therapeutic drug, ongoing research 
into the epidemiology and spread of HIV subtypes and recombinants within 
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Figure 6.1: REGA subtyping results of the gag p24 sequences. All data are 




Figure 6.2: REGA subtyping results of the pol - integrase sequences. The 
subtype and the bootstrap values are included. 
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Figure 6.3: REGA subtyping results of the env gp41 sequences. The subtype 
and the bootstrap values are included. 
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Table 6.1: jpHMM subtyping results of gag p24 subgenomic regions.  























Table 6.2: jpHMM subtyping results of pol - integrase subgenomic regions.  
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Table 6.4: Sequencing primers used for the characterization of R84. 
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
9110R GCAAGAGAGACCCAGTACAG 10166 - 10147 50 Personal Communication, John Hackett 
R749 LTR-gag ATTTTGCACTATAGGGTAAT 1181 - 1200 45 Personal Communication, John Hackett 
p24-1  AGYCAAAATTAYCCYATAGT 1174 - 1193 45 Swanson et al, 2003 
p24-2  AGRACYTTRAAYGCATGGGT 1237 - 1256 50 Swanson et al, 2003 
GagA AGAGAACCAAGGGGAAGTGA  1474 - 1493 50 Kemp et al, 1989 
GagB TCTCTAAAGGGTTCCTTTGG 1654 - 1673 45 Kemp et al, 1989 
p24-6  TGTGWAGCTTGYTCRGCTC 1703 - 1721 50 Swanson et al, 2003 
cm237R2020 GGTGGGGCTGTTGGCTCTGG 2146 - 2165 60 Personal Communication, John Hackett 
cm237F2030 GGAAACCAAAAATGATAGGGGG 2377 - 2398 50 Personal Communication, John Hackett 
JA217 CTTTTATTTTTTCTTCTGTCAATGG 2622 - 2646 50 Plantier et al, 2005 
ABB20-3F ATCAGTACAATGTGCTTCCA 2980 - 2999 45 Personal Communication, John Hackett 
RTUG F3 GAAGCAGAATTAGAAYTGGCAGA 3441 - 3463 50 Personal Communication, John Hackett 
cm237F3000 TGTGRGTCTGTTACTATRTTTACTTC 4023 - 4048 50 Personal Communication, John Hackett 
rtin seq F2 CAACCAGAYARRAGTGAATCAGA 4074 - 4096 50 Personal Communication, S Engelbrecht 
poli7 AACAAGTAGATAAATTAGTCAGT 4186 - 4208 45 Swanson et al, 2003 
PPF17 AATTGGAGAGCAATGGCTAGTGA 4281 - 4303 50 Swanson et al, 2003 
ppr15 CCTTCTAAATGTGTACAATC 4419 - 4438 45 Personal Communication, John Hackett 
PPF2b  GCAGTCCATGTAGCCAGTGG 4455 - 4474 50 Personal Communication, John Hackett 
FGF46 GCATTCCCTACAATCCCCAAAG 4648 - 4669 55 Fong et al, 1996 
Key: TA, (Annealing temperature), and Ref (Reference) 
Table 6.4 continued: Sequencing primers used for the characterization of R84. 
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
poli10b TATTCATAGATTCYACTACTCCTTG 4671 - 4695 50 Personal Communication, John Hackett 
poli2 TAAARACARYAGTACWAATGGCA 4744 - 4766 50 Personal Communication, John Hackett 
PPR5b  ACTACTGCCCCTTCACCTTTCCA 4956 - 4978 55 Personal Communication, John Hackett 
poli6  ATACATATGRTGTTTTACTAARCT 5107 - 5130 45 Personal Communication, John Hackett 
PPR6 CCTGCCATCTGTTTTCCATA 5040 - 5059 45 Personal Communication, John Hackett 
55env272R TCTGGGGCTTGTTCCATCTATCTT 5552 - 5575 55 Personal Communication, John Hackett 
55env-5820R ATCAAAGTCCCCCATCTCCACAAG 6251 - 6273 55 Personal Communication, John Hackett 
20env5'2287F CTTTGAGCCCATTCCCATACATTA 6851 - 6874 50 Personal Communication, John Hackett 
55env222R AATCGCAAAACCAGCTGGAGCAC 6877 - 6899 55 Personal Communication, John Hackett 
ES7X CTGTTAAATGGCAGTCTAGC 7002 - 7021 55 Bachmann et al, 1994 
ES125 CAATTTCTGGGTCCCCTCCTGAG 7316 - 7338 60 Bachmann et al, 1994 
ES8X CACTTCTCCAATTGTCCCTCA 7648 - 7668 55 Bachmann et al, 1994 
SK68 AGCAGCAGGAAGCACTATGG 7796 - 7815 55 Ou et al, 1988 
env 27F CTGGYATAGTGCARCARCA 7861 - 7879 50 Swanson et al, 2003 
7496F CCTKGCYCTGGAAAGATACCTA 7964 - 7985 45 Personal Communication, John Hackett 
7542F.1 TGGGGCTGCTCTGGAAAACT 8010 - 8029 55 Personal Communication, John Hackett 
LP7728R CCACTTGTCCAATGCCAATAAGTCTTT 8222 - 8195 55 Personal Communication, John Hackett 
Menv 19R  AARCCTCCTACTATCATTATRA 8278 - 8299 45 Swanson et al, 2003 
GP41R1 AACGACAAAGGTGAGTATCCCTGCCTA 8347 - 8374 60 Pieniazek et al, 1998 
20LTR-3825F TGGGTGGCAAGTGGTCAAAAAGTA 8798 - 8821 55 Personal Communication, John Hackett 
20env 4038R GTACCTGCGGCCTGACTGGA 9000 - 9019 55 Personal Communication, John Hackett 
Key: TA, (Annealing temperature), and Ref (Reference) 
Table 6.5: Sequencing primers used for the sequencing of sample TV239  
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
env N CTGCCAATCAGGGAAGTAGCCTTGTGT 60 - 86 55 Derdeyn et al, 2004 
p24-2  AGRACYTTRAAYGCATGGGT 1237 - 1245 50 Swanson et al, 2003 
p24-6  TGTGWAGCTTGYTCRGCTC 1703 - 1721 50 Swanson et al, 2003 
F1432 AGGCAATGAGTCAAGTACAACA 1883 - 1904 50 Personal Communication, John Hackett 
cm237R2020 GGTGGGGCTGTTGGCTCTGG 2146 - 2165 60 Personal Communication, John Hackett 
cm237F2030 GGAAACCAAAAATGATAGGGGG 2377 - 2398 50 Personal Communication, John Hackett 
JA217 CTTTTATTTTTTCTTCTGTCAATGG 2622 - 2646 50 Plantier et al, 2005 
ABB20-3F ATCAGTACAATGTGCTTCCA 2980 - 2999 45 Personal Communication, John Hackett 
ABB20-11R TATGTCCATTGGTCTTGCCC 3546 - 3565 50 Personal Communication, John Hackett 
RTUG F3 GAAGCAGAATTAGAAYTGGCAGA 3441 - 3463 50 Personal Communication, John Hackett 
cm237F3000 TGTGRGTCTGTTACTATRTTTACTTC 4023 - 4048 50 Personal Communication, John Hackett 
rtin seq F2 CAACCAGAYARRAGTGAATCAGA 4074 - 4096 50 Personal Communication, S Engelbrecht 
poli7 AACAAGTAGATAAATTAGTCAGT 4186 - 4208 45 Swanson et al, 2003 
PPF17 AATTGGAGAGCAATGGCTAGTGA 4281 - 4303 50 Personal Communication, John Hackett 
ppr15 CCTTCTAAATGTGTACAATC 4419 - 4438 45 Personal Communication, John Hackett 
PPF2b  GCAGTCCATGTAGCCAGTGG 4455 - 4474 50 Personal Communication, John Hackett 
FGF46 GCATTCCCTACAATCCCCAAAG 4648 - 4669 55 Fong et al, 1996 
poli10b TATTCATAGATTCYACTACTCCTTG 4671 - 4695 50 Personal Communication, John Hackett 
poli2 TAAARACARYAGTACWAATGGCA 4744 - 4766 50 Swanson et al, 2003 
PPR6 CCTGCCATCTGTTTTCCATA 5040 - 5059 45 Personal Communication, John Hackett 
55env272R TCTGGGGCTTGTTCCATCTATCTT 5552 - 5575 55 Personal Communication, John Hackett 
Key: TA, (Annealing temperature), and Ref (Reference) 
Table 6.5 continued: Sequencing primers used for the sequencing of sample TV239  
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
55env-5521R GCTTCCGCTTCTTCCTGCCATAG 5968 - 5990 55 Personal Communication, John Hackett 
20env5'2287F CTTTGAGCCCATTCCCATACATTA 6851 - 6874 50 Personal Communication, John Hackett 
55env222R AATCGCAAAACCAGCTGGAGCAC 6877 - 6899 55 Personal Communication, John Hackett 
ES7X CTGTTAAATGGCAGTCTAGC 7002 - 7021 55 Bachmann et al, 1994 
ES8X CACTTCTCCAATTGTCCCTCA 7648 - 7668 55 Bachmann et al, 1994 
SK68 AGCAGCAGGAAGCACTATGG 7796 - 7815 55 Ou et al, 1988 
ED12 AGTGCTTCCTGCTGCTCCCAAGAACCCA 7782 - 7811 60 Delwart et al, 1993 
env 27F CTGGYATAGTGCARCARCA 7861 - 7879 50 Personal Communication, John Hackett 
LP7725R GTCCAATGCCAATAAGTCTTGTTC 8193 - 8216  50  Personal Communication, John Hackett 
Menv 19R  AARCCTCCTACTATCATTATRA 8278 - 8299 45 Swanson et al, 2003 
69env-3848F TGCTGCGAGGGGTGTGGAACTT 8555 - 8576 60 Personal Communication, John Hackett 
20env 4038R GTACCTGCGGCCTGACTGGA 9000 - 9019 55 Personal Communication, John Hackett 
Key: TA, (Annealing temperature), and Ref (Reference) 
Table 6.6: Sequencing primers used for the sequencing of TV314.  
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
p24-6  TGTGWAGCTTGYTCRGCTC 1703 - 1721 50 Swanson et al, 2003 
F1432 AGGCAATGAGTCAAGTACAACA 1883 - 1904 50 Personal Communication, John Hackett 
cm237R2020 GGTGGGGCTGTTGGCTCTGG 2146 - 2165 60 Personal Communication, John Hackett 
cm237F2030 GGAAACCAAAAATGATAGGGGG 2377 - 2398 50 Personal Communication, John Hackett 
JA217 CTTTTATTTTTTCTTCTGTCAATGG 2622 - 2646 50 Plantier et al, 2005 
ABB20-3F ATCAGTACAATGTGCTTCCA 2980 - 2999 45 Personal Communication, John Hackett 
ABB20-11R TATGTCCATTGGTCTTGCCC 3546 - 3565 50 Personal Communication, John Hackett 
RTUG F3 GAAGCAGAATTAGAAYTGGCAGA 3441 - 3463 50 Personal Communication, John Hackett 
cm237F3000 TGTGRGTCTGTTACTATRTTTACTTC 4023 - 4048 50 Personal Communication, John Hackett 
rtin seq F2 CAACCAGAYARRAGTGAATCAGA 4074 - 4096 50 Personal Communication, S Engelbrecht 
PPF2b  GCAGTCCATGTAGCCAGTGG 4455 - 4474 50 Personal Communication, John Hackett 
poli10b TATTCATAGATTCYACTACTCCTTG 4671 - 4695 50 Personal Communication, John Hackett 
poli2 TAAARACARYAGTACWAATGGCA 4744 - 4766 50 Swanson et al, 2003 
PPR6 CCTGCCATCTGTTTTCCATA 5040 - 5059 45 Personal Communication, John Hackett 
55env4F GGTGGTGGGGCCTCCATAGAAT 5284 - 5305 55 Personal Communication, John Hackett 
55env272R TCTGGGGCTTGTTCCATCTATCTT 5552 - 5575 55 Personal Communication, John Hackett 
20env-1301F ACTATGGGGTACCGGTGTGGAGA 6340 - 6362 55 Personal Communication, John Hackett 
55env222R AATCGCAAAACCAGCTGGAGCAC 6877 - 6899 55 Personal Communication, John Hackett 
ES7X CTGTTAAATGGCAGTCTAGC 7002 - 7021 55 Bachmann et al, 1994 
E120 GTAGAAATTAATTGTACAAGACCC  7098 - 7121 45 Bachmann et al, 1994 
Key: TA (Annealing temperature), F (Forward primer) and R (Reverse primer) 
Table 6.6 continued: Sequencing primers used for the sequencing of TV314.  
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
SK68 AGCAGCAGGAAGCACTATGG 7796 - 7815 55 Ou et al, 1988 
7542F.1 TGGGGCTGCTCTGGAAAACT 8010 - 8029 55 Personal Communication, John Hackett 
LP7725R GTCCAATGCCAATAAGTCTTGTTC 8193 - 8216 50 Personal Communication, John Hackett 
20env-3481R CAGGCAAGCGCGAAGAATCC 8475 - 8494 55 Personal Communication, John Hackett 
69env-3848F TGCTGCGAGGGGTGTGGAACTT 8555 - 8576 60 Personal Communication, John Hackett 
20LTR-3825F TGGGTGGCAAGTGGTCAAAAAGTA 8798 - 8821 55 Personal Communication, John Hackett 
20env 4038R GTACCTGCGGCCTGACTGGA 9000 - 9019 55 Personal Communication, John Hackett 
ABB55-4-1186 CCAGGGCCAGGGGTTAGAT 9181 - 9199 55 Personal Communication, John Hackett 
Key: TA (Annealing temperature), F (Forward primer) and R (Reverse primer) 
Table 6.7: Sequencing primers used for the sequencing of TV 412.  
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
p24-2  AGRACYTTRAAYGCATGGGT 1237 - 1256 50 Swanson et al, 2003 
p24-6  TGTGWAGCTTGYTCRGCTC 1703 - 1721 50 Swanson et al, 2003 
cm237F2030 GGAAACCAAAAATGATAGGGGG 2377 - 2398 50 Personal Communication, John Hackett 
JA217 CTTTTATTTTTTCTTCTGTCAATGG 2622 - 2646 50 Plantier et al, 2005 
ABB20-3F ATCAGTACAATGTGCTTCCA 2980 - 2999 45 Personal Communication, John Hackett 
ABB20-11R TATGTCCATTGGTCTTGCCC 3546 - 3565 50 Personal Communication, John Hackett 
RTUG F3 GAAGCAGAATTAGAAYTGGCAGA 3441 - 3463 50 Personal Communication, John Hackett 
cm237F3000 TGTGRGTCTGTTACTATRTTTACTTC 4023 - 4048 50 Personal Communication, John Hackett 
rtin seq F2 CAACCAGAYARRAGTGAATCAGA 4074 - 4096 50 Personal Communication, S Engelbrecht 
PPF17 AATTGGAGAGCAATGGCTAGTGA 4281 - 4303 50 Personal Communication, John Hackett 
ppr15 CCTTCTAAATGTGTACAATC 4419 - 4438 45 Personal Communication, John Hackett 
PPF2b  GCAGTCCATGTAGCCAGTGG 4455 - 4474 50 Personal Communication, John Hackett 
poli10b TATTCATAGATTCYACTACTCCTTG 4671 - 4695 50 Swanson et al, 2003 
poli2 TAAARACARYAGTACWAATGGCA 4744 - 4766 50 Personal Communication, John Hackett 
PPR6 CCTGCCATCTGTTTTCCATA 5040 - 5059 45 Personal Communication, John Hackett 
55env272R TCTGGGGCTTGTTCCATCTATCTT 5552 - 5575 55 Personal Communication, John Hackett 
55env-5820R ATCAAAGTCCCCCATCTCCACAAG 6251 - 6273 55 Personal Communication, John Hackett 
20env-1301F ACTATGGGGTACCGGTGTGGAGA 6340 - 6362 55 Personal Communication, John Hackett 
20env5'2287F CTTTGAGCCCATTCCCATACATTA 6851 - 6874 50 Personal Communication, John Hackett 
Key: TA (Annealing temperature), and Ref (Reference) 
Table 6.7 continued: Sequencing primers used for the sequencing of TV 412.  
Primer Oligo Nucleotide Sequence HXB2 Position TA Ref 
55env222R AATCGCAAAACCAGCTGGAGCAC 6877 - 6899 55 Personal Communication, John Hackett 
ES7X CTGTTAAATGGCAGTCTAGC 7002 - 7021 55 Bachmann et al, 1994 
20env-2513F GCAGAAAGTAGGGCAAGCAATGTA 7505 - 7528 55 Personal Communication, John Hackett 
SK68 AGCAGCAGGAAGCACTATGG 7796 - 7815 55 Ou et al, 1988 
LP7725R GTCCAATGCCAATAAGTCTTGTTC 8193 - 8216 50  Personal Communication, John Hackett 
GP41R1 AACGACAAAGGTGAGTATCCCTGCCTAA 8374 - 8374 60 Pieniazek et al, 1998 
JH38 GGTGARTATCCCTKCCTAAC 8346 - 8365 45  Swanson et al, 2003 
GP47R2 TTAAACCTATCAAGCCTCCTACTATCATTA 8281 - 8310 50 Pieniazek et al, 1998 
env-end CTTTTTGACCACTTGCCACCCAT 8797 - 8819 55 Personal Communication, S Engelbrecht 
Key: TA (Annealing temperature), and Ref (Reference) 
Appendix D 
 
6.4 Gene Cutter Results of NFLG’s 
 
Sample R84 from 601 – 9514 (coordinates relative to HXB2) 
Nucleotide and Amino Acid composition.  
 
gag – Red 
pol - Blue 
vif - Orange 
vpr - Green 
tat - Pink 
rev – Dark Red 
vpu – Sky Blue 
env – Sea Green 
nef – Dark Teal 
 
1         TTTTGACTAGCGGAGGCTAGAAGGAGAGAGATGGGTGCGAGAGCGTCAGTATTAAGCGGG 
1        F  *  L  A  E  A  R  R  R  E  M  G  A  R  A  S  V  L  S  G   
 
61        GGAGAATTAGATAGATGGGAAAAAATTCGGTTAAGGCCAGGGGGAAAGAAAAAATATAGA 
21         G  E  L  D  R  W  E  K  I  R  L  R  P  G  G  K  K  K  Y  R   
 
121       TTAAAACATATAGTATGGGCAAGCAGGGAGCTAGAACGATTCGCAGTTAACCCTGGCCTG 
41         L  K  H  I  V  W  A  S  R  E  L  E  R  F  A  V  N  P  G  L   
 
181       TTAGAAACATCAGAAGGCTGTAGACAAATACTGGGACAGCTACAACCAGCCCTTCAGACA 
61         L  E  T  S  E  G  C  R  Q  I  L  G  Q  L  Q  P  A  L  Q  T   
 
241       GGATCAGAAGAACTTAGATCATTATATAATACAGTAGCAACCCTCTATTGTGTACATCAA 
81         G  S  E  E  L  R  S  L  Y  N  T  V  A  T  L  Y  C  V  H  Q   
 
301       AAGATAGAGGTAAGAGACACCAAGGAAGCTTTAGAAAAGATAGAGGAAGAGCAAAACAAA 
101        K  I  E  V  R  D  T  K  E  A  L  E  K  I  E  E  E  Q  N  K   
 
361       AGTAAGAAAAAAGCACAGCAAGCAGCAGCTGACACAGGAAACAGCAGTCAGGTCAGCCAA 
121        S  K  K  K  A  Q  Q  A  A  A  D  T  G  N  S  S  Q  V  S  Q   
 
421       AATTACCCTATAGTGCAGAATATCCAGGGGCAAATGGTACATCAGGCCATATCACCTAGA 
141        N  Y  P  I  V  Q  N  I  Q  G  Q  M  V  H  Q  A  I  S  P  R   
 
481       ACTTTAAATGCATGGGTAAAAGTAGTAGAAGAGAAGGCTTTCAGCCCAGAAGTGATACCC 
161        T  L  N  A  W  V  K  V  V  E  E  K  A  F  S  P  E  V  I  P   
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541       ATGTTTTCAGCATTATCAGAAGGAGCCACCCCACAAGATTTAAACACCATGCTAAACACA 
181        M  F  S  A  L  S  E  G  A  T  P  Q  D  L  N  T  M  L  N  T   
 
601       GTGGGGGGACATCAAGCAGCCATGCAAATGTTAAAAGAGACCATCAATGAGGAAGCTGCA 
201        V  G  G  H  Q  A  A  M  Q  M  L  K  E  T  I  N  E  E  A  A   
 
661       GAATGGGATAGATTGCATCCAGTGCATGCAGGGCCTATTGCACCAGGCCAGATGAGAGAA 
221        E  W  D  R  L  H  P  V  H  A  G  P  I  A  P  G  Q  M  R  E   
 
721       CCAAGGGGAAGTGACATAGCAGGAACTACTAGTACCCTTCAGGAACAAATAGGATGGATG 
241        P  R  G  S  D  I  A  G  T  T  S  T  L  Q  E  Q  I  G  W  M   
 
781       ACAAATAATCCACCTATCCCAGTAGGAGAAATCTATAAAAGATGGATAATCCTAGGATTA 
261        T  N  N  P  P  I  P  V  G  E  I  Y  K  R  W  I  I  L  G  L   
 
841       AATAAAATAGTAAGGATGTATAGCCCTGTCAGCATTCTGGACATAAGACAAGGACCAAAG 
281        N  K  I  V  R  M  Y  S  P  V  S  I  L  D  I  R  Q  G  P  K   
 
901       GAACCCTTTAGAGACTATGTAGACCGGTTCTATAAAACTCTAAGAGCCGAACAAGCTTCA 
301        E  P  F  R  D  Y  V  D  R  F  Y  K  T  L  R  A  E  Q  A  S   
 
961       CAGGATGTAAAAAATTGGATGACAGAAACCTTGTTGGTCCAAAATGCGAACCCAGATTGT 
321        Q  D  V  K  N  W  M  T  E  T  L  L  V  Q  N  A  N  P  D  C   
 
1021      AAGACAATTTTAAAAGCATTGGGACCAGCAGCTACCCTAGAAGAAATGATGACAGCATGT 
341        K  T  I  L  K  A  L  G  P  A  A  T  L  E  E  M  M  T  A  C   
 
1081      CAGGGAGTAGGAGGACCCGGCCATAAAGCAAGAGTTTTGGCGGAAGCAATGGGCCAAGTA 
361        Q  G  V  G  G  P  G  H  K  A  R  V  L  A  E  A  M  G  Q  V   
 
1141      ACAAATGCAGCTACCATAATGATGCAGAAAGGCAATTTTAGGAACCAAAGAAAAAATGTT 
381        T  N  A  A  T  I  M  M  Q  K  G  N  F  R  N  Q  R  K  N  V   
 
1201      AAGTGTTTCAATTGTGGCAAAGAAGGGCACATAGCCAGAAATTGCAGGGCCCCTAGGAAA 
401        K  C  F  N  C  G  K  E  G  H  I  A  R  N  C  R  A  P  R  K   
 
1261      AGGGGCTGTTGGAAATGTGGAAAGGAAGGACACCAAATGAAAGATTGTACTGAGAGACAG 
421        R  G  C  W  K  C  G  K  E  G  H  Q  M  K  D  C  T  E  R  Q   
 
1321      GCTAATTTTTTAGGGAAGATCTGGCCTTCCCACAAGGGAAGGCCAGGGAATTTTCTTCAG 
441        A  N  F  L  G  K  I  W  P  S  H  K  G  R  P  G  N  F  L  Q   




1381      AGCAGACCAGAGCCAACAGCCCCACCAGAAGAGAGCTTCAGGTTTGGGGAAGAGACAACA 
461        S  R  P  E  P  T  A  P  P  E  E  S  F  R  F  G  E  E  T  T   
461          Q  T  R  A  N  S  P  T  R  R  E  L  Q  V  W  G  R  D  N  N 
 
1441      ACTCCCTCTCAGAAGCAGGAGCCGATAGACAAGGAACTATATCCTTTAGCTTCCCTCAGA 
481        T  P  S  Q  K  Q  E  P  I  D  K  E  L  Y  P  L  A  S  L  R   
481          S  L  S  E  A  G  A  D  R  Q  G  T  I  S  F  S  F  P  Q  I 
 
1501      TCACTCTTTGGCAACGACCCCTCGTCACAATAAAGATAGGGGGGCACCTAAAGGAAGCTC 
501        S  L  F  G  N  D  P  S  S  Q  *  R  *  G  G  T  *  R  K  L   
501          T  L  W  Q  R  P  L  V  T  I  K  I  G  G  H  L  K  E  A  L 
 
1561      TATTAGATACAGGAGCAGATGATACAGTATTAGAAGAAATGAGTTTGCCAGGAAGATGGA 
521          L  D  T  G  A  D  D  T  V  L  E  E  M  S  L  P  G  R  W  K 
 
1621      AACCAAAAATGATAGGGGGAATTGGAGGTTTTATCAAAGTAAGACAGTATGATCAGATAC 
541          P  K  M  I  G  G  I  G  G  F  I  K  V  R  Q  Y  D  Q  I  P 
 
1681      CCATAGAAATCTGTGGACATAAAGCTATAGGTACAGTATTAATAGGACCTACACCTGTCA  
561          I  E  I  C  G  H  K  A  I  G  T  V  L  I  G  P  T  P  V  N 
 
1741      ACATAATTGGAAGAAATCTGTTGACTCAGCTTGGTTGCACTTTAAATTTTCCCATTAGTC 
581          I  I  G  R  N  L  L  T  Q  L  G  C  T  L  N  F  P  I  S  P 
 
1801      CTATTGAAACTGTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAAAGTTAAACAAT 
601          I  E  T  V  P  V  K  L  K  P  G  M  D  G  P  K  V  K  Q  W 
 
1861      GGCCATTGACAGAAGAAAAAATAAAAGCATTAGTAGAAATTTGTACAGAAATGGAAAAGG 
621          P  L  T  E  E  K  I  K  A  L  V  E  I  C  T  E  M  E  K  E 
 
1921      AAGGGAAAATTTCAAAAATTGGGCCTGAAAATCCATACAATACTCCAGTATTTGCCATAA 
641          G  K  I  S  K  I  G  P  E  N  P  Y  N  T  P  V  F  A  I  K 
 
1981      AGAAAAAAGACAGTACTAAATGGAGAAAATTAGTAGATTTCAGAGAACTTAATAAGAAAA 
661          K  K  D  S  T  K  W  R  K  L  V  D  F  R  E  L  N  K  K  T 
 
2041      CTCAAGACTTCTGGGAAGTTCAATTAGGAATACCACATCCCGCAGGGTTAAAAAAGAAAA 
681          Q  D  F  W  E  V  Q  L  G  I  P  H  P  A  G  L  K  K  K  K 
 
2101      AATCAGTAACAGTACTGGATGTGGGTGATGCATATTTTTCAGTTCCCTTAGATAAAGACT 
701          S  V  T  V  L  D  V  G  D  A  Y  F  S  V  P  L  D  K  D  F 
 
2161      TCAGGAAGTATACTGCATTTACCATACCTAGTATAAACAATGAGACACCAGGGATTAGAT 




2221      ATCAGTACAATGTGCTTCCACAGGGATGGAAAGGATCACCAGCAATATTCCAAAGTAGCA 
741          Q  Y  N  V  L  P  Q  G  W  K  G  S  P  A  I  F  Q  S  S  M 
 
2281      TGACAAAAATCTTAGAGCCTTTTAGAAAGCAAAATCCAGACATAGTTATCTATCAATACA 
761          T  K  I  L  E  P  F  R  K  Q  N  P  D  I  V  I  Y  Q  Y  M 
 
2341      TGGATGATTTGTATGTAGGATCTGATTTAGAAATAGGGCAGCATAGAACAAAAATAGAAG 
781          D  D  L  Y  V  G  S  D  L  E  I  G  Q  H  R  T  K  I  E  E 
 
2401      AATTGAGACAACATCTGTTGAGGTGGGGATTCACCACACCAGACAAAAAACATCAGAAAG 
801          L  R  Q  H  L  L  R  W  G  F  T  T  P  D  K  K  H  Q  K  E 
 
2461      AACCTCCATTCCTTTGGATGGGTTATGAACTCCATCCTGATAAATGGACAGTACAGCCTA 
821          P  P  F  L  W  M  G  Y  E  L  H  P  D  K  W  T  V  Q  P  I 
 
2521      TAGTGCTGCCAGAAAAAGACAGCTGGACTGTCAATGACATACAGAAGTTAGTGGGAAAAT 
841          V  L  P  E  K  D  S  W  T  V  N  D  I  Q  K  L  V  G  K  L 
 
2581      TGAATTGGGCAAGTCAGATTTACGCAGGGATTAAAGTAAGGCAATTATGTAAACTCCTTA 
861          N  W  A  S  Q  I  Y  A  G  I  K  V  R  Q  L  C  K  L  L  R 
 
2641      GGGGAGCCAAAGCACTAACAGAAGTAATACCACTAACAGAAGAAGCAGAGCTAGAACTGG 
881          G  A  K  A  L  T  E  V  I  P  L  T  E  E  A  E  L  E  L  A 
 
2701      CAGAAAACAGGGAAATTCTAAAAGAACCAGTACATGGAGTGTATTATGACCCATCAAAAA 
901          E  N  R  E  I  L  K  E  P  V  H  G  V  Y  Y  D  P  S  K  N 
 
2761      ACTTAATAGCAGAAATACAGAAGCAGGGGCAAGGCCAATGGACATATCAAATTTATCAAG 
921          L  I  A  E  I  Q  K  Q  G  Q  G  Q  W  T  Y  Q  I  Y  Q  E 
 
2821      AGCCATTTAAAAATCTGAAAACAGGAAAATATGCAAGAATGAGGGGTGCCCACACTAATG 
941          P  F  K  N  L  K  T  G  K  Y  A  R  M  R  G  A  H  T  N  D 
 
2881      ATGTAAAACAATTAACAGAGGCAGTGCAAAAAATAGCCATAGAAAGCATAGTAATATGGG 
961          V  K  Q  L  T  E  A  V  Q  K  I  A  I  E  S  I  V  I  W  G 
 
2941      GAAAGACTCCTAAATTTAAACTACCCATACAAAAAGAAACATGGGAAGCATGGTGGACAG 
981          K  T  P  K  F  K  L  P  I  Q  K  E  T  W  E  A  W  W  T  E 
 
3001      AGTATTGGCAAGCCACCTGGATTCCTGAGTGGGAGTTTGTCAATACCCCTCCCTTAGTGA 
1001         Y  W  Q  A  T  W  I  P  E  W  E  F  V  N  T  P  P  L  V  K 
 
3061      AATTATGGTACCAGTTAGAGAAAGAACCCATAGTAGGAGCAGAAACTTTCTATGTAGATG 
1021         L  W  Y  Q  L  E  K  E  P  I  V  G  A  E  T  F  Y  V  D  G 
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3121      GGGCAGCTAACAGGGAGACTAAATTAGGAAAAGCAGGATATGTTACTAACAAAGGAAGAC 
1041         A  A  N  R  E  T  K  L  G  K  A  G  Y  V  T  N  K  G  R  Q 
 
3181      AAAAAGTTATCACCCTAACTGACACAACAAATCAGAAGACTGAGTTACAAGCAATTCATC 
1061         K  V  I  T  L  T  D  T  T  N  Q  K  T  E  L  Q  A  I  H  L 
 
3241      TAGCGTTGCAGGATTCGGGATTAGAAGTAAACATAGTAACAGACTCACAATATGCATTAG 
1081         A  L  Q  D  S  G  L  E  V  N  I  V  T  D  S  Q  Y  A  L  G 
 
3301      GAATCATTCAAGCACAACCAGATAAAAGTGAATCAGAGTTAGTCAGTCAAATAATAGAGC 
1101         I  I  Q  A  Q  P  D  K  S  E  S  E  L  V  S  Q  I  I  E  Q 
 
3361      AGTTAATAAAAAAGGAAAAGGTCTACCTGGCATGGGTACCAGCACACAAAGGAATTGGAG 
1121         L  I  K  K  E  K  V  Y  L  A  W  V  P  A  H  K  G  I  G  G 
 
3421      GAAATGAACAAGTAGATAAATTAGTCAGTGCTGGAATCAGGAAAGTACTATTTTTAGATG 
1141         N  E  Q  V  D  K  L  V  S  A  G  I  R  K  V  L  F  L  D  G 
 
3481      GGATAGATAAGGCCCAAGAAGAACATGAGAAATATCACAGTAATTGGAGAGCAATGGCTA 
1161         I  D  K  A  Q  E  E  H  E  K  Y  H  S  N  W  R  A  M  A  S 
 
3541      GTGATTTTAACCTGCCACCTATAGTAGCAAAAGAGATAGTAGCCAGCTGTGATAAATGTC 
1181         D  F  N  L  P  P  I  V  A  K  E  I  V  A  S  C  D  K  C  Q 
 
3601      AGTTAAAAGGAGAAGCCATACATGGACAAGTAGACTGTAGTCCAGGAATATGGCAACTAG 
1201         L  K  G  E  A  I  H  G  Q  V  D  C  S  P  G  I  W  Q  L  D 
 
3661      ATTGTACACATTTAGAAGGAAAAGTTATCCTGGTAGCAGTTCATGTAGCCAGTGGATATA 
1221         C  T  H  L  E  G  K  V  I  L  V  A  V  H  V  A  S  G  Y  I 
 
3721      TAGAAGCAGAAGTTATTCCAGCAGAGACAGGGCAGGAAACAGCATACTTTCTCTTAAAAT 
1241         E  A  E  V  I  P  A  E  T  G  Q  E  T  A  Y  F  L  L  K  L 
 
3781      TAGCAGGAAGATGGCCAGTAAAAACAATACATACAGACAATGGCAGCAATTTCACCAGTA 
1261         A  G  R  W  P  V  K  T  I  H  T  D  N  G  S  N  F  T  S  T 
 
3841      CTACGGTTAAGGCCGCCTGTTGGTGGGCGGGGATCAAGCAGGAATTTGGCATTCCCTACA 
1281         T  V  K  A  A  C  W  W  A  G  I  K  Q  E  F  G  I  P  Y  N 
 
3901      ATCCCCAAAGTCAAGGAGTAGTAGAATCTATGAATAAAGAATTAAAGAAAATTATAGGAC 
1301         P  Q  S  Q  G  V  V  E  S  M  N  K  E  L  K  K  I  I  G  Q 
 
3961      AGGTAAGAGATCAGGCTGAACATCTTAAGACAGCAGTACAAATGGCAGTATTCATCCACA 
1321         V  R  D  Q  A  E  H  L  K  T  A  V  Q  M  A  V  F  I  H  N 
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4021      ATTTTAAAAGAAAAGGGGGGATTGGGGGGTACAGTGCAGGGGAAAGAATAGTAGACATAA 
1341         F  K  R  K  G  G  I  G  G  Y  S  A  G  E  R  I  V  D  I  I 
 
4081      TAGCAACAGACATACAAACTAAAGAATTACAAAAACAAATTACAAAAATTCAAAATTTTC 
1361         A  T  D  I  Q  T  K  E  L  Q  K  Q  I  T  K  I  Q  N  F  R 
 
4141      GGGTTTATTACAGGGACAGCAGAGAGCCACTTTGGAAAGGACCAGCAAAGCTTCTCTGGA 
1381         V  Y  Y  R  D  S  R  E  P  L  W  K  G  P  A  K  L  L  W  K 
 
4201      AAGGTGAAGGGGCAGTAGTAATACAAGATAATAGTGACATAAAAGTAGTGCCAAGAAGAA 
1401         G  E  G  A  V  V  I  Q  D  N  S  D  I  K  V  V  P  R  R  K 
 
4261      AAGTAAAAATCATTAGGGATTATGGAAAACAGATGGCAGGTGATGATTGTGTGGCAAGTA 
1421       K  *  K  S  L  G  I  M  E  N  R  W  Q  V  M  I  V  W  Q  V   
1421         V  K  I  I  R  D  Y  G  K  Q  M  A  G  D  D  C  V  A  S  R 
 
4321      GACAGGATGAGGATTAGAACATGGAACAGTTTAGTAAAACACCATATGTATAGGTCAGGG 
1441       D  R  M  R  I  R  T  W  N  S  L  V  K  H  H  M  Y  R  S  G   
1441         Q  D  E  D  *  N  M  E  Q  F  S  K  T  P  Y  V  *  V  R  E 
 
4381      AAAGCTAGGGGATGGGTTTATAGACATCACTATGAAAGCACTCATCCAAGAATAAGTTCA 
1461       K  A  R  G  W  V  Y  R  H  H  Y  E  S  T  H  P  R  I  S  S   
 
4441      GAAGTACACATCCCACTAGGGGACGCTAGATTGATAATAACAACATATTGGGGTCTGCAT 
1481       E  V  H  I  P  L  G  D  A  R  L  I  I  T  T  Y  W  G  L  H   
 
4501      ACAGGAGAAAGAGACTGGCATTTGGGTCAGGGAGTCTCCATAGAATGGAGGAAAGAGAGA 
1501       T  G  E  R  D  W  H  L  G  Q  G  V  S  I  E  W  R  K  E  R   
 
4561      TATAGCACACAAGTAGACCCTAGCCTAGCAGACCAACTAATTCATATGTATTACTTTAAT 
1521       Y  S  T  Q  V  D  P  S  L  A  D  Q  L  I  H  M  Y  Y  F  N   
 
4621      TGTTTTTCAGAATCTGCTATAAGAAATGCCATATTAGGACATAGAGTTAGTCCTAGTTGT 
1541       C  F  S  E  S  A  I  R  N  A  I  L  G  H  R  V  S  P  S  C   
 
4681      GAATATCAAGCAGGACATAACAAGGTAGGATCTCTACAGTACTTGGCACTAGCAGCATTA 
1561       E  Y  Q  A  G  H  N  K  V  G  S  L  Q  Y  L  A  L  A  A  L   
 
4741      ATAACACCAAAAAGGATAAAGCCACCTTTGCCTAGTGTTACGAAACTGACAGAGGATAGA 
1581       I  T  P  K  R  I  K  P  P  L  P  S  V  T  K  L  T  E  D  R   
1581         N  T  K  K  D  K  A  T  F  A  *  C  Y  E  T  D  R  G  *  M 
 
4801      TGGAACAAGCCCCAGAAGACCAAGGGCCACAGAGGGAGCCATACAATGAATGGACACTAG 
1601       W  N  K  P  Q  K  T  K  G  H  R  G  S  H  T  M  N  G  H  *   
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1601         E  Q  A  P  E  D  Q  G  P  Q  R  E  P  Y  N  E  W  T  L  E 
 
4861      AGCTTTTAGAGGAGCTTAAGAATGAAGCTGTTAGACACTTTCCTAGGATCTGGCTCCATG 
1621         L  L  E  E  L  K  N  E  A  V  R  H  F  P  R  I  W  L  H  G 
 
4921      GATTAGGGCAACATATCTATGAAACATATGGGGATACTTGGGCAGGAGTGGAAGCCATAA 
1641         L  G  Q  H  I  Y  E  T  Y  G  D  T  W  A  G  V  E  A  I  I 
 
4981      TAAGAATTTTGCAACAACTGCTGTTTATTCATTTCAGAATTGGGTGTCGCCATAGCAGAA 
1661         R  I  L  Q  Q  L  L  F  I  H  F  R  I  G  C  R  H  S  R  I 
 
5041      TAGGCATTACTCTACAGAGAAGAGCAAGAAATGGAGCCAGTAGATCCTAGACTAGAGCCC 
1681       *  A  L  L  Y  R  E  E  Q  E  M  E  P  V  D  P  R  L  E  P   
1681         G  I  T  L  Q  R  R  A  R  N  G  A  S  R  S  *  T  R  A  L 
 
5101      TGGAAGCATCCAGGAAGTCAGCCTAAGACTGCTTGTACCCCTTGCTATTGTAAAAGGTGT 
1701       W  K  H  P  G  S  Q  P  K  T  A  C  T  P  C  Y  C  K  R  C   
 
5161      TGCTTTCATTGCCAAGTTTGTTTCATAAAAAAAGCTTTAGGCATCTCCTATGGCAGGAAG 
1721       C  F  H  C  Q  V  C  F  I  K  K  A  L  G  I  S  Y  G  R  K   
1721        A  F  I  A  K  F  V  S  *  K  K  L  *  A  S  P  M  A  G  R  
 
5221      AAGCGGAGACAGCGACGAAGAGCTCCTCAAAGCAGTCAGACTCATCAAGTTTCTCTATCA 
1741       K  R  R  Q  R  R  R  A  P  Q  S  S  Q  T  H  Q  V  S  L  S   
1741        S  G  D  S  D  E  E  L  L  K  A  V  R  L  I  K  F  L  Y  Q  
 
5281      AAGCAGTAAGTAGTACATGTAATGCAATCTTTACACATATTAGCAATAGTAGCATTAGTA 
1761       K  Q  *  V  V  H  V  M  Q  S  L  H  I  L  A  I  V  A  L  V   
1761        S  S  K  *  Y  M  *  C  N  L  Y  T  Y  *  Q  *  *  H  *  *  
 
5341      GTAGCAATAATAATAGCAATAGTTGTGTGGTCCATAGTATTCATAGAATATAGGAAAATA 
1781       V  A  I  I  I  A  I  V  V  W  S  I  V  F  I  E  Y  R  K  I   
 
5401      TTAAGACAAAGAAAAATAGACAGGTTAATTGATAGAATAAGAGAAAGAGCAGAAGACAGT 
1801       L  R  Q  R  K  I  D  R  L  I  D  R  I  R  E  R  A  E  D  S   
 
5461      GGCAATGAAAGTGAAGGGGATCAGGAAGAATTATCAGCACTTGTGGAGATGGGGCACCAT 
1821       G  N  E  S  E  G  D  Q  E  E  L  S  A  L  V  E  M  G  H  H   
1821        A  M  K  V  K  G  I  R  K  N  Y  Q  H  L  W  R  W  G  T  M  
 
5521      GCTCCTTGGGATGTTAATGATCTGTAGTGCTGCAGAACAATTGTGGGTCACAGTCTATTA 
1841       A  P  W  D  V  N  D  L  *  C  C  R  T  I  V  G  H  S  L  L   




5581      TGGGGTACCTGTGTGGAAAGAAGCAACCACCACTCTATTTTGTGCCTCAGATGCTAAAGC 
1861        G  V  P  V  W  K  E  A  T  T  T  L  F  C  A  S  D  A  K  A  
 
5641      ATATGATACAGAGGTACATAATGTTTGGGCCACACATGCCTGTGTACCCACAGACCCCAA 
1881        Y  D  T  E  V  H  N  V  W  A  T  H  A  C  V  P  T  D  P  N  
 
5701      CCCACAAGAAGTAGTATTGGAAAATGTGACAGAATATTTTAACATGTGGAAAAATGACAT 
1901        P  Q  E  V  V  L  E  N  V  T  E  Y  F  N  M  W  K  N  D  M  
 
5761      GGTAGAACAGATGCATGAGGATATAATCAGTTTATGGGATCAAAGCCTAAAGCCATGTGT 
1921        V  E  Q  M  H  E  D  I  I  S  L  W  D  Q  S  L  K  P  C  V  
 
5821      AAAATTAACCCCACTCTGTGTTACTTTAAATTGCACTGATTGGAAGAATACTACTAATAC 
1941        K  L  T  P  L  C  V  T  L  N  C  T  D  W  K  N  T  T  N  T  
 
5881      CACTAGTAGTGGCGGGGAAATGATGGGGGAAGGAGAAATGAAAAACTGCTCTTTCAACAT 
1961        T  S  S  G  G  E  M  M  G  E  G  E  M  K  N  C  S  F  N  I  
 
5941      CACCACAAGCTTAAAAGATAAGGTGCAGAGAGAATATGCACTTCTTTATAAACTTGATGT 
1981        T  T  S  L  K  D  K  V  Q  R  E  Y  A  L  L  Y  K  L  D  V  
 
6001      AGTGCCAATAGAGAATGATGATAGTAATTCCAGATATAGGTTGATAAGTTGTAACACCTC 
2001        V  P  I  E  N  D  D  S  N  S  R  Y  R  L  I  S  C  N  T  S  
 
6061      AGTCATTACACAGGCCTGTCCAAAAGTATCCTTTCASCCAATTCCCATACATTATTGTGC 
2021        V  I  T  Q  A  C  P  K  V  S  F  X  P  I  P  I  H  Y  C  A  
 
6121      CCCGGCTGGTTTTGCGATTCTAAAGTGTAACGATAAGAGGTTCGAGGGAAAAGGGCCGTG 
2041        P  A  G  F  A  I  L  K  C  N  D  K  R  F  E  G  K  G  P  C  
 
6181      TACAAATGTCAGCACAGTACAATGTACACATGGAATTAAGCCAGTAGTATCAACTCAACT 
2061        T  N  V  S  T  V  Q  C  T  H  G  I  K  P  V  V  S  T  Q  L  
 
6241      GYTGTTAAATGGCAGTCTAGCAGAAGAAGAGGTAGTAATTAGATCTGACAATTTCACGAA 
2081        X  L  N  G  S  L  A  E  E  E  V  V  I  R  S  D  N  F  T  N  
 
6301      CAATGCTAAAACCATAATAGTACAACTGAAAGAATCTGTAGAAATTAATTGTACAAGGCC 
2101        N  A  K  T  I  I  V  Q  L  K  E  S  V  E  I  N  C  T  R  P  
 
6361      CAACAACAATACAAGAAAAAGTATACATATAGGACCAGGGAGAGCATTTTATACAACAGG 
2121        N  N  N  T  R  K  S  I  H  I  G  P  G  R  A  F  Y  T  T  G  
 
6421      AGAAATAATAGGAGATATAAGACAAGCATATTGTAACATTAGTAGTACAAAATGGAATAA 
2141        E  I  I  G  D  I  R  Q  A  Y  C  N  I  S  S  T  K  W  N  N  
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6481      CACTTTAAGACAGATAGTTGGAAAATTAAGAGAAAAATTTGGGAATAAAACAATAGTTTT 
2161        T  L  R  Q  I  V  G  K  L  R  E  K  F  G  N  K  T  I  V  F  
 
6541      TAATCAATCCTCAGGAGGGGACATAGAAATTGTAATGCACAGTTTTAATTGTGGAGGGGA 
2181        N  Q  S  S  G  G  D  I  E  I  V  M  H  S  F  N  C  G  G  E  
 
6601      ATTTTTCTACTGTAACTTAACACAACTGTTTAATAGTACTTGGAATGTAAATGGTACTGA 
2201        F  F  Y  C  N  L  T  Q  L  F  N  S  T  W  N  V  N  G  T  E  
 
6661      AGGGTCAAATAACACTGACAAAAATATCACACTCCCATGCAGGATAAAACAAATTATAAA 
2221        G  S  N  N  T  D  K  N  I  T  L  P  C  R  I  K  Q  I  I  N  
 
6721      CATGTGGCAGACAGTAGGAAAAGCAATGTATGCCCCTCCCATCAGAGGACAAATTAGATG 
2241        M  W  Q  T  V  G  K  A  M  Y  A  P  P  I  R  G  Q  I  R  C  
 
6781      TTCATCAAATATTACAGGGCTGCTATTAACAAGAGATGGTGGTAATAACGAGAACGATCC 
2261        S  S  N  I  T  G  L  L  L  T  R  D  G  G  N  N  E  N  D  P  
 
6841      CGAAAATTCACCCGGAGGAGGAGATATGAGGGACAATTGGAGAAGTGAATTATATAAATA 
2281        E  N  S  P  G  G  G  D  M  R  D  N  W  R  S  E  L  Y  K  Y  
 
6901      TAAAGTATTAAAAATTAAAGCATTAGGAGTAGCACCCCCCAAGGCCAAGAGAAGAGTGGT 
2301        K  V  L  K  I  K  A  L  G  V  A  P  P  K  A  K  R  R  V  V  
 
6961      GCAAAGAGTAAAAAGAGCAGTGGGAATAGGAGCTGTGTTCTTTGGGTTCTTGGGAGCAGC 
2321        Q  R  V  K  R  A  V  G  I  G  A  V  F  F  G  F  L  G  A  A  
 
7021      AGGAAGCACTATGGGCGCAGCGTCAATGACGCTGACGGTACAGGCCAGACTATTATTGTC 
2341        G  S  T  M  G  A  A  S  M  T  L  T  V  Q  A  R  L  L  L  S  
 
7081      TGGTATAGTGCAACAGCAAAACAATTTGCTGAAGGCTATTGAGGCGCAACAGCACCTGTT 
2361        G  I  V  Q  Q  Q  N  N  L  L  K  A  I  E  A  Q  Q  H  L  L  
 
7141      GCAACTCACAGTCTGGGGCATCAAGCAGCTCCAGGCAAGAGTCCTGGCTATAGAAAGATA 
2381        Q  L  T  V  W  G  I  K  Q  L  Q  A  R  V  L  A  I  E  R  Y  
 
7201      CCTAAAGGATCAACAGCTCCTGGGGATTTGGGGTTGCTCTGGAAAACTCATTTGCACCAC 
2401        L  K  D  Q  Q  L  L  G  I  W  G  C  S  G  K  L  I  C  T  T  
 
7261      TGCTGTGCCTTGGAATGCTAGTTGGAGTAATAAATCTCAGGATAAGATTTGGCATAACAT 
2421        A  V  P  W  N  A  S  W  S  N  K  S  Q  D  K  I  W  H  N  M  
 
7321      GACCTGGATGGAGTGGGAAAGAGAAATTAGCAATTACACAAGCTTAATATACAACTTACT 
2441        T  W  M  E  W  E  R  E  I  S  N  Y  T  S  L  I  Y  N  L  L  
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7381      TGAAGAATCGCAAAACCAACAAGAAAAGAATGAACAAGAATTATTGGAATTAGATAAATG 
2461        E  E  S  Q  N  Q  Q  E  K  N  E  Q  E  L  L  E  L  D  K  W  
 
7441      GGCAAATTTGTGGAATTGGTTTAGCATATCAAACTGGCTGTGGTATATAAAAATATTCAT 
2481        A  N  L  W  N  W  F  S  I  S  N  W  L  W  Y  I  K  I  F  I  
 
7501      AATGATAATAGGAGGCTTGGTAGGTTTAAGAATAGTTTTTGCTGTACTTTCTATAGTGAA 
2501        M  I  I  G  G  L  V  G  L  R  I  V  F  A  V  L  S  I  V  N  
 
7561      TAGAGTTAGGCAGGGATACTCACCATTATCGTTGCAGACCCGCCTGCCAGCAGCCTCGAG 
2521       *  S  *  A  G  I  L  T  I  I  V  A  D  P  P  A  S  S  L  E   
2521        R  V  R  Q  G  Y  S  P  L  S  L  Q  T  R  L  P  A  A  S  R  
2521         E  L  G  R  D  T  H  H  Y  R  C  R  P  A  C  Q  Q  P  R  G 
 
7621      GGGACCCGACAGGCCCGAAGGAATCGAAGAAGAAGGTGGAGAGAGAGACAGAGACAGATC 
2541       G  T  R  Q  A  R  R  N  R  R  R  R  W  R  E  R  Q  R  Q  I   
2541        G  P  D  R  P  E  G  I  E  E  E  G  G  E  R  D  R  D  R  S  
2541         D  P  T  G  P  K  E  S  K  K  K  V  E  R  E  T  E  T  D  P 
 
7681      CGGTGGATTAGTGAACGGATTCTTAGCACTTATCTGGATCGACCTACGGAGCCTGTGCCT 
2561       R  W  I  S  E  R  I  L  S  T  Y  L  D  R  P  T  E  P  V  P   
2561        G  G  L  V  N  G  F  L  A  L  I  W  I  D  L  R  S  L  C  L  
2561         V  D  *  *  T  D  S  *  H  L  S  G  S  T  Y  G  A  C  A  S 
 
7741      CTTCAGCTACCACCGCTTGAGAGACTTACTCTTGATTGTAACGAGGATTGTGGAACTTCT 
2581       L  Q  L  P  P  L  E  R  L  T  L  D  C  N  E  D  C  G  T  S   
2581        F  S  Y  H  R  L  R  D  L  L  L  I  V  T  R  I  V  E  L  L  
 
7801      GGGACGCAGGGGGTGGGAACCCCTCAAATATTGGTGGAATCTCCTACAGTATTGGAGTCA 
2601       G  T  Q  G  V  G  T  P  Q  I  L  V  E  S  P  T  V  L  E  S   
2601        G  R  R  G  W  E  P  L  K  Y  W  W  N  L  L  Q  Y  W  S  Q  
 
7861      GGAACTAAAGAATAGTGCTATTAGCTTGCTCAATGCCACAGCCATAGCAGTAGCTGAGGG 
2621       G  T  K  E  *  C  Y  *  L  A  Q  C  H  S  H  S  S  S  *  G   
2621        E  L  K  N  S  A  I  S  L  L  N  A  T  A  I  A  V  A  E  G  
 
7921      GACAGATAGGGTTATAGAAGTATTACAAAGAGCTTATAGAGTTATTCTCCACATACCTAG 
2641        T  D  R  V  I  E  V  L  Q  R  A  Y  R  V  I  L  H  I  P  R  
 
7981      AAGAATAAGACAGGGCGCGGAAAGGGCTTTGGTATAAGATGGGTGGCAAGTGGTCAAAAA 
2661        R  I  R  Q  G  A  E  R  A  L  V  *  D  G  W  Q  V  V  K  K  
2661         E  *  D  R  A  R  K  G  L  W  Y  K  M  G  G  K  W  S  K  S 
 
8041      GTAGTGTGGTTGGATGGCCTACTGTAAGGGAAAGAATGAGACGAGCACGAGCTGAGCCAG 
2681         S  V  V  G  W  P  T  V  R  E  R  M  R  R  A  R  A  E  P  A 
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8101      CAGCAGAGCCAGCAGCATGTGGGGTGGGAGCAGCATCTCGAGACCTGGAAAAACATGGAG 
2701         A  E  P  A  A  C  G  V  G  A  A  S  R  D  L  E  K  H  G  A 
 
8161      CACTCACAAGTAGCAATACAGCAACTAACAATGCTGATTGTGCCTGGCTAAAAGCACAAG 
2721         L  T  S  S  N  T  A  T  N  N  A  D  C  A  W  L  K  A  Q  E 
 
8221      AGGAGGAGGTGGTGGTTTTTCCAGTCAGACCTCAGGTACCTTTAAGACCAATGACTTACA 
2741         E  E  V  V  V  F  P  V  R  P  Q  V  P  L  R  P  M  T  Y  K 
 
8281      AGGCAGCTTTAGATCTTAGCCACTTTTTAAAAGAAAAGGGGGGACTGGAAGGGCTAATTC 
2761         A  A  L  D  L  S  H  F  L  K  E  K  G  G  L  E  G  L  I  H 
 
8341      ACTCCCAAAAAAGACAAGATATCCTTGATCTGTGGGTCTACCACACACAAGGCTACTTCC 
2781         S  Q  K  R  Q  D  I  L  D  L  W  V  Y  H  T  Q  G  Y  F  P 
 
8401      CTGATTGGCAGAACTACACACCAGGGCCAGGGATCAGGTACCCACTGACCTTCGGATGGT 
2801         D  W  Q  N  Y  T  P  G  P  G  I  R  Y  P  L  T  F  G  W  C 
 
8461      GCTTCAAGCTAGTACCTGTTGAACCAGAGAAGATAGAAGAAGCCAATGAAGGAGAGAACA 
2821         F  K  L  V  P  V  E  P  E  K  I  E  E  A  N  E  G  E  N  N 
 
8521      ACAGATTGTTACACCCTATGAGCCTGCATGGGATGGAGGACCCGGAGAGAGAAGTGTTAG 
2841         R  L  L  H  P  M  S  L  H  G  M  E  D  P  E  R  E  V  L  E 
 
8581      AGTGGAGGTTTGACAGTCGCCTAGCATATCATCACTTGGCCCGAGAGATACATCCGGAGT 
2861         W  R  F  D  S  R  L  A  Y  H  H  L  A  R  E  I  H  P  E  Y 
 
8641      ACTACAAGGACTGCTGACATCGAGCTTTCTACAAGGGACTTTCCCCTGGGGGACTTTCCA 
2881         Y  K  D  C   
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Sample TV 239 gag-pol from 1245 – 5534 (coordinates relative to HSB2) 
Nucleotide and Amino Acid composition 
 
gag – Red 
pol - Blue 
vif - Orange 
 
1         TTGAATGCATGGGTAAAAGTAATAGAAGAAAAGGCTTTCAGCCCAGAAGTAATACCCATG 
1          L  N  A  W  V  K  V  I  E  E  K  A  F  S  P  E  V  I  P  M   
 
61        TTCTCAGCATTATCAGAAGGAGCCACCCCGCAAGATTTAAATATGATGCTAAACATAGTG 
21         F  S  A  L  S  E  G  A  T  P  Q  D  L  N  M  M  L  N  I  V   
 
121       GGGGGACACCAGGCAGCAATGCAAATGTTAAAAGATACCATCAATGAGGAGGCTATAGAA 
41         G  G  H  Q  A  A  M  Q  M  L  K  D  T  I  N  E  E  A  I  E   
 
181       TGGGACAGGACACATCCAGTACATGCAGGACCTATCCCACCAGGCCAGATGAGAGAACCA 
61         W  D  R  T  H  P  V  H  A  G  P  I  P  P  G  Q  M  R  E  P   
 
241       AGGGGAAGTGATATAGCAGGAACTACTAGTACCCTTCAAGAACAGATAGGATGGATGACA 
81         R  G  S  D  I  A  G  T  T  S  T  L  Q  E  Q  I  G  W  M  T   
 
301       AGTAACCCACCTATCCCAGTGGGAGACATCTATAAAAGGTGGATAATCCTGGGATTAAAT 
101        S  N  P  P  I  P  V  G  D  I  Y  K  R  W  I  I  L  G  L  N   
 
361       AAAATAGTAAGAATGTATAGCCCTGTCAGCATTTTGGACATAAGACAAGGGCCAAAAGAA 
121        K  I  V  R  M  Y  S  P  V  S  I  L  D  I  R  Q  G  P  K  E   
 
421       CCCTTCAGAGACTATGTAGATAGGTTCTTTAAAGCTCTCAGAGCTGAGCAAGCTACACAA 
141        P  F  R  D  Y  V  D  R  F  F  K  A  L  R  A  E  Q  A  T  Q   
 
481       GAAGTAAAAAACTGGATGACAGAAACTTTACTGGTCCAAAATGCAAATCCAGACTGTAAG 
161        E  V  K  N  W  M  T  E  T  L  L  V  Q  N  A  N  P  D  C  K   
 
541       TCTATTTTAAAAGCATTAGGACAGGGGCCTACATTAGAAGAAATGATGACAGCATGCCAG 
181        S  I  L  K  A  L  G  Q  G  P  T  L  E  E  M  M  T  A  C  Q   
 
601       GGAGTGGGAGGACCCAGCCATAAGGCAAGGGTTTTAGCAGAAGCAATGAGTCAAGTACAA 
201        G  V  G  G  P  S  H  K  A  R  V  L  A  E  A  M  S  Q  V  Q   
 
661       AACACAAACATAATGATGCAGAGAGGCAATTTTAAGGGCCAGAAAAGAACTATTAAGTGT 
221        N  T  N  I  M  M  Q  R  G  N  F  K  G  Q  K  R  T  I  K  C   
 
721       TTCAATTGTGGCAAAGAAGGACACCTAGCCAGAAATTGCAGGGCCCCTAGAAAAAAGGGC 
241        F  N  C  G  K  E  G  H  L  A  R  N  C  R  A  P  R  K  K  G   
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781       TGTTGGAAATGTGGAAAAGAAGGGCACCAGATGAAGGACTGTACTGAGAGACAGGCTAAT 
261        C  W  K  C  G  K  E  G  H  Q  M  K  D  C  T  E  R  Q  A  N   
 
841       TTTTTAGGGAAAATCTGGCCTTCCAGCAAAGGGAGGCCAGGGAATTTTCCTCAGAACAGA 
281        F  L  G  K  I  W  P  S  S  K  G  R  P  G  N  F  P  Q  N  R   
281          F  R  E  N  L  A  F  Q  Q  R  E  A  R  E  F  S  S  E  Q  T 
 
901       CTGGAGCCAACAGCCCCACCAGCAGAGAGCTTTGGGATGGGAGAAGGAATAACCTCCCCT 
301        L  E  P  T  A  P  P  A  E  S  F  G  M  G  E  G  I  T  S  P   
301          G  A  N  S  P  T  S  R  E  L  W  D  G  R  R  N  N  L  P  S 
 
961       CCGAAGCAGGAGCAGAGAGACAGGGAACAGCCCCCTCCCTTAGTTTCCCTCAAATCACTC 
321        P  K  Q  E  Q  R  D  R  E  Q  P  P  P  L  V  S  L  K  S  L   
321          E  A  G  A  E  R  Q  G  T  A  P  S  L  S  F  P  Q  I  T  L 
 
1021      TTTGGCAACGACCCCTTGTCACAGTAAAAATAGGGGGACAACTAAGAGAAGCCCTATTAG 
341        F  G  N  D  P  L  S  Q  *  K  *  G  D  N  *  E  K  P  Y  *   
341          W  Q  R  P  L  V  T  V  K  I  G  G  Q  L  R  E  A  L  L  D 
 
1081      ATACAGGGGCAGATGATACAGTATTAGAAGAAATAAATTTGCCAGGAAAATGGAAACCAA 
361          T  G  A  D  D  T  V  L  E  E  I  N  L  P  G  K  W  K  P  K 
 
1141      AAATGATAGGGGGAATTGGAGGTTTTATTAAGGTAAGACAATATGATCAGATACTTATAG 
381          M  I  G  G  I  G  G  F  I  K  V  R  Q  Y  D  Q  I  L  I  E 
 
1201      AAATTTGTGGAAAGAAGGCAATAGGTACAGTATTGGTAGGACCTACACCTGTCAACATAA 
401          I  C  G  K  K  A  I  G  T  V  L  V  G  P  T  P  V  N  I  I 
 
1261      TTGGAAGAAATATGTTGACCCAGATTGGTTGTACCTTAAATTTTCCAATTAGTCCTATTG 
421          G  R  N  M  L  T  Q  I  G  C  T  L  N  F  P  I  S  P  I  E 
 
1321      AAACTGTACCAGTAACATTAAAGCCAGGAATGGATGGCCCAAAGGTTAAACAATGGCCAT 
441          T  V  P  V  T  L  K  P  G  M  D  G  P  K  V  K  Q  W  P  L 
 
1381      TGACAGAAGAAAAAATAAAAGCATTAACAGAAATTTGTACAGAAATGGAAAAGGAAGGAA 
461          T  E  E  K  I  K  A  L  T  E  I  C  T  E  M  E  K  E  G  K 
 
1441      AAATTTCAAAAATTGGGCCTGAAAATCCATACAATACTCCAGTATTTGCTATAAAGAAGA 
481          I  S  K  I  G  P  E  N  P  Y  N  T  P  V  F  A  I  K  K  K 
 
1501      AGGACAGCACTAAATGGAGGAAGTTAGTAGATTTCAGAGAACTCAATAAAAGAACTCAGG 




1561      ACTTCTGGGAAGTTCAATTAGGAATACCACATCCAGCAGGTTTAAAAAAGAAAAAATCAG 
521          F  W  E  V  Q  L  G  I  P  H  P  A  G  L  K  K  K  K  S  V 
 
1621      TAACAGTACTAGATGTGGGGGACGCATATTTTTCAGTTCCTTTAGATGAAAACTTTAGAA 
541          T  V  L  D  V  G  D  A  Y  F  S  V  P  L  D  E  N  F  R  K 
 
1681      AGTATACTGCGTTCACCATACCTAGTACAAACAATGAGACACCAGGAGTCAGGTATCAAT 
561          Y  T  A  F  T  I  P  S  T  N  N  E  T  P  G  V  R  Y  Q  Y 
 
1741      ACAATGTGCTTCCACAGGGATGGAAAGGATCACCAGCAATATTCCAAAGTAGCATGACAA 
581          N  V  L  P  Q  G  W  K  G  S  P  A  I  F  Q  S  S  M  T  K 
 
1801      AAATCTTAGAACCCTTTAGATCACAAAATCCAGAAATAGTTATCTATCAATACATGGATG 
601          I  L  E  P  F  R  S  Q  N  P  E  I  V  I  Y  Q  Y  M  D  D 
 
1861      ACTTATATGTAGGATCTGATTTAGAAATAGGGCAGCATAGAGAAAAGGTGGAAGAGTTAA 
621          L  Y  V  G  S  D  L  E  I  G  Q  H  R  E  K  V  E  E  L  R 
 
1921      GAAAGCATCTATTGAGCTGGGGATTAACTACACCAGACAAAAAGCACCAGAAAGAACCTC 
641          K  H  L  L  S  W  G  L  T  T  P  D  K  K  H  Q  K  E  P  P 
 
1981      CATTTCTTTGGATGGGGTATGAACTCCATCCTGACAAATGGACAGTCCAGCCTATACAGC 
661          F  L  W  M  G  Y  E  L  H  P  D  K  W  T  V  Q  P  I  Q  L 
 
2041      TGCCAGACAAGGACAGCTGGACTGTTAATGATATACAGAAATTAGTGGGAAAACTAAATT 
681          P  D  K  D  S  W  T  V  N  D  I  Q  K  L  V  G  K  L  N  W 
 
2101      GGGCAAGTCAGATTTATCCAGGGATTAGAGTAAAACAACTGTGTAAACTCCTCAGGGGAG 
701          A  S  Q  I  Y  P  G  I  R  V  K  Q  L  C  K  L  L  R  G  A 
 
2161      CCAAAGCACTAACAGATGTAGTAACACTGACAGAGGAAGCAGAATTAGAATTGGCAGAGA 
721          K  A  L  T  D  V  V  T  L  T  E  E  A  E  L  E  L  A  E  N 
 
2221      ACAGGGAAATTCTAAAAGACCCTGTGCATGGGGTATATTATGACCCATCAAAAGACCTAG 
741          R  E  I  L  K  D  P  V  H  G  V  Y  Y  D  P  S  K  D  L  V 
 
2281      TAGCAGAAATACAGAAACAGGGACAAGACCAATGGACATATCAAATTTATCAAGAGCCAT 
761          A  E  I  Q  K  Q  G  Q  D  Q  W  T  Y  Q  I  Y  Q  E  P  F 
 
2341      TTAAAAATCTAAAGACAGGAAAATATGCAAAAAAGAAGTCTGCTCACACTAATGATGTAA 
781          K  N  L  K  T  G  K  Y  A  K  K  K  S  A  H  T  N  D  V  K 
 
2401      AACAGTTAACAGAAGTGGTGCAAAAAGTGGTTACAGAAAGCATAGTAATCTGGGGAAAGA 
801          Q  L  T  E  V  V  Q  K  V  V  T  E  S  I  V  I  W  G  K  T 
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2461      CCCCTAAATTTAAGTTACCTATACAAAAAGAAACATGGGAAACATGGTGGACGGAGTATT 
821          P  K  F  K  L  P  I  Q  K  E  T  W  E  T  W  W  T  E  Y  W 
 
2521      GGCAGGCTACTTGGATTCCTGAATGGGAGTTTGTCAATACCCCTCCTCTAGTAAAATTAT 
841          Q  A  T  W  I  P  E  W  E  F  V  N  T  P  P  L  V  K  L  W 
 
2581      GGTATCAGTTAGAAAAAGACCCCATATTAGGAGTAGAGACTTTTTATGTAGATGGGGCAG 
861          Y  Q  L  E  K  D  P  I  L  G  V  E  T  F  Y  V  D  G  A  A 
 
2641      CTAACAGGGAGACTAAGCTAGGAAAAGCAGGGTATGTCACTGATAGGGGAAGACAAAAGG 
881          N  R  E  T  K  L  G  K  A  G  Y  V  T  D  R  G  R  Q  K  V 
 
2701      TTGTTTCCCTAACTGAGACAACAAATCAAAAGACTGAATTACATGCAATCTATCTAGCCT 
901          V  S  L  T  E  T  T  N  Q  K  T  E  L  H  A  I  Y  L  A  L 
 
2761      TGCAGGATTCAGGACCAGAAGTAAACATAGTAACAGACTCACAGTATGCATTAGGAATCA 
921          Q  D  S  G  P  E  V  N  I  V  T  D  S  Q  Y  A  L  G  I  I 
 
2821      TTCAGGCACAACCAGACAGGAGTGAAACAGAAATAGTCAATCAAATAATAGAGAAGCTAA 
941          Q  A  Q  P  D  R  S  E  T  E  I  V  N  Q  I  I  E  K  L  I 
 
2881      TAGAAAAAGAAAAAGTCTACCTGTCATGGGTACCAGCACATAAGGGAATTGGAGGAAATG 
961          E  K  E  K  V  Y  L  S  W  V  P  A  H  K  G  I  G  G  N  E 
 
2941      AACAAGTAGATAAATTAGTCAGTTCTGGAATCAGGAAGGTGCTATTTTTAGATGGGATAG 
981          Q  V  D  K  L  V  S  S  G  I  R  K  V  L  F  L  D  G  I  D 
 
3001      ATAAAGCTCAAGAAGAGCATGAAAGGTATCACAGCAATTGGAGAGCAATGGCTAGTGATT 
1001         K  A  Q  E  E  H  E  R  Y  H  S  N  W  R  A  M  A  S  D  F 
 
3061      TCAACCTGCCACCAGTAGTAGCAAAGGAAATAGTAGCCAGCTGTGATAAATGTCAACTAA 
1021         N  L  P  P  V  V  A  K  E  I  V  A  S  C  D  K  C  Q  L  K 
 
3121      AAGGGGAAGCCATGCATGGACAAGTAGACTGTAGTCCAGGAATATGGCAAGTAGATTGCA 
1041         G  E  A  M  H  G  Q  V  D  C  S  P  G  I  W  Q  V  D  C  T 
 
3181      CACATCTAGAAGGAAAAGTAATCATAGTAGCAGTCCATGTAGCCAGTGGCTATATAGAGG 
1061         H  L  E  G  K  V  I  I  V  A  V  H  V  A  S  G  Y  I  E  A 
 
3241      CAGAAGTTATCCCAGCAGAAACAGGACAGGAGGCAGCATACTTTCTGTTAAAATTAGCAG 
1081         E  V  I  P  A  E  T  G  Q  E  A  A  Y  F  L  L  K  L  A  A 
 
3301      CAAGATGGCCAGTAAAGGTAATACACACAGACAATGGCAGTAATTTCACCAGTGCCGCAG 
1101         R  W  P  V  K  V  I  H  T  D  N  G  S  N  F  T  S  A  A  V 
 
 182
3361      TTAAAGCAGCCTGTTGGTGGGCAAATATCCAACAGGAATTTGGAATTCCCTACAATCCCC 
1121         K  A  A  C  W  W  A  N  I  Q  Q  E  F  G  I  P  Y  N  P  Q 
 
3421      AAAGTCAAGGAGTAGTGGAATCTATGAATAAAGAATTAAAGAAAATCATAGGTCAGGTAA 
1141         S  Q  G  V  V  E  S  M  N  K  E  L  K  K  I  I  G  Q  V  R 
 
3481      GAGAACAAGCTGAGCACCTTAAGACAGCAGTACAAATGGCAGTATTCATTCACAATTTTA 
1161         E  Q  A  E  H  L  K  T  A  V  Q  M  A  V  F  I  H  N  F  K 
 
3541      AAAGAAAAGGGGGGATTGGGGGGTACAGTGCAGGGGAAAGAATAATAGACATAATAGCAA 
1181         R  K  G  G  I  G  G  Y  S  A  G  E  R  I  I  D  I  I  A  T 
 
3601      CAGACATACAAACTAAAGAATTACAAAAACAAATTACAAAAATTCAAAATTTCCGGGTTT 
1201         D  I  Q  T  K  E  L  Q  K  Q  I  T  K  I  Q  N  F  R  V  Y 
 
3661      ATTACAGGGACAGCAGAGACCCAATTTGGAAAGGACCAGCAAGACTGCTCTGGAAAGGTG 
1221         Y  R  D  S  R  D  P  I  W  K  G  P  A  R  L  L  W  K  G  E 
 
3721      AAGGGGCAGTAGTAATACAGGACAATAGTGATATAAAGGTAGTACCAAGAAGAAAAGCAA 
1241         G  A  V  V  I  Q  D  N  S  D  I  K  V  V  P  R  R  K  A  K 
 
3781      AAATCATTAGGGACTATGGAAAACAGATGGCAGGTGATGATTGTGTGGCAGGTAGACAGG 
1261       K  S  L  G  T  M  E  N  R  W  Q  V  M  I  V  W  Q  V  D  R   
1261         I  I  R  D  Y  G  K  Q  M  A  G  D  D  C  V  A  G  R  Q  D 
 
3841      ATGAGGATTAGAACATGGCACAGTTTAGTAAAATATCATATATATGTCTCTAAGAAAGCT 
1281       M  R  I  R  T  W  H  S  L  V  K  Y  H  I  Y  V  S  K  K  A   
1281         E  D  *  N  M  A  Q  F  S  K  I  S  Y  I  C  L  *  E  S  * 
 
3901      AAAGATTGGTTTTATAGACACCACTATGAAAGCCTGCATCCAAAAGTGAGTTCAGAAATA 
1301       K  D  W  F  Y  R  H  H  Y  E  S  L  H  P  K  V  S  S  E  I   
 
3961      CACATCCCACTAGGGGATGCTAGATTAGTAGTAAAAACATATTGGGGTCTGCAGACAGGA 
1321       H  I  P  L  G  D  A  R  L  V  V  K  T  Y  W  G  L  Q  T  G   
 
4021      GAAAAAGACTGGCAATTGGGTCATGGGGTCTCCATAGAATGGAGACAGAACAGATATGTT 
1341       E  K  D  W  Q  L  G  H  G  V  S  I  E  W  R  Q  N  R  Y  V   
 
4081      ACACAAATAGATCCTGATCTAGCTGACCAACTAATTCACCTTCATCCTTTTAACTGTTTT 
1361       T  Q  I  D  P  D  L  A  D  Q  L  I  H  L  H  P  F  N  C  F   
 
4141      TCAGAATCTGCCATAAGGAAAGTCATATTAGGACAAGTAGTTAGTCCTAGGTGTGAATAT 




4201      CCAACAGGACATAATAAGGTAGGATCTCTACAATATTTGGCTCTGAAAGCATTAGTAGCA 
1401       P  T  G  H  N  K  V  G  S  L  Q  Y  L  A  L  K  A  L  V  A   
 
4261      CCAAGAAAGCCAAAGCCACCTGCCCAG 







































Sample TV 239 env-nef from 6195-9146 (coordinates relative to HXB2) 
Nucleotide and amino acid composition.  
 
vpr - Green 
tat - Pink 
rev – Dark Red 
vpu – Sky Blue 
env – Sea Green 
nef – Dark Teal 
 
1         GAATTAGGGAAAGAGCAGAAGACAGTGGCAATGAGAGTGATGGGGATACAGAGGAATTGT 
1          E  L  G  K  E  Q  K  T  V  A  M  R  V  M  G  I  Q  R  N  C   
1            I  R  E  R  A  E  D  S  G  N  E  S  D  G  D  T  E  E  L  S 
 
61        CAACAATGGTGGATATGGGGCATCTTAGGCTTTTGGATGATATATAATGGGATGGGGGCG 
21         Q  Q  W  W  I  W  G  I  L  G  F  W  M  I  Y  N  G  M  G  A   
21           T  M  V  D  M  G  H  L  R  L  L  D  D  I  *  W  D  G  G  G 
 
121       GGCTTGTGGGTCACGGTCTATTATGGAGTACCTGTGTGGAAAGACGCAGATACCACCCTA 
41         G  L  W  V  T  V  Y  Y  G  V  P  V  W  K  D  A  D  T  T  L   
 
181       TTTTGTGCATCAGATGCTAAGGCATATGATACAGAAGTGCATAATGTCTGGGCTACACAT 
61         F  C  A  S  D  A  K  A  Y  D  T  E  V  H  N  V  W  A  T  H   
 
241       GCCTGTGTACCCACAGACCCCAACCCACAAGAAATGACTTTAATGAATGTAACAGAAAAG 
81         A  C  V  P  T  D  P  N  P  Q  E  M  T  L  M  N  V  T  E  K   
 
301       TTTAACATGTGGAAAAATAACATGGTAGAACAAATGCACACAGATATAATCAGTTTATGG 
101        F  N  M  W  K  N  N  M  V  E  Q  M  H  T  D  I  I  S  L  W   
 
361       GACCAAAGCCTAAAACCATGTGTAAGCTTAACCCCTCTCTGTGTTACTTTAAATTGCAGA 
121        D  Q  S  L  K  P  C  V  S  L  T  P  L  C  V  T  L  N  C  R   
 
421       AATGTCACTATTAATGACACTATTAGAAACAGCAGTGTTATTGGTGACATGAAAGAAGAA 
141        N  V  T  I  N  D  T  I  R  N  S  S  V  I  G  D  M  K  E  E   
 
481       GTAACAAATTGCTCTTTCAATATAACCACAGAACTAAGAGATAAGAGACAAAAAGTATAT 
161        V  T  N  C  S  F  N  I  T  T  E  L  R  D  K  R  Q  K  V  Y   
 
541       TCACTTTTTTATAAACTTGATGTAGTACAAATTAATCCTGCTGATAAGAATAGTACCCAA 
181        S  L  F  Y  K  L  D  V  V  Q  I  N  P  A  D  K  N  S  T  Q   
 
601       TATAGACTAATAAATTGTAATACCTCAACCATTACACAGGCTTGTCCAAAGGTATCCTTT 
201        Y  R  L  I  N  C  N  T  S  T  I  T  Q  A  C  P  K  V  S  F   
 
 
661       GAGCCAATTCCCATACATTATTGTGCTCCAGCTGGTTTTGCGATTCTAAAGTGTAATGAT 
221        E  P  I  P  I  H  Y  C  A  P  A  G  F  A  I  L  K  C  N  D   
 185
 
721       AAGAGGTTCAATGGAACAGGGACATGCAATAATGTCAGTACAGTACAGTGCACACATGGA 
241        K  R  F  N  G  T  G  T  C  N  N  V  S  T  V  Q  C  T  H  G   
 
781       ATCAGGCCAGTAGTATCAACTCAATTGTTGTTAAATGGCAGTTTAGCAGAAGAAAAGATA 
261        I  R  P  V  V  S  T  Q  L  L  L  N  G  S  L  A  E  E  K  I   
 
841       ATGATTAGATCTGAAAATATCACAAACAATGCCAAAATCATAATAGTACAGCTTAATGAG 
281        M  I  R  S  E  N  I  T  N  N  A  K  I  I  I  V  Q  L  N  E   
 
901       ACTGTACAAATTAATTGTACCAGGCCTAACAACAATACAAGAACAAGTGTACGTATAGGT 
301        T  V  Q  I  N  C  T  R  P  N  N  N  T  R  T  S  V  R  I  G   
 
961       CCAGGACAAACATTCTATGCAACAGGGGAAATCATAGGGGATATAAGAAAAGCACATTGT 
321        P  G  Q  T  F  Y  A  T  G  E  I  I  G  D  I  R  K  A  H  C   
 
1021      AATGTCAGTGAAAGAGAATGGATGAAAACTTTATATCATGTAGCTAAAAGATTAAGAGAG 
341        N  V  S  E  R  E  W  M  K  T  L  Y  H  V  A  K  R  L  R  E   
 
1081      GTACACTTTGAAAACAAGACAATAATCTTTAATAAGTCCTCAGGAGGGGATTTAGAAATT 
361        V  H  F  E  N  K  T  I  I  F  N  K  S  S  G  G  D  L  E  I   
 
1141      ACAACACATAGTTTTAATTGTGGAGGAGAATTCTTCTATTGCAATACATCAGGCCTGTTT 
381        T  T  H  S  F  N  C  G  G  E  F  F  Y  C  N  T  S  G  L  F   
 
1201      AACAGCACTTGGGAGTTTAACAACCCTTTTAATGAAACTGAGTGGCCACAAAATAAAACT 
401        N  S  T  W  E  F  N  N  P  F  N  E  T  E  W  P  Q  N  K  T   
 
1261      ATAATTCTCCAATGCAGAATAAAGCAAATTGTAAATATGTGGCAGAGAGTAGGACAGGCG 
421        I  I  L  Q  C  R  I  K  Q  I  V  N  M  W  Q  R  V  G  Q  A   
 
1321      ATGTATGCCCCTCCCATCAAAGGAGTAATAAGGTGTAATTCAACCATTACAGGACTATTC 
441        M  Y  A  P  P  I  K  G  V  I  R  C  N  S  T  I  T  G  L  F   
 
1381      TTAACAAGAGATGGTGGAAATACTAGCAGTACAAATGAGACCTTCAGGCCTGGAGGAGGA 
461        L  T  R  D  G  G  N  T  S  S  T  N  E  T  F  R  P  G  G  G   
 
1441      GATATGAGGGACAATTGGAGAAGTGAATTGTATAAATATAAAGTAATAAAAATTGAACCA 
481        D  M  R  D  N  W  R  S  E  L  Y  K  Y  K  V  I  K  I  E  P   
 
1501      ATAGGAGTAGCACCCACCAGGGCAAAAAGAAGAGTGGTGGAAAGAGAAAAAAGAGCAGTT 
501        I  G  V  A  P  T  R  A  K  R  R  V  V  E  R  E  K  R  A  V   
 
1561      GGACTGGGAGCTGTTTTCCTTGGGTTCTTAGGAGCAGCAGGAAGCACTATGGGCGCAGCG 
521        G  L  G  A  V  F  L  G  F  L  G  A  A  G  S  T  M  G  A  A   
 186
 
1621      TCAATAACGCTGACGGTACAGGCCAGACAATTATTGTCTGGCATAGTGCAACAGCAAAGC 
541        S  I  T  L  T  V  Q  A  R  Q  L  L  S  G  I  V  Q  Q  Q  S   
 
1681      AATTTGCTGAGGGCTATAGAGGCTCAACAGCATCTGTTGAAACTCACAGTCTGGGGCATT 
561        N  L  L  R  A  I  E  A  Q  Q  H  L  L  K  L  T  V  W  G  I   
 
1741      AAACAGCTCCAGGCAAGAGTCCTGGCTGTGGAAAGATACCTAAAGGATCAACAGCTTCTA 
581        K  Q  L  Q  A  R  V  L  A  V  E  R  Y  L  K  D  Q  Q  L  L   
 
1801      GGAATTTGGGGCTGCTCAGGAAAGTTAATCTGCACCACTGCTGTGCCCTGGAACTCTAGT 
601        G  I  W  G  C  S  G  K  L  I  C  T  T  A  V  P  W  N  S  S   
 
1861      TGGAGTAATAAATCTTACAATGAAATATGGGATAACATGACCTGGATGCAATGGGAAAAG 
621        W  S  N  K  S  Y  N  E  I  W  D  N  M  T  W  M  Q  W  E  K   
 
1921      GAAATTGACAATTACACAGGCATAATATATACTCTAATTGAAGAATCGCAGAACCAACAG 
641        E  I  D  N  Y  T  G  I  I  Y  T  L  I  E  E  S  Q  N  Q  Q   
 
1981      GAAAAGAATGAACAAGATTTATTGGCATTGGACAAGTGGGCAAGTCTGTGGAATTGGTTT 
661        E  K  N  E  Q  D  L  L  A  L  D  K  W  A  S  L  W  N  W  F   
 
2041      GACATAACAAATTGGCTATGGTATATAAAAATATTCATAATGAAGGTAGGGGGCTTGATA 
681        D  I  T  N  W  L  W  Y  I  K  I  F  I  M  K  V  G  G  L  I   
 
2101      GGTTTAAGAATAATTTTTACTGTACTCTCTATAGTGAATAGAGTTAGGCAGGGATACTCA 
701        G  L  R  I  I  F  T  V  L  S  I  V  N  R  V  R  Q  G  Y  S   
 
2161      CCTTTGTCGTTTCAGACCCTTACCCCAAACCCGAGGGAACTCCACAGGCTCGGAAGAATC 
721        P  L  S  F  Q  T  L  T  P  N  P  R  E  L  H  R  L  G  R  I   
721         L  C  R  F  R  P  L  P  Q  T  R  G  N  S  T  G  S  E  E  S  
721          F  V  V  S  D  P  Y  P  K  P  E  G  T  P  Q  A  R  K  N  R 
 
2221      GAAGAAGAAGGTGGAGAGCCAGACAGAGACAGATCAGTTCGCTTAGTGAGCGGATTCTTA 
741        E  E  E  G  G  E  P  D  R  D  R  S  V  R  L  V  S  G  F  L   
741         K  K  K  V  E  S  Q  T  E  T  D  Q  F  A  *  *  A  D  S  *  
741          R  R  R  W  R  A  R  Q  R  Q  I  S  S  L  S  E  R  I  L  S 
 
2281      GCACTTTTCTGGGACGACCTACGGAACCTGTGCCTCTTCAGTTACCACCGCTTGAGAGAC 
761        A  L  F  W  D  D  L  R  N  L  C  L  F  S  Y  H  R  L  R  D   






2341      TTCATCTTGATTGCAGCGAGGACTGTGGAACTTCTGGGACACAACAGTCTCAAGGGACTG 
781        F  I  L  I  A  A  R  T  V  E  L  L  G  H  N  S  L  K  G  L   
781          H  L  D  C  S  E  D  C  G  T  S  G  T  Q  Q  S  Q  G  T  E 
 
2401      AGACTGGGGTGGGAAGGAATCAAGTATCTGTGGAATCTCCTGTTATATTGGGGTCAGGAA 
801        R  L  G  W  E  G  I  K  Y  L  W  N  L  L  L  Y  W  G  Q  E   
801          T  G  V  G  R  N  Q  V  S  V  E  S  P  V  I  L  G  S  G  T 
 
2461      CTAAAGAATAGTGCTATCTCTCTGTTTGATGCTACAGCAATAACAGTAGCTGGGTGGACA 
821        L  K  N  S  A  I  S  L  F  D  A  T  A  I  T  V  A  G  W  T   
821          K  E  *  C  Y  L  S  V  *  C  Y  S  N  N  S  S  W  V  D  R 
 
2521      GACAGGGTTATAGAACTAGGACAAAGAATTGTTAGAGCTTTTCTCCACATACCTAGAAGA 
841        D  R  V  I  E  L  G  Q  R  I  V  R  A  F  L  H  I  P  R  R   
 
2581      ATCAGACAGGGCTTCGAAAGAGCTTTGCTATAGCATGGGGGGCAAGTGGTCAAAAAGTAG 
861        I  R  Q  G  F  E  R  A  L  L  *  H  G  G  Q  V  V  K  K  *   
861         S  D  R  A  S  K  E  L  C  Y  S  M  G  G  K  W  S  K  S  S  
 
2641      CATAGTGGGGTGGCCTGCGATTAGGGAGAGAATAAGAAGGACTGAGCCAGCAGCAGAGGG 
881         I  V  G  W  P  A  I  R  E  R  I  R  R  T  E  P  A  A  E  G  
 
2701      AGTAGGAGCAGCGTCTCGAGACTTGGATAAACATGGGGCACTTACAACCAGCAACACAGT 
901         V  G  A  A  S  R  D  L  D  K  H  G  A  L  T  T  S  N  T  V  
 
2761      CGCCAACAATGCTGCTTGTGCCTGGCTGGAAGCACAAGAGGAAGAAGGAGAGGTAGGCTT 
921         A  N  N  A  A  C  A  W  L  E  A  Q  E  E  E  G  E  V  G  F  
 
2821      TCCAGTCAGACCCCAGGTACCTTTAAGACCAATGACTTTTAAGGCAGCATTTGATCTCAG 
941         P  V  R  P  Q  V  P  L  R  P  M  T  F  K  A  A  F  D  L  S  
 
2881      CTTCTTTTTAAAAGAAAAGGGGGGACTGGAAGGGTTAATTTACTCCAGGAAAAGGCAAGA 
961         F  F  L  K  E  K  G  G  L  E  G  L  I  Y  S  R  K  R  Q  E  
 
2941      GATCCTTGATTGTGGTCCCTGAGCGC 











Sample TV 314 from 1235 – 9551 (coordinate relative to HXB2) 
Nucleotide and amino acid composition 
 
gag – Red 
pol - Blue 
vif - Orange 
vpr - Green 
tat - Pink 
rev – Dark Red 
vpu – Sky Blue 
env – Sea Green 
nef – Dark Teal 
 
 
1         TCAGGACTTTGGATGCATGGGTAAAAGTAATAGAAGAAAAGGCTTTCAGCCCTGAAGTAA 
1            R  T  L  D  A  W  V  K  V  I  E  E  K  A  F  S  P  E  V  I 
 
61        TACCCATGTTCTCAGCATTATCAGAAGGAGCCACCCCACAAGATTTAAATATGATGCTGA 
21           P  M  F  S  A  L  S  E  G  A  T  P  Q  D  L  N  M  M  L  N 
 
121       ACATAGTGGGGGGACACCAGGCAGCTATGCAAATGTTAAAGGATACCATCAATGAGGAAG 
41           I  V  G  G  H  Q  A  A  M  Q  M  L  K  D  T  I  N  E  E  A 
 
181       CTGCAGAATGGGATAGGCTACATCCAGTACATGCAGGGCCAGTTGCACCAGGCCAGATGA 
61           A  E  W  D  R  L  H  P  V  H  A  G  P  V  A  P  G  Q  M  R 
 
241       GAGAACCAAGGGGAAGTGATATAGCAGGAACTACTAGTACCCCTCAAGAACAAATAGCAT 
81           E  P  R  G  S  D  I  A  G  T  T  S  T  P  Q  E  Q  I  A  W 
 
301       GGATGACAGGCAACCCACCTATCCCAGTGGGAGACATCTATAAAAGATGGATAATCCTAG 
101          M  T  G  N  P  P  I  P  V  G  D  I  Y  K  R  W  I  I  L  G 
 
361       GGTTAAATAAAATAGTAAGAATGTATAGCCCTGTTAGCATTTTGGATATAAAACAAGGGC 
121          L  N  K  I  V  R  M  Y  S  P  V  S  I  L  D  I  K  Q  G  P 
 
421       CAAAAGAACCCTTCAGAGACTATGTAGATAGGTTCTTTAAAACTCTCAGGGCTGAGCAAG 
141          K  E  P  F  R  D  Y  V  D  R  F  F  K  T  L  R  A  E  Q  A 
 
481       CTACACAGGAAGTAAAAAATTGGATGACAGAAACATTATTAGTACAAAATGCAAATCCAG 
161          T  Q  E  V  K  N  W  M  T  E  T  L  L  V  Q  N  A  N  P  D 
 
541       ATTGTAAGTCCATTTTAAGAGCATTAGGACCAGGGGCTACATTAGAAGAAATGATGACAG 
181          C  K  S  I  L  R  A  L  G  P  G  A  T  L  E  E  M  M  T  A 
 
601       CATGCCAGGGAGTGGGAGGACCTAGCCATAAAGCAAGGGTTTTAGCCGAGGCAATGAGTC 
201          C  Q  G  V  G  G  P  S  H  K  A  R  V  L  A  E  A  M  S  Q 
 189
 
661       AAGCACAACAAACAAACATACTGGTGCAGAGAGGCAATTTTGGGGGTCATAAAAGGATTA 
221          A  Q  Q  T  N  I  L  V  Q  R  G  N  F  G  G  H  K  R  I  K 
 
721       AGTGTTTCAACTGTGGCAAAGAAGGACACCTAGCCAGAAATTGCAGGGCCCCTAGGAAAA 
241          C  F  N  C  G  K  E  G  H  L  A  R  N  C  R  A  P  R  K  K 
 
781       AGGGCTGTTGGAAATGTGGGAAAGAGGGACACCAAATGAAAGACTGCACTGAAAGACAGG 
261          G  C  W  K  C  G  K  E  G  H  Q  M  K  D  C  T  E  R  Q  A 
 
841       CTAATTTTTTAGGGAAAATTTGGCCTTCCCACAAGGGGAGGCCAGGGAACTTCCCTCAGA 
281         *  F  F  R  E  N  L  A  F  P  Q  G  E  A  R  E  L  P  S  E  
281          N  F  L  G  K  I  W  P  S  H  K  G  R  P  G  N  F  P  Q  S 
 
901       GCAGACCAGAGCCAACAGCCCCACCAGCAGAGATGTTTGGGATGAGGGAAGAGATAGCCT 
301         Q  T  R  A  N  S  P  T  S  R  D  V  W  D  E  G  R  D  S  L  
301          R  P  E  P  T  A  P  P  A  E  M  F  G  M  R  E  E  I  A  S 
 
961       CCCCTCCGAAGCAGGAGCAGAACAGCAGGGACCAGAACCCACCTTCAATTTCCCTCAAAT 
321         P  S  E  A  G  A  E  Q  Q  G  P  E  P  T  F  N  F  P  Q  I  
321          P  P  K  Q  E  Q  N  S  R  D  Q  N  P  P  S  I  S  L  K  S 
 
1021      CACTCTTTGGCAACGACCTATTGTCACAGTAAGAATAGAGGGACAGCTAAAGGAAGCTCT 
341         T  L  W  Q  R  P  I  V  T  V  R  I  E  G  Q  L  K  E  A  L  
341          L  F  G  N  D  L  L  S  Q  *  E  *  R  D  S  *  R  K  L  Y 
 
1081      ATTAGATACAGGAGCAGATGATACAGTATTAGAAGACATAAATTTGCCAGGGAAATGGAA 
361         L  D  T  G  A  D  D  T  V  L  E  D  I  N  L  P  G  K  W  K  
 
1141      ACCAAAAATGATAGGGGGAATTGGAGGTTTCATCAAAGTAAGACAGTATGATCAAATACT 
381         P  K  M  I  G  G  I  G  G  F  I  K  V  R  Q  Y  D  Q  I  L  
 
1201      TATAGAAATTTGTGGAAAAAAGGCTATGGGTACAGTATTGGTAGGACCTACACCTGTCAA 
401         I  E  I  C  G  K  K  A  M  G  T  V  L  V  G  P  T  P  V  N  
 
1261      CATAATTGGAAGAAATATGTTGACCCAGATTGGTTGTACTTTAAATTTCCCAATTAGCCC 
421         I  I  G  R  N  M  L  T  Q  I  G  C  T  L  N  F  P  I  S  P  
 
1321      TATCGATACTGTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAAGGTTAAACAATG 
441         I  D  T  V  P  V  K  L  K  P  G  M  D  G  P  K  V  K  Q  W  
 
1381      GCCATTGACAGAAGAAAAAATAAAAGCATTAACAGAAATTTGTACAGAAATGGAAAAGGA 




1441      AGGAAAAATTTCAAAAATTGGGCCTGAAAATCCATACAATACTCCAATATTTGCTATAAA 
481         G  K  I  S  K  I  G  P  E  N  P  Y  N  T  P  I  F  A  I  K  
 
1501      GAAAAAAGACAGCACTAAATGGAGAAAATTAGTAGATTTCAGAGAGCTCAATAAAAGAAC 
501         K  K  D  S  T  K  W  R  K  L  V  D  F  R  E  L  N  K  R  T  
 
1561      TCAAGACTTTTGGGAAGTTCAATTAGGAATACCGCATCCAGCGGGCTTAAAAAAGAAAAA 
521         Q  D  F  W  E  V  Q  L  G  I  P  H  P  A  G  L  K  K  K  K  
 
1621      ATCAGTAACAGTACTAGATGTGGGGGACGCATATTTTTCAGTTCCCTTAGATGAAAGTTT 
541         S  V  T  V  L  D  V  G  D  A  Y  F  S  V  P  L  D  E  S  F  
 
1681      TAGAAAGTATACTGCATTCACCATACCTAGTATAAACAATGAGACACCAGGAATCAGGTA 
561         R  K  Y  T  A  F  T  I  P  S  I  N  N  E  T  P  G  I  R  Y  
 
1741      TCAGTACAATGTGCTTCCACAGGGATGGAAAGGATCACCAGCAATATTCCAGAGTAGCAT 
581         Q  Y  N  V  L  P  Q  G  W  K  G  S  P  A  I  F  Q  S  S  M  
 
1801      GACAAAAATCTTAGATCCCTTTAGGTCAAAAAATCCAGAACTAATTATCTATCAATACAT 
601         T  K  I  L  D  P  F  R  S  K  N  P  E  L  I  I  Y  Q  Y  M  
 
1861      GGATGACTTGTATGTAGGATCTGATTTAGAAATAGGGCAGCATAGAGCAAAAATAGAAGA 
621         D  D  L  Y  V  G  S  D  L  E  I  G  Q  H  R  A  K  I  E  E  
 
1921      GTTGAGAGCTCATCTATTAAGCTGGGGATTTACTACACCAGACAAAAAGCATCAGAAAGA 
641         L  R  A  H  L  L  S  W  G  F  T  T  P  D  K  K  H  Q  K  E  
 
1981      GCCTCCATTCCTTTGGATGGGATATGAACTCCATCCTGACAAGTGGACAGTCCAACCTAT 
661         P  P  F  L  W  M  G  Y  E  L  H  P  D  K  W  T  V  Q  P  I  
 
2041      ACAGCTGCCAGAAAAAGACAGTTGGACTGTCAATGATATACAGAAGCTAGTGGGGAAACT 
681         Q  L  P  E  K  D  S  W  T  V  N  D  I  Q  K  L  V  G  K  L  
 
2101      AAATTGGGCAAGTCAGATTTACCCAGGGATTCAAGTAAGACAATTGTGTAAACTCCTCAG 
701         N  W  A  S  Q  I  Y  P  G  I  Q  V  R  Q  L  C  K  L  L  R  
 
2161      GGGAGCCAAAGCACTAACAGATATAGTAACATTGACTGAGGAAGCAGAATTAGAATTGGC 
721         G  A  K  A  L  T  D  I  V  T  L  T  E  E  A  E  L  E  L  A  
 
2221      AGAGAACAGGGAAATTCTAAAAGACCCTGTGCATGGAGTCTATTATGACCCATCAAAAGA 
741         E  N  R  E  I  L  K  D  P  V  H  G  V  Y  Y  D  P  S  K  D  
 
2281      CTTAATAACAGAAATACAGAAACAAGGGCAAGACCAATGGACATATCAAATTTATCAAGA 
761         L  I  T  E  I  Q  K  Q  G  Q  D  Q  W  T  Y  Q  I  Y  Q  E  
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2341      ACCATTTAAAAATCTAAAAACAGGAAAATATGCAAGAAGGAGGTCTGCTCACACTAATGA 
781         P  F  K  N  L  K  T  G  K  Y  A  R  R  R  S  A  H  T  N  D  
 
2401      TGTAAAACAGTTAACAGAAGTGGTGCAAAAAGTGGCCACGGAAAGTATAGTAATATGGGG 
801         V  K  Q  L  T  E  V  V  Q  K  V  A  T  E  S  I  V  I  W  G  
 
2461      AAAGACTCCTAAATTTAGACTACCCATACAAAAAGAAACATGGGAAACATGGTGGATGGA 
821         K  T  P  K  F  R  L  P  I  Q  K  E  T  W  E  T  W  W  M  D  
 
2521      CTATTGGCAGGCTACCTGGATCCCTGAATGGGAATTTGTCAATACCCCTCCCCTAGTAAA 
841         Y  W  Q  A  T  W  I  P  E  W  E  F  V  N  T  P  P  L  V  K  
 
2581      ATTATGGTACCAGTTAGAAAAAGACCCCATAGCAGGAGCAGAGACTTTCTATGTAGATGG 
861         L  W  Y  Q  L  E  K  D  P  I  A  G  A  E  T  F  Y  V  D  G  
 
2641      GGCATCCAGTAGGGAGACTAAGTTAGGAAAAGCAGGGTATGTCACTGACAGAGGAAGACA 
881         A  S  S  R  E  T  K  L  G  K  A  G  Y  V  T  D  R  G  R  Q  
 
2701      AAAGGTTGTTTCCCTAACTGAAACAACAAATCAAAAAGCTGAATTACATGCAATCCATCT 
901         K  V  V  S  L  T  E  T  T  N  Q  K  A  E  L  H  A  I  H  L  
 
2761      AGCCTTGCAGGATTCAGGATCAGAAGTAAACATAGTAACAGACTCACAGTATGCATTAGG 
921         A  L  Q  D  S  G  S  E  V  N  I  V  T  D  S  Q  Y  A  L  G  
 
2821      CATCATTCAGGCACAACCAGACAGGAGTGAGTCAGAATTAGTCAATCAAATAATAGAGAA 
941         I  I  Q  A  Q  P  D  R  S  E  S  E  L  V  N  Q  I  I  E  K  
 
2881      GCTAATAGGAAAAGATAAAGTCTACCTGTCATGGGTACCAGCACACAAGGGAATTGGAGG 
961         L  I  G  K  D  K  V  Y  L  S  W  V  P  A  H  K  G  I  G  G  
 
2941      AAATGAACAAGTAGATAAACTGGTCAGTTCTGGAATCAGGAAGGTGCTATTTCTAGATGG 
981         N  E  Q  V  D  K  L  V  S  S  G  I  R  K  V  L  F  L  D  G  
 
3001      GATAGATAAGGCTCAAGAAGAACATGAAAGATATCACAGCAACTGGAGAGCTATGGCTAG 
1001        I  D  K  A  Q  E  E  H  E  R  Y  H  S  N  W  R  A  M  A  S  
 
3061      TGATTTTAATCTGCCACCTATAGTAGCAAAGGAGATAGTAGCCAGCTGTGATAAATGCCA 
1021        D  F  N  L  P  P  I  V  A  K  E  I  V  A  S  C  D  K  C  Q  
 
3121      GCTAAAAGGGGAAGCCATGCATGGACAAGTAGACTGCAGTCCAGGAATATGGCAATTAGA 
1041        L  K  G  E  A  M  H  G  Q  V  D  C  S  P  G  I  W  Q  L  D  
 
3181      CTGCACACATCTAGAAGGAAAAGTAATTCTGGTAGCAGTCCATGTAGCCAGTGGCTATAT 
1061        C  T  H  L  E  G  K  V  I  L  V  A  V  H  V  A  S  G  Y  I  
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3241      AGAAGCAGAAGTTATCCCAGCAGAAACAGGACAAGAGACAGCATACTTTCTATTAAAATT 
1081        E  A  E  V  I  P  A  E  T  G  Q  E  T  A  Y  F  L  L  K  L  
 
3301      AGCAGGAAGATGGCCAGTAAAAACAGTACACACAGACAATGGCAGCAATTTCACCAGTGC 
1101        A  G  R  W  P  V  K  T  V  H  T  D  N  G  S  N  F  T  S  A  
 
3361      TGCAGTTAAAGCAGCCTGTTGGTGGGCAGGTATCAAACAGGAATTTGGAATTCCCTACAA 
1121        A  V  K  A  A  C  W  W  A  G  I  K  Q  E  F  G  I  P  Y  N  
 
3421      TCCCCAAAGTCAAGGAGTAGTGGAATCTATGAATAAGGAATTAAAGAAAATCATAGGGCA 
1141        P  Q  S  Q  G  V  V  E  S  M  N  K  E  L  K  K  I  I  G  Q  
 
3481      GGTAAGAGAGCAAGCTGAACACCTTAAGACAGCAGTACAAATGGCAGTATTCATTCACAA 
1161        V  R  E  Q  A  E  H  L  K  T  A  V  Q  M  A  V  F  I  H  N  
 
3541      TTTTAAAAGAAAAGGGGGGATTGGGGGGTACAGTGCAGGGGAAAGAATAATAGACATAAT 
1181        F  K  R  K  G  G  I  G  G  Y  S  A  G  E  R  I  I  D  I  I  
 
3601      AGCAACAGACATACAAACTAAAGAATTACAAAAACAAATTACAAAAATTCAAAAATTTCG 
1201        A  T  D  I  Q  T  K  E  L  Q  K  Q  I  T  K  I  Q  K  F  R  
 
3661      GGTTTATTACAGGGACAGCAGAGATCCAATTTGGAAAGGACCAGCAAAACTACTCTGGAA 
1221        V  Y  Y  R  D  S  R  D  P  I  W  K  G  P  A  K  L  L  W  K  
 
3721      AGGTGAAGGGGCAGTGGTAATACAGGACAATAGTGATATAAAGGTAGTACCAAGAAGAAA 
1241        G  E  G  A  V  V  I  Q  D  N  S  D  I  K  V  V  P  R  R  K  
 
3781      AGCAAAGATCCTTAAGGATTATGGAAAACAGATGGCAGGTGATGATTGTGTGGCAGGTAG 
1261        A  K  I  L  K  D  Y  G  K  Q  M  A  G  D  D  C  V  A  G  R  
1261         Q  R  S  L  R  I  M  E  N  R  W  Q  V  M  I  V  W  Q  V  D 
 
3841      ACAGGATGAGGATTAGAACATGGCACAGTTTAGTAAAACATCATATGTATGTCTCAAGGA 
1281        Q  D  E  D  *  N  M  A  Q  F  S  K  T  S  Y  V  C  L  K  E  
1281         R  M  R  I  R  T  W  H  S  L  V  K  H  H  M  Y  V  S  R  K 
 
3901      AAACTAAAGATTGGTCTTATAGACATCACTATGAAAGCAGACATCCAAGAGTAAGTTCAG 
1301         T  K  D  W  S  Y  R  H  H  Y  E  S  R  H  P  R  V  S  S  E 
 
3961      AAGTACACATCCCACTAGGGGACGCTAGAATAATAGTAAAAACATATTGGGGTCTGCATA 
1321         V  H  I  P  L  G  D  A  R  I  I  V  K  T  Y  W  G  L  H  T 
 
4021      CAGGAGAAAAAGACTGGCAATTGGGTCATGGGGTCTCCATAGAATGGAGGCTGAAAAGCT 




4081      ATAACACACAAATAGACCCTGACCTGGCAGACCAACTAATTCATCTGCATTATTTTGAAT 
1361         N  T  Q  I  D  P  D  L  A  D  Q  L  I  H  L  H  Y  F  E  C 
 
4141      GTTTTTCAGATTCTGCCATAAGGAAAGCCATATTAGGGCGAGTAGTTAACCCTAGGTGTG 
1381         F  S  D  S  A  I  R  K  A  I  L  G  R  V  V  N  P  R  C  E 
 
4201      AATATCAAACAGGAAATAAAAAGGTAGGATCTCTACAATATTTAGCACTAAAAGCATTAG 
1401         Y  Q  T  G  N  K  K  V  G  S  L  Q  Y  L  A  L  K  A  L  V 
 
4261      TAGGACCAAAAAAGACAAAGCCACCTTTGCCTAGTGTTAGTAAACTAACAGAGGATAGAT 
1421        R  T  K  K  D  K  A  T  F  A  *  C  *  *  T  N  R  G  *  M  
1421         G  P  K  K  T  K  P  P  L  P  S  V  S  K  L  T  E  D  R  W 
 
4321      GGAACAAGCCCCAGAAGACCAGGGGCCCCAGAGAGAGCCATACAATGAATGGATGTTAGA 
1441        E  Q  A  P  E  D  Q  G  P  Q  R  E  P  Y  N  E  W  M  L  E  
1441         N  K  P  Q  K  T  R  G  P  R  E  S  H  T  M  N  G  C  *  S 
 
4381      GCTGTTAGAAGAACTTAAGCATGAAGCTGTTAGACATTTCCCTAGACCATGGCTCCAGGG 
1461        L  L  E  E  L  K  H  E  A  V  R  H  F  P  R  P  W  L  Q  G  
 
4441      ACTAGGACAATATATCTACAACACCCATGGGGATACTTGGGAAGGAGTTGAAGCTATTAT 
1481        L  G  Q  Y  I  Y  N  T  H  G  D  T  W  E  G  V  E  A  I  I  
 
4501      AAGAATTTTGCAGCAACTACTGTTTGTTCATTTCAGGATTGGGTGCCAACACAGCAGAAT 
1501        R  I  L  Q  Q  L  L  F  V  H  F  R  I  G  C  Q  H  S  R  I  
 
4561      AGGCATTATTCGAGGGAGAAGAGTCAGAAATGGATCCAGTAGATCCTAACCTAGAGCCCT 
1521        G  I  I  R  G  R  R  V  R  N  G  S  S  R  S  *  P  R  A  L  
1521         A  L  F  E  G  E  E  S  E  M  D  P  V  D  P  N  L  E  P  W 
 
4621      GGAACCATCCAGGAAGTCAGCCTACAACTCCTTGTAGCAAGTGTTACTGTAAAGCGTGTT 
1541         N  H  P  G  S  Q  P  T  T  P  C  S  K  C  Y  C  K  A  C  C 
 
4681      GCTACCATTGCTTAGTTTGCTTTCAGACCAAAGGCTTAGGCATCTCCTATGGCAGGAAGA 
1561       A  T  I  A  *  F  A  F  R  P  K  A  *  A  S  P  M  A  G  R   
1561         Y  H  C  L  V  C  F  Q  T  K  G  L  G  I  S  Y  G  R  K  K 
 
4741      AGCGGAGACAGCGACGAGGCACTCCTCACAGCCGTACGGATCATCAAAATCCTGTATCAA 
1581       S  G  D  S  D  E  A  L  L  T  A  V  R  I  I  K  I  L  Y  Q   
1581         R  R  Q  R  R  G  T  P  H  S  R  T  D  H  Q  N  P  V  S  K 
 
4801      AGCAGTAAGTGTTTATATATGTAATGACCCCTTTAGAAATTAGTGCAATAATAGGATTGA 
1601       S  S  K  C  L  Y  M  *  *  P  L  *  K  L  V  Q  *  *  D  *   
1601         Q  *  V  F  I  Y  V  M  T  P  L  E  I  S  A  I  I  G  L  I 
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4861      TAGTAGCGCTAATCTTAGCAATAGTTGTATGGACTATAGTAGGTATAGAATATAAGAAAA 
1621         V  A  L  I  L  A  I  V  V  W  T  I  V  G  I  E  Y  K  K  I 
 
4921      TAAGAAGGCAAAGAAAAATAGACAGGTTACTTGAGAGAATAAGAGAAAGAGCAGAAGACA 
1641         R  R  Q  R  K  I  D  R  L  L  E  R  I  R  E  R  A  E  D  S 
 
4981      GTGGCAATGAGAGTGAGGGGGATACAGATGACTTGGCAGCACTTATTGGGATGGGGAATT 
1661       V  A  M  R  V  R  G  I  Q  M  T  W  Q  H  L  L  G  W  G  I   
1661         G  N  E  S  E  G  D  T  D  D  L  A  A  L  I  G  M  G  N  Y 
 
5041      ATGATCTTGGGGATGATTATAATGTGTAGTACTGCAGACAACTTGTGGGTTACTGTTTAC 
1681       M  I  L  G  M  I  I  M  C  S  T  A  D  N  L  W  V  T  V  Y   
1681         D  L  G  D  D  Y  N  V  *  Y  C  R  Q  L  V  G  Y  C  L  L 
 
5101      TATGGGGTACCTGTGTGGAAAGATGCAGAGACCACCCTATTTTGTGCATCAGATGCTAAA 
1701       Y  G  V  P  V  W  K  D  A  E  T  T  L  F  C  A  S  D  A  K   
 
5161      GCATATGAGAAAGAAGTGCATAATGTCTGGGCTACACATGCCTGTGTACCCACAGACCCC 
1721       A  Y  E  K  E  V  H  N  V  W  A  T  H  A  C  V  P  T  D  P   
 
5221      AACCCACAAGAAATACATTTGGTAAATGTGACAGAAAATTTTAATATGTGGAAAAATAAA 
1741       N  P  Q  E  I  H  L  V  N  V  T  E  N  F  N  M  W  K  N  K   
 
5281      ATGGTAGAGCAGATGCATGCAGATATAATCAGTCTATGGGACCAAAGCCTAAAGCCATGT 
1761       M  V  E  Q  M  H  A  D  I  I  S  L  W  D  Q  S  L  K  P  C   
 
5341      GTAAAGCTAACCCCTCTCTGTGTAACTTTAAATTGTACCAATGCCAATATCACCTATGTC 
1781       V  K  L  T  P  L  C  V  T  L  N  C  T  N  A  N  I  T  Y  V   
 
5401      AGTACCAACAGCACGAAGGCCTATGTCACTGTCAACGGCACAACGGAAGAAATAAAAAAC 
1801       S  T  N  S  T  K  A  Y  V  T  V  N  G  T  T  E  E  I  K  N   
 
5461      TGCTCTTATAATATGACCACAGAACTAAGGGATAAGAAACAGAAAGTATATTCACTTTTT 
1821       C  S  Y  N  M  T  T  E  L  R  D  K  K  Q  K  V  Y  S  L  F   
 
5521      TATAGACTTGATGTAGTACAGATTAATAAAAATAATAATAGTAGAGATAATGATAGTGGT 
1841       Y  R  L  D  V  V  Q  I  N  K  N  N  N  S  R  D  N  D  S  G   
 
5581      GAGTATAGATTAATAAATTGTAATACCTCAGCCATTACACAAGCTTGTCCAAAGGTCTCC 
1861       E  Y  R  L  I  N  C  N  T  S  A  I  T  Q  A  C  P  K  V  S   
 
5641      TTTGAGCCAATTCCCATACATTATTGTGCTCCAGCTGGTTTTGCGATCCTAAAATGTAAT 




5701      GAGGAGGAGTTCAACGGAACAGGGCCATGCAAGAATGTCAGCTCAGTACAATGCACACAT 
1901       E  E  E  F  N  G  T  G  P  C  K  N  V  S  S  V  Q  C  T  H   
 
5761      GGAATCAGGCCAGTAGTATCAACTCAACTGCTGTTAAATGGCAGTCTAGCCCAAGGAGAG 
1921       G  I  R  P  V  V  S  T  Q  L  L  L  N  G  S  L  A  Q  G  E   
 
5821      GTAAAAATTAGATCTGAAAATATCTCAGACAATGCTAAAACCATAATAGTACAATTTAAC 
1941       V  K  I  R  S  E  N  I  S  D  N  A  K  T  I  I  V  Q  F  N   
 
5881      CAGTCTGTAATAATTAATTGTACCAGACCTAGCAACAATACAAGGAGAAGTGTACGTATA 
1961       Q  S  V  I  I  N  C  T  R  P  S  N  N  T  R  R  S  V  R  I   
 
5941      GGACCAGGACAAGCATTCTATGCAACAGGTGAGATAATAGGGGACATAAGGAAAGCACAT 
1981       G  P  G  Q  A  F  Y  A  T  G  E  I  I  G  D  I  R  K  A  H   
 
6001      TGTAATGTCAGTGAATCAGAATGGAATAAAGCTTTACAACAGGTAGCTACACAATTAGGA 
2001       C  N  V  S  E  S  E  W  N  K  A  L  Q  Q  V  A  T  Q  L  G   
 
6061      AGATACTGGAGTAACAAAACAATAATTTTTAATAGCTCCTCAGGAGGGGATTTAGAAATT 
2021       R  Y  W  S  N  K  T  I  I  F  N  S  S  S  G  G  D  L  E  I   
 
6121      ACAACACATAGTTTTAATTGTGGAGGAGTATTTTTCTATTGTAATACATCAGGTCTGTTT 
2041       T  T  H  S  F  N  C  G  G  V  F  F  Y  C  N  T  S  G  L  F   
 
6181      AGTAGCAGGTGGTTCACTAATGGCACTAACAGCACGGAGTCAAATGGCACAGGCAATATA 
2061       S  S  R  W  F  T  N  G  T  N  S  T  E  S  N  G  T  G  N  I   
 
6241      ACTCTCCAATGCAGGATAAAGCAAATTATAAATATGTGGCAGAGAGTAGGACAAGCAACG 
2081       T  L  Q  C  R  I  K  Q  I  I  N  M  W  Q  R  V  G  Q  A  T   
 
6301      TACACCCCTCCCATCCAAGGAGAAATAAGGTGTAGATCAAACATTACAGGACTACTATTA 
2101       Y  T  P  P  I  Q  G  E  I  R  C  R  S  N  I  T  G  L  L  L   
 
6361      ACAAGAGATGGTGGGATTAACACAACAGAGGAAATCTTCAGACCTGGAGGGGGAAATATG 
2121       T  R  D  G  G  I  N  T  T  E  E  I  F  R  P  G  G  G  N  M   
 
6421      AAGGACAATTGGAGAAGTGAATTATATAAGTATAAAGTAGTAAAAATTGAACCACTAGGA 
2141       K  D  N  W  R  S  E  L  Y  K  Y  K  V  V  K  I  E  P  L  G   
 
6481      GTAGCACCATCCAAGGCAAAGAGAAGAGTGGTGGGAAGAGAAAAAAGAGCAGTTGGACTG 
2161       V  A  P  S  K  A  K  R  R  V  V  G  R  E  K  R  A  V  G  L   
 
6541      GGAGCTGTATTCATTGGGTTCTTGGGAGCAGCAGGAAGCACTATGGGCGCGGCGTCAGTG 
2181       G  A  V  F  I  G  F  L  G  A  A  G  S  T  M  G  A  A  S  V   
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6601      ACGCTGACGGTACAGGCCAGACAATTATTGTCTGGCATAGTGCAGCAGCAAAGCAATTTG 
2201       T  L  T  V  Q  A  R  Q  L  L  S  G  I  V  Q  Q  Q  S  N  L   
 
6661      CTGAGGGCTATAGAGGCTCAACAGCATCTGTTGAAACTCACAGTCTGGGGCATTAAACAG 
2221       L  R  A  I  E  A  Q  Q  H  L  L  K  L  T  V  W  G  I  K  Q   
 
6721      CTCCAGGCAAGAGTCCTGGCTCTAGAGAGATACCTAAGGGATCAACAGCTCCTAGGAATT 
2241       L  Q  A  R  V  L  A  L  E  R  Y  L  R  D  Q  Q  L  L  G  I   
 
6781      TGGGGCTGCTCTGGAAAACTCATTTGCGCCACTAATGTGCCTTGGAACTCTAGTTGGAGT 
2261       W  G  C  S  G  K  L  I  C  A  T  N  V  P  W  N  S  S  W  S   
 
6841      AATAAATCTTATAATGAAATATGGGATAACATGACCTGGCTGCAGTGGGATAAAGAAATT 
2281       N  K  S  Y  N  E  I  W  D  N  M  T  W  L  Q  W  D  K  E  I   
 
6901      GACAATTACACAGAAACAATATATAGGCTAATTGAAGAATCGCAAAACCAGCAGGAAAGG 
2301       D  N  Y  T  E  T  I  Y  R  L  I  E  E  S  Q  N  Q  Q  E  R   
 
6961      AATGAACAAGACTTATTGGCATTGGACAAGTGGACAAATCTGTGGAGTTGGTTTGACATA 
2321       N  E  Q  D  L  L  A  L  D  K  W  T  N  L  W  S  W  F  D  I   
 
7021      TCGAACTGGCTGTGGTATATAAAAATATTTATAATGATAGTAGGAGGCTTAATAGGATTA 
2341       S  N  W  L  W  Y  I  K  I  F  I  M  I  V  G  G  L  I  G  L   
 
7081      AGAATAGTTTTTGCTGTGCTTTCTATAATAAATAGAGTTAGGCAGGGATACTCACCTTTG 
2361       R  I  V  F  A  V  L  S  I  I  N  R  V  R  Q  G  Y  S  P  L   
 
7141      TCATTTCAGACCCATACCCCAAACCCAGGGGGACTCGACAGGCCCGAAAGAACAGAAGAA 
2381       S  F  Q  T  H  T  P  N  P  G  G  L  D  R  P  E  R  T  E  E   
2381        H  F  R  P  I  P  Q  T  Q  G  D  S  T  G  P  K  E  Q  K  K  
2381         I  S  D  P  Y  P  K  P  R  G  T  R  Q  A  R  K  N  R  R  R 
 
7201      GAAGGTGGAGTGCAAGGCAGAGACAGATCGATTCGATTAGTCAGCGGATTCTTAGCTCTT 
2401       E  G  G  V  Q  G  R  D  R  S  I  R  L  V  S  G  F  L  A  L   
2401        K  V  E  C  K  A  E  T  D  R  F  D  *  S  A  D  S  *  L  L  
2401         R  W  S  A  R  Q  R  Q  I  D  S  I  S  Q  R  I  L  S  S  C 
 
7261      GCCTGGGACGATCTGAGGAGCCTGTGCCTTTTCAGCTACCACCGCTTGAGAGACTTCATA 
2421       A  W  D  D  L  R  S  L  C  L  F  S  Y  H  R  L  R  D  F  I   
2421         L  G  R  S  E  E  P  V  P  F  Q  L  P  P  L  E  R  L  H  I 
 
7321      TTGATTGCAGCGAGGACTGTGGAACTTCTGGGACACAGCAGTCTCAAGGGGCTGAGACTG 
2441       L  I  A  A  R  T  V  E  L  L  G  H  S  S  L  K  G  L  R  L   
2441         D  C  S  E  D  C  G  T  S  G  T  Q  Q  S  Q  G  A  E  T  G 
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7381      GGGTGGGAAGGAATCAAGTATCTGGGGAATCTCCTGTTGTATTGGATTCGGGAACTAAAG 
2461       G  W  E  G  I  K  Y  L  G  N  L  L  L  Y  W  I  R  E  L  K   
2461         V  G  R  N  Q  V  S  G  E  S  P  V  V  L  D  S  G  T  K  E 
 
7441      AATAGTGCTATTAATTTGCTTGATACCATAGCAATAGCAGTAGCTGGCTGGACAGATAGG 
2481       N  S  A  I  N  L  L  D  T  I  A  I  A  V  A  G  W  T  D  R   
 
7501      GTTATAGAAGTAGGACAAAGATTTGGTAGAGCTATTCTCCACATACCTAGAAGGATCAGA 
2501       V  I  E  V  G  Q  R  F  G  R  A  I  L  H  I  P  R  R  I  R   
 
7561      CAAGGACTTGAAAGAGCTTTACTATAACATGGGTAGCAAGTGGTCAAAAAGCAGCATAGT 
2521       Q  G  L  E  R  A  L  L  *  H  G  *  Q  V  V  K  K  Q  H  S   
2521        K  D  L  K  E  L  Y  Y  N  M  G  S  K  W  S  K  S  S  I  V  
 
7621      GGGATGGCCCGAGGTTAGGGAAAGAATGAGACAAGCTCAAGCTCCTCCAGCAGCAAAGGG 
2541        G  W  P  E  V  R  E  R  M  R  Q  A  Q  A  P  P  A  A  K  G  
 
7681      AGTAGGAGCAGTATCTCAAGATCTAGAAAAACATGGAGCAATCACAAGCAGCAACATGAA 
2561        V  G  A  V  S  Q  D  L  E  K  H  G  A  I  T  S  S  N  M  N  
 
7741      TCATCCTAGTTGTGTCTGGCTGGAAGCACAAGAAGAAGAGGAGGTAGGCTTTCCAGTCAG 
2581        H  P  S  C  V  W  L  E  A  Q  E  E  E  E  V  G  F  P  V  R  
 
7801      GCCACAAGTACCTTTAAGACCAATGACTTATAAGGGAGCTCTGGATCTCAGCCACTTTTT 
2601        P  Q  V  P  L  R  P  M  T  Y  K  G  A  L  D  L  S  H  F  L  
 
7861      AAAAGAAAAGGGGGGACTGGATGGGTTAATTTACTCCAAAAAGAGACAAGACATCCTTGA 
2621        K  E  K  G  G  L  D  G  L  I  Y  S  K  K  R  Q  D  I  L  D  
 
7921      TCTGTGGGTCTACAACACACAAGGCTATTTCCCTGATTGGCAGAATTACACACCAGGGCC 
2641        L  W  V  Y  N  T  Q  G  Y  F  P  D  W  Q  N  Y  T  P  G  P  
 
7981      AGGGATTAGATACCCACTAACATTTGGCAGGTGCTTTAAGCTAGTACCAGTGGATCCAGA 
2661        G  I  R  Y  P  L  T  F  G  R  C  F  K  L  V  P  V  D  P  E  
 
8041      GGAAGTAGAGAAGGCCAACGAGGGAGAGAACAACAGCCTATTACACCCGGTATGCCAACA 
2681        E  V  E  K  A  N  E  G  E  N  N  S  L  L  H  P  V  C  Q  H  
 
8101      TGGAATGGATGATGAGGACAGAGAAGTATTAAAGTGGAGCTTTGACAGTCGCCTGGCACT 
2701        G  M  D  D  E  D  R  E  V  L  K  W  S  F  D  S  R  L  A  L  
 
8161      AAAACACAGAGCACAAGAGCTGCATCCGGAGTTCTACAAAGACTGCTGACACAGGAATTG 




Sample TV412 from 1246 – 8254 (coordinates relative to HXB2)    
Nucleotide and amino acid composition 
 
gag – Red 
pol - Blue 
vif - Orange 
vpr - Green 
tat - Pink 
rev – Dark Red 
vpu – Sky Blue 
env – Sea Green 
nef – Dark Teal 
 
1         TAGTTAGGACTTTGAATGCATGGGTAAAAGTAATAGAAGAAAAGGCTTTCAGCCCAGAAG 
1            V  R  T  L  N  A  W  V  K  V  I  E  E  K  A  F  S  P  E  V 
 
61        TAATACCCATGTTCTCAGCATTATCAGAAGGAGCCACCCCACAAGATTTAAATATGATGC 
21           I  P  M  F  S  A  L  S  E  G  A  T  P  Q  D  L  N  M  M  L 
 
121       TGAACATAGTGGGGGGACACCAGGCAGCCATGCAAATGTTAAAAGATACCATTAATGAGG 
41           N  I  V  G  G  H  Q  A  A  M  Q  M  L  K  D  T  I  N  E  E 
 
181       AAGCTGCAGAATGGGACAGAGTACATCCAGTACATGCAGGGCCTATTCCACCAGGCCAGA 
61           A  A  E  W  D  R  V  H  P  V  H  A  G  P  I  P  P  G  Q  M 
 
241       TGAGAGAACCAAGGGGAAGTGACATAGCAGGAACTACTAGTACCATTCAAGAACAAATAG 
81           R  E  P  R  G  S  D  I  A  G  T  T  S  T  I  Q  E  Q  I  G 
 
301       GATGGATGACAAGCAACCCACCTGTCCCAGTGGGAGAAATCTATAAAAGATGGATAATCC 
101          W  M  T  S  N  P  P  V  P  V  G  E  I  Y  K  R  W  I  I  L 
 
361       TGGGATTAAATAAAATAGTAAGAATGTATAGCCCTGTTAGCATTTTGGATATAAAACAAG 
121          G  L  N  K  I  V  R  M  Y  S  P  V  S  I  L  D  I  K  Q  G 
 
421       GGCCAAAAGAACCCTTCAGAGATTATGTAGATAGGTTCTTTAAAACTCTCAGAGCAGAGC 
141          P  K  E  P  F  R  D  Y  V  D  R  F  F  K  T  L  R  A  E  Q 
 
481       AAGCTACCCAGGAGGTAAAAGGTTGGATGACTGAAACATTACTGGTCCAAAATGCAAATC 
161          A  T  Q  E  V  K  G  W  M  T  E  T  L  L  V  Q  N  A  N  P 
 
541       CAGATTGTAAGTCCATTTTAAGAGCATTAGGACCAGGGGCTACATTAGAAGAAATGATGA 
181          D  C  K  S  I  L  R  A  L  G  P  G  A  T  L  E  E  M  M  T 
 
601       CAGCATGCCAGGGAGTGGGAGGACCCAGTCATAAAGCAAGAGTCTTGGCTGAGGCAATGA 
201          A  C  Q  G  V  G  G  P  S  H  K  A  R  V  L  A  E  A  M  S 
 199
 
661       GCCAAGCAACAAGTGCAAATGCTGCTATAATGATGCAGAGAGGCAATTTTAAGGGTCCAA 
221          Q  A  T  S  A  N  A  A  I  M  M  Q  R  G  N  F  K  G  P  R 
 
721       GGAAAAGCATTAAGTGTTTCAACTGTGGCAAAGAAGGGCACCTAGCAAGAAACTGCAGGG 
241          K  S  I  K  C  F  N  C  G  K  E  G  H  L  A  R  N  C  R  A 
 
781       CTCCTAGGAAAAAGGGTTGTTGGAAATGTGGAAGGGAAGGACACCAAATGAGAGATTGCA 
261          P  R  K  K  G  C  W  K  C  G  R  E  G  H  Q  M  R  D  C  T 
 
841       CTGAAAGACAGGCTAATTTTTTAGGGAGAATTTGGCCTCTCAACAAGGGGAGGCCAGGAA 
281         *  K  T  G  *  F  F  R  E  N  L  A  S  Q  Q  G  E  A  R  K  
281          E  R  Q  A  N  F  L  G  R  I  W  P  L  N  K  G  R  P  G  N 
 
901       ATTTTCCTCAGAACAGACTGGAACCAACAGCTCCACCAATGGAGACCTTTGGGATGGGGG 
301         F  S  S  E  Q  T  G  T  N  S  S  T  N  G  D  L  W  D  G  G  
301          F  P  Q  N  R  L  E  P  T  A  P  P  M  E  T  F  G  M  G  E 
 
961       AAGAGACAGCCTCCCCTCAGAAGCAGGAACAGAAAGGCAGGGAACAGTCCCAACCCTTAA 
321         R  D  S  L  P  S  E  A  G  T  E  R  Q  G  T  V  P  T  L  N  
321          E  T  A  S  P  Q  K  Q  E  Q  K  G  R  E  Q  S  Q  P  L  I 
 
1021      TTTCCCTCAAATCACTCTTTGGCAACGACCCCTCGTCACAGTAAAGGTAGGGGGGCAGCT 
341         F  P  Q  I  T  L  W  Q  R  P  L  V  T  V  K  V  G  G  Q  L  
341          S  L  K  S  L  F  G  N  D  P  S  S  Q  *  R  *  G  G  S  * 
 
1081      AAAAGAAGCTCTATTAGATACAGGAGCAGATGATACAGTATTAGAAGACATAAATTTGCC 
361         K  E  A  L  L  D  T  G  A  D  D  T  V  L  E  D  I  N  L  P  
 
1141      AGGAAAATGGAAACCAAAAATGATAGGGGGAATTGGAGGTTTCATTAAAGTAAAACAGTA 
381         G  K  W  K  P  K  M  I  G  G  I  G  G  F  I  K  V  K  Q  Y  
 
1201      TGATCAGATACTTATAGAAATTTGTGGAAAAAAGGCTATAGGTACAGTCTTAGTAGGACC 
401         D  Q  I  L  I  E  I  C  G  K  K  A  I  G  T  V  L  V  G  P  
 
1261      CACACCTGTCAACATAATTGGAAGAAACATGTTGACCCAGATTGGTTGTACTCTAAATTT 
421         T  P  V  N  I  I  G  R  N  M  L  T  Q  I  G  C  T  L  N  F  
 
1321      CCCAATTAGTCCTATTGAGACTGTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAG 
441         P  I  S  P  I  E  T  V  P  V  K  L  K  P  G  M  D  G  P  R  
 
1381      GGTTAAACAATGGCCATTAACAGAAGAAAAAATAAAAGCATTGACAGAAATTTGTACAGA 




1441      GATGGAAAAGGAAGGAAAAATTTCAAAAATTGGGCCTGAAAATCCATACAATACTCCAAT 
481         M  E  K  E  G  K  I  S  K  I  G  P  E  N  P  Y  N  T  P  I  
 
1501      ATTTGCAATAAAGAAAAAAGATAGCACTAAATGGAGAAAATTAGTAGATTTCAGAGAGCT 
501         F  A  I  K  K  K  D  S  T  K  W  R  K  L  V  D  F  R  E  L  
 
1561      CAATAAAAGAACACAAGACTTTTGGGAAGTTCAATTGGGAATACCGCATCCAGCGGGCCT 
521         N  K  R  T  Q  D  F  W  E  V  Q  L  G  I  P  H  P  A  G  L  
 
1621      AAAAAAGAAAAAATCAGTAACAGTACTAGATGTGGGGGATGCATATTTTTCAGTTCCTTT 
541         K  K  K  K  S  V  T  V  L  D  V  G  D  A  Y  F  S  V  P  L  
 
1681      AGATGTAAACTTTAGAAAGTATACTGCATTCACCATACCTAGTAGAAACAATGAGACACC 
561         D  V  N  F  R  K  Y  T  A  F  T  I  P  S  R  N  N  E  T  P  
 
1741      AGGAATCAGGTATCAGTACAATGTGCTTCCACAGGGATGGAAAGGATCACCGGCAATATT 
581         G  I  R  Y  Q  Y  N  V  L  P  Q  G  W  K  G  S  P  A  I  F  
 
1801      CCAGAGTAGCATGACAAAAATCTTAGAGCCCTTTAGAACAAAAAATCCAGAACTAATTAT 
601         Q  S  S  M  T  K  I  L  E  P  F  R  T  K  N  P  E  L  I  I  
 
1861      CTATCAATACATGGATGACTTGTATGTAGGATCTGATTTAGAAATAGGACAGCATAGAAC 
621         Y  Q  Y  M  D  D  L  Y  V  G  S  D  L  E  I  G  Q  H  R  T  
 
1921      AAAAATAGAAGAGTTGAGAGCTCATCTATTGAGCTGGGGATTTACCACACCAGACAAAAA 
641         K  I  E  E  L  R  A  H  L  L  S  W  G  F  T  T  P  D  K  K  
 
1981      GCATCAGAAAGAACCTCCATTCCTTTGGATGGGATATGAGCTCCATCCTGACAAGTGGAC 
661         H  Q  K  E  P  P  F  L  W  M  G  Y  E  L  H  P  D  K  W  T  
 
2041      AGTCCAGCCTGTAAAGCTGCCAGAAAAAGAGCACTGGACTGTCAATGATATACAGAAATT 
681         V  Q  P  V  K  L  P  E  K  E  H  W  T  V  N  D  I  Q  K  L  
 
2101      AGTAGGGAAACTAAATTGGGCAAGTCAAATTTATGCAGGGATTAAAGTAAAGCAATTGTG 
701         V  G  K  L  N  W  A  S  Q  I  Y  A  G  I  K  V  K  Q  L  C  
 
2161      CAAGCTCCTCAGGGGAGCCAAAGCATTAACAGACATAGTAACATTGACTGAGGAAGCAGA 
721         K  L  L  R  G  A  K  A  L  T  D  I  V  T  L  T  E  E  A  E  
 
2221      ATTAGAATTGGCAGAAAACAGGGAGATTCTAAAAGACCCTGTGCATGGAGTATACTATGA 
741         L  E  L  A  E  N  R  E  I  L  K  D  P  V  H  G  V  Y  Y  D  
 
2281      CCCATCAAAAGACTTAATAGCAGAAATACAGAAACAGGGGCAAGACCAATGGACATATCA 
761         P  S  K  D  L  I  A  E  I  Q  K  Q  G  Q  D  Q  W  T  Y  Q  
 
 201
2341      AATTTATCAAGAGCCATTTAAGAATCTGAAAACAGGGAAATATGCAAGAAAAAGATCAGC 
781         I  Y  Q  E  P  F  K  N  L  K  T  G  K  Y  A  R  K  R  S  A  
 
2401      ACACACTAATGATGTAAAACAATTAACAGAAGTGGTGCAAAAAGTGGTCATGGAAAGCAT 
801         H  T  N  D  V  K  Q  L  T  E  V  V  Q  K  V  V  M  E  S  I  
 
2461      AGTAATATGGGGAAAGACTCCTAAATTTAAACTACCCATACAAAAAGAAACATGGGAAAC 
821         V  I  W  G  K  T  P  K  F  K  L  P  I  Q  K  E  T  W  E  T  
 
2521      ATGGTGGATGGACTATTGGCAGGCTACCTGGATTCCTGAATGGGAATTTGTCAATACCCC 
841         W  W  M  D  Y  W  Q  A  T  W  I  P  E  W  E  F  V  N  T  P  
 
2581      TCCTCTAGTAAAATTGTGGTACCAATTAGAGAAAGACCCCATAATGGGAGCAGAGACTTT 
861         P  L  V  K  L  W  Y  Q  L  E  K  D  P  I  M  G  A  E  T  F  
 
2641      CTATGTAGATGGGGCAGCCAATAGGGAGACTAAGCTAGGAAAAGCAGGGTATGTCACTGA 
881         Y  V  D  G  A  A  N  R  E  T  K  L  G  K  A  G  Y  V  T  D  
 
2701      TAGGGGAAGACAAAAGGTTGTCTCCCTAACAGAGACAACAAATCAAAAAACTGAACTACA 
901         R  G  R  Q  K  V  V  S  L  T  E  T  T  N  Q  K  T  E  L  H  
 
2761      TGCAATCTATCTAGCCTTGCAGGATTCAGGATCAGAAGTAAACATAGTAACAGACTCACA 
921         A  I  Y  L  A  L  Q  D  S  G  S  E  V  N  I  V  T  D  S  Q  
 
2821      GTATGCATTAGGAATCATTCAGGCACAACCAGACAGGAGTGAATCAGAGTTAGTCAATCA 
941         Y  A  L  G  I  I  Q  A  Q  P  D  R  S  E  S  E  L  V  N  Q  
 
2881      AATAATAGAGAAGTTAATAGAAAAGGACAAAGTCTATCTGTCATGGGTACCAGCACACAA 
961         I  I  E  K  L  I  E  K  D  K  V  Y  L  S  W  V  P  A  H  K  
 
2941      AGGAATTGGAGGAAATGAACAAGTAGATAAATTAGTCAGTAATGGAATCAGGAAGATACT 
981         G  I  G  G  N  E  Q  V  D  K  L  V  S  N  G  I  R  K  I  L  
 
3001      ATTTTTAGATGGGATAGATAAGGCTCAAGAAGAACATGAAAGATATCATAGCAATTGGAG 
1001        F  L  D  G  I  D  K  A  Q  E  E  H  E  R  Y  H  S  N  W  R  
 
3061      AGCAATGGCTAATGATTTTAACCTGCCACCTGTGGTAGCAAAGGAAATAGTAGCCAGCTG 
1021        A  M  A  N  D  F  N  L  P  P  V  V  A  K  E  I  V  A  S  C  
 
3121      TGATAAATGTCAGCTAAAAGGGGAAGCCATGCATGGACAGGTAGACTGTAGTCCAGGAAT 
1041        D  K  C  Q  L  K  G  E  A  M  H  G  Q  V  D  C  S  P  G  I  
 
3181      ATGGCAATTAGATTGCACACATCTAGAAGGAAAAGTAATTCTGGTAGCAGTTCATGTAGC 
1061        W  Q  L  D  C  T  H  L  E  G  K  V  I  L  V  A  V  H  V  A  
 
 202
3241      CAGTGGCTATATAGAAGCAGAAGTTATCCCAGCAGAAACAGGACAGGAGACAGCATACTT 
1081        S  G  Y  I  E  A  E  V  I  P  A  E  T  G  Q  E  T  A  Y  F  
 
3301      TCTGCTAAAATTAGCAGGAAGGTGGCCAGTAAAAGTAGTTCACACAGACAATGGCAGCAA 
1101        L  L  K  L  A  G  R  W  P  V  K  V  V  H  T  D  N  G  S  N  
 
3361      TTTCACCAGTGCTGCAGTTAAAGCAGCCTGTTGGTGGGCAAATATCCAGCAGGAATTTGG 
1121        F  T  S  A  A  V  K  A  A  C  W  W  A  N  I  Q  Q  E  F  G  
 
3421      GATTCCCTACAATCCCCAAAGTCAAGGAGTAGTAGAATCTATGAATAAAGAATTAAAGAA 
1141        I  P  Y  N  P  Q  S  Q  G  V  V  E  S  M  N  K  E  L  K  K  
 
3481      AATTATAGGACAGGTAAGAGATCAAGCTGAACATCTTAAGACAGCAGTACAAATGGCAGT 
1161        I  I  G  Q  V  R  D  Q  A  E  H  L  K  T  A  V  Q  M  A  V  
 
3541      ATTCATTCACAATTTTAAAAGAAAAGGGGGGATTGGGGGGTACAGTGCAGGGGAAAGAAT 
1181        F  I  H  N  F  K  R  K  G  G  I  G  G  Y  S  A  G  E  R  I  
 
3601      AATAGACATAATAGCAACAGACATACAAACTAAAGAACTACAAAAACAAATTACAAAAAT 
1201        I  D  I  I  A  T  D  I  Q  T  K  E  L  Q  K  Q  I  T  K  I  
 
3661      TCAAAATTTTCGGGTTTATTACAGGGACAGCAGAGATCCAGTTTGGAAAGGACCAGCAAA 
1221        Q  N  F  R  V  Y  Y  R  D  S  R  D  P  V  W  K  G  P  A  K  
 
3721      GCTTCTCTGGAAAGGTGAAGGGGCAGTAGTAATACAAGACAATAGTGAAATAAAGGTAGT 
1241        L  L  W  K  G  E  G  A  V  V  I  Q  D  N  S  E  I  K  V  V  
 
3781      ACCAAGAAGAAAAGCAAAGATCATTAGGGATTATGGAAAACAGATGGCAGGTGATGATTG 
1261        P  R  R  K  A  K  I  I  R  D  Y  G  K  Q  M  A  G  D  D  C  
1261         Q  E  E  K  Q  R  S  L  G  I  M  E  N  R  W  Q  V  M  I  V 
 
3841      TGTGGCAGGTAGACAGGATGAGGATTAAAACATGGAACAGTTTAGTAAAGCATCATATGT 
1281        V  A  G  R  Q  D  E  D  *  N  M  E  Q  F  S  K  A  S  Y  V  
1281         W  Q  V  D  R  M  R  I  K  T  W  N  S  L  V  K  H  H  M  Y 
 
3901      ATGTCTCAAAGAAAGCTAAAGATTGGTTCTATAGACATCATTATGAAAGCAGGCATCCAA 
1301         V  S  K  K  A  K  D  W  F  Y  R  H  H  Y  E  S  R  H  P  K 
 
3961      AAGTAAGTTCAGAAGTACACATCCCACTCGGAGAAGCTAGACTGGTAGTAAGAACATATT 
1321         V  S  S  E  V  H  I  P  L  G  E  A  R  L  V  V  R  T  Y  W 
 
4021      GGGGTCTGCATACAGGAGAGAGAGAATGGCATCTGGGTCAGGGAGTCTCCATAGAATGGA 




4081      GGAAAAGGAGATATAGCACACAAATAGACCCTGGCCTGGCAGACCAACTAATTCATATAC 
1361         K  R  R  Y  S  T  Q  I  D  P  G  L  A  D  Q  L  I  H  I  H 
 
4141      ATTATTTTGATTGTTTTGCAGAATCTGCTATAAGAAAAGCCATATTAGGACATATAGTTA 
1381         Y  F  D  C  F  A  E  S  A  I  R  K  A  I  L  G  H  I  V  T 
 
4201      CTCCTAGGTGTAATTATCAAGCAGGACATAACAAGGTAGGATCTTTACAATATTTGGCAT 
1401         P  R  C  N  Y  Q  A  G  H  N  K  V  G  S  L  Q  Y  L  A  L 
 
4261      TAACAGCATTAATAGCACCAAAAAAGATAAAACCACCTCTGCCTAGCGTGAGGAAGCTGA 
1421         T  A  L  I  A  P  K  K  I  K  P  P  L  P  S  V  R  K  L  T 
 
4321      CAGAAGATAGATGGAACGAACCCCAGAGGACCAAGGACCACAGAGGGAGCCATGCAATGA 
1441        R  R  *  M  E  R  T  P  E  D  Q  G  P  Q  R  E  P  C  N  E  
1441         E  D  R  W  N  E  P  Q  R  T  K  D  H  R  G  S  H  A  M  N 
 
4381      ATGGACATTAGAGCTTTTAGAGGAGCTCAAGAGTGAAGCTGTTAGACACTTTCCTAGGCC 
1461        W  T  L  E  L  L  E  E  L  K  S  E  A  V  R  H  F  P  R  P  
1461         G  H  *  S  F  *  R  S  S  R  V  K  L  L  D  T  F  L  G  H 
 
4441      ATGGCTTCACAGCCTAGGACAATATATCTATGAAACTTATGGGGATACCTGGACAGGAGT 
1481        W  L  H  S  L  G  Q  Y  I  Y  E  T  Y  G  D  T  W  T  G  V  
 
4501      TGAAACTATAATAAGAATTCTTCAACAACTACTGTTTATCCATTTCAGAATTGGGTGTCA 
1501        E  T  I  I  R  I  L  Q  Q  L  L  F  I  H  F  R  I  G  C  Q  
 
4561      ACATAGCAGAATAGGCATTACTCGACAGAGGAGATCAAGAAATGGACCCAGTAGATTTTA 
1521        H  S  R  I  G  I  T  R  Q  R  R  S  R  N  G  P  S  R  F  *  
1521         I  A  E  *  A  L  L  D  R  G  D  Q  E  M  D  P  V  D  F  N 
 
4621      ACCTAGAGCCCTGGAACCATCCAGGAAGTCAGCCTAGGACTCCTTGTAACAGGTGTTATT 
1541         L  E  P  W  N  H  P  G  S  Q  P  R  T  P  C  N  R  C  Y  C 
 
4681      GTAAAAAGTGCTGCTATCATTGTCAAGTGTGCTTCGTAACGAAAGGCTTAGGCATCTCCT 
1561         K  K  C  C  Y  H  C  Q  V  C  F  V  T  K  G  L  G  I  S  Y 
 
4741      ATGGCAGGAAGAAGCGGAAACAGCGACGAAGACCTCCTGAAGGCGGTCAGGCTCATCAAG 
1581       M  A  G  R  S  G  N  S  D  E  D  L  L  K  A  V  R  L  I  K   
1581         G  R  K  K  R  K  Q  R  R  R  P  P  E  G  G  Q  A  H  Q  D 
 
4801      ATCCTATACCAAAGCAGTAAGTAGTACATGTAATGTTACCTTTAGTGATATTAGCAATAG 
1601       I  L  Y  Q  S  S  K  *  Y  M  *  C  Y  L  *  *  Y  *  Q  *   




4861      TAGCCTTAGTGGTAGCACTAATACTAGCAATAGTTGTGTGGACTATAGTAGCTATAGAGT 
1621         A  L  V  V  A  L  I  L  A  I  V  V  W  T  I  V  A  I  E  C 
 
4921      GTATAAGATTAAGAAAGCAAAGAAAAATAGACAGGTTAATTGAAAGAATAAGGGAAAGAG 
1641         I  R  L  R  K  Q  R  K  I  D  R  L  I  E  R  I  R  E  R  A 
 
4981      CAGAAGACAGTGGCAATGAGAGTGATGGGGACACAGATGAATTGGCAAAACTGGTGGAGA 
1661       Q  K  T  V  A  M  R  V  M  G  T  Q  M  N  W  Q  N  W  W  R   
1661         E  D  S  G  N  E  S  D  G  D  T  D  E  L  A  K  L  V  E  M 
 
5041      TGGGGAACCATGATTATGGGGATATTAATAATTTGTAGTACTGCAGAAGAAACGTGGGTT 
1681       W  G  T  M  I  M  G  I  L  I  I  C  S  T  A  E  E  T  W  V   
1681         G  N  H  D  Y  G  D  I  N  N  L  *  Y  C  R  R  N  V  G  Y 
 
5101      ACTGTCTACTATGGGGTACCTGTGTGGAGAGACGCAGAGACCACCTTATTTTGTGCATCA 
1701       T  V  Y  Y  G  V  P  V  W  R  D  A  E  T  T  L  F  C  A  S   
 
5161      GATGCTAAGGCATATGAGACAGAAAAGCATAATGTCTGGGCTACACATGCCTGTGTACCC 
1721       D  A  K  A  Y  E  T  E  K  H  N  V  W  A  T  H  A  C  V  P   
 
5221      ACAGACCCCAGCCCACAAGAAATATATTTGGAAAATGTGACAGAACAGTTTAACATGTGG 
1741       T  D  P  S  P  Q  E  I  Y  L  E  N  V  T  E  Q  F  N  M  W   
 
5281      AAAAATAACATGGTAGAGCAAATGCATGCAGATATAATCAGTCTATGGGACCAAAGCTTA 
1761       K  N  N  M  V  E  Q  M  H  A  D  I  I  S  L  W  D  Q  S  L   
 
5341      AAGCCATGTGTACGGTTAACCCCTCTCTGTGTTACTTTAGAGTGTAGTGACGTCATTAAC 
1781       K  P  C  V  R  L  T  P  L  C  V  T  L  E  C  S  D  V  I  N   
 
5401      AAAACCAGAGGTACCATCAACCAAACCATAGAACAAAGAATGGAAGGAGAAATAAAAAAC 
1801       K  T  R  G  T  I  N  Q  T  I  E  Q  R  M  E  G  E  I  K  N   
 
5461      TGCTCTTACAATATGACCACAGAACTAAGGGATAAGAGACAAAAAGTACAGTCATTATTT 
1821       C  S  Y  N  M  T  T  E  L  R  D  K  R  Q  K  V  Q  S  L  F   
 
5521      TATAGACTTGATGTAGTAAAAATTAATAAAAATAGTAATAACACAAATACCAGTGAATAT 
1841       Y  R  L  D  V  V  K  I  N  K  N  S  N  N  T  N  T  S  E  Y   
 
5581      AGATTAATAAATTGTAATACCTCAGCCATTACACAAGCATGCCCAAAGGTAACCTTTGAG 
1861       R  L  I  N  C  N  T  S  A  I  T  Q  A  C  P  K  V  T  F  E   
 
5641      ACAATTCCCATACATTATTGTGCCCCAGCTGGTTTTGCGATTCTAAAATGTAATGACAAA 




5701      GAGTTCAATGGAATAGGGGAATGCAAAAATGTCAGCACAGTCCAATGCACACATGGAATC 
1901       E  F  N  G  I  G  E  C  K  N  V  S  T  V  Q  C  T  H  G  I   
 
5761      AGGCCAGTAGTAACAACTCAACTGCTGTTAAATGGCAGTCTACCAGACGGAAAGGTAATG 
1921       R  P  V  V  T  T  Q  L  L  L  N  G  S  L  P  D  G  K  V  M   
 
5821      ATTAGATCTGAAAATATCACAAACAATGCCAAAAATATAATAGTACAATTTAACGAGACT 
1941       I  R  S  E  N  I  T  N  N  A  K  N  I  I  V  Q  F  N  E  T   
 
5881      GCACAAATTAATTGTACCAGACCTAACAACAATACAAGAAAAAGTGTACGTATAGGACCA 
1961       A  Q  I  N  C  T  R  P  N  N  N  T  R  K  S  V  R  I  G  P   
 
5941      GGACAAGCATACTATGCAGCAGGTGACATAATAGGGGATATAAGACAAGCATATTGTAAT 
1981       G  Q  A  Y  Y  A  A  G  D  I  I  G  D  I  R  Q  A  Y  C  N   
 
6001      GTCAGTAAAAAACAATGGGATGGAATGTTGCAAAAAGTAGCCGACCAATTAAGAACACAT 
2001       V  S  K  K  Q  W  D  G  M  L  Q  K  V  A  D  Q  L  R  T  H   
 
6061      TTTGGGGAAAACAAAACAATAATCTTTGCTAACTCCTCAGGAGGGGACGTACAAATTACA 
2021       F  G  E  N  K  T  I  I  F  A  N  S  S  G  G  D  V  Q  I  T   
 
6121      ACACATAGTTTTAATTGTGGAGGAGAATTTTTCTATTGTGGTACATCAGACCTGTTTAAT 
2041       T  H  S  F  N  C  G  G  E  F  F  Y  C  G  T  S  D  L  F  N   
 
6181      AGCATTTGGGATCTCAATAATGCCACAAATGGCTCAGAGTCAACTGACACTATAATAAAA 
2061       S  I  W  D  L  N  N  A  T  N  G  S  E  S  T  D  T  I  I  K   
 
6241      CTCCCATGCAGAATAAAGCTAATCATAAATATGTGGCAGAGAACAGGACAAGCAATGTAT 
2081       L  P  C  R  I  K  L  I  I  N  M  W  Q  R  T  G  Q  A  M  Y   
 
6301      CCCCCTCCCCTCCGAGGAGTAATAAGATGTGATTCAAACATTACAGGACTAATATTAACA 
2101       P  P  P  L  R  G  V  I  R  C  D  S  N  I  T  G  L  I  L  T   
 
6361      AGAGATGGTGGGAATGGGAACAGTAGTACAAATGAAACCTTTAGACCTGGAGGAGGAAAT 
2121       R  D  G  G  N  G  N  S  S  T  N  E  T  F  R  P  G  G  G  N   
 
6421      ATGAGGGACAATTGGAGAAGTGAATTATATAAGTATAAAGTAGTAAAAATTGAACCACTA 
2141       M  R  D  N  W  R  S  E  L  Y  K  Y  K  V  V  K  I  E  P  L   
 
6481      GGAGTAGCACCCACCAGGGCAAAGAGAAGAGTGGTGGAGAGAGAAAAAAGAGCAGTTGGA 
2161       G  V  A  P  T  R  A  K  R  R  V  V  E  R  E  K  R  A  V  G   
 
6541      ATAGGAGCTGTTTTCATTGGGTTCTTAGGAGCAGCAGGAAGCACTATGGGCGCGGCGTCA 
2181       I  G  A  V  F  I  G  F  L  G  A  A  G  S  T  M  G  A  A  S   
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6601      ATAACGCTGACGGTACAGGCCAGACAATTGTTGTCTGGCATAGTGCAGCAGCAAAGCAAT 
2201       I  T  L  T  V  Q  A  R  Q  L  L  S  G  I  V  Q  Q  Q  S  N   
 
6661      TTGCTGAGGGCTATAGAGGCTCAACAACATCTGTTGAAACTCACGGTCTGGGGCATTAAA 
2221       L  L  R  A  I  E  A  Q  Q  H  L  L  K  L  T  V  W  G  I  K   
 
6721      CAGCTCCAGGCAAGAGTCCTGGCTGTGGAAAGATACCTAAAGGATCAACAGCTCCTAGGA 
2241       Q  L  Q  A  R  V  L  A  V  E  R  Y  L  K  D  Q  Q  L  L  G   
 
6781      ATTTGGGGCTGCTCTGGAAAACTCATCTGCACCACTAATGTGCCCTGGAATTCTAGTTGG 
2261       I  W  G  C  S  G  K  L  I  C  T  T  N  V  P  W  N  S  S  W   
 
6841      AGTAATAAATCTCAGGATGAGATATGGAATAACATGACCTGGCTGCAGTGGGATAAAGAA 
2281       S  N  K  S  Q  D  E  I  W  N  N  M  T  W  L  Q  W  D  K  E   
 
6901      ATTAGCAATTACACAGAAACAATATATAGGCTAATTGAAGAATCGCAAAACCAGCAGGAA 
2301       I  S  N  Y  T  E  T  I  Y  R  L  I  E  E  S  Q  N  Q  Q  E   
 
6961      AAGAATGAACAAGACTTATTGGCATTGGACAAGTGGACAAATCTGTGGAATTGGTTTGAC 
2321       K  N  E  Q  D  L  L  A  L  D  K  W  T  N  L  W  N  W  F  D   
 
7021      ATATCGAACTGGCTGTGGTATATAAAAATATTTATAATGATAGTAGGAGGCTTAATAGGA 
2341       I  S  N  W  L  W  Y  I  K  I  F  I  M  I  V  G  G  L  I  G   
 
7081      TTAAGAATAGTTGCTGTGCTTTCTATAATAAATAGAGTTAGGCAGGGATACTCACCTTTG 
2361       L  R  I  V  A  V  L  S  I  I  N  R  V  R  Q  G  Y  S  P  L   
 
7141      TCATTTCAGACCCATACCCCAAACCCAGGGGGACTCGACAGGCCCGAAAGAACAGAAGAA 
2381       S  F  Q  T  H  T  P  N  P  G  G  L  D  R  P  E  R  T  E  E   
2381        H  F  R  P  I  P  Q  T  Q  G  D  S  T  G  P  K  E  Q  K  K  
2381         I  S  D  P  Y  P  K  P  R  G  T  R  Q  A  R  K  N  R  R  R 
 
7201      GAAGGTGGAGTGCAAGGCAGAGACAGATCGATTCGATTAGTCAGCGGATTCTTAGCTCTT 
2401       E  G  G  V  Q  G  R  D  R  S  I  R  L  V  S  G  F  L  A  L   
2401        K  V  E  C  K  A  E  T  D  R  F  D  *  S  A  D  S  *  L  L  
2401         R  W  S  A  R  Q  R  Q  I  D  S  I  S  Q  R  I  L  S  S  C 
 
7261      GCCTGGGACGATCTGAGGAGCCTGTGCCTTTTCAGCTGCCGCCGCTTGAGAGACTTCATG 
2421       A  W  D  D  L  R  S  L  C  L  F  S  C  R  R  L  R  D  F  M   
2421         L  G  R  S  E  E  P  V  P  F  Q  L  P  P  L  E  R  L  H  V 
 
7321      TTGATTGCAGCGAGGACTGTGGAACTTCTGGGACACAGCAGTCTCAAGGGGCTGAGACTG 
2441       L  I  A  A  R  T  V  E  L  L  G  H  S  S  L  K  G  L  R  L   
2441         D  C  S  E  D  C  G  T  S  G  T  Q  Q  S  Q  G  A  E  T  G 
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7381      GGGTGGGAAGGAATCAAGTATCTGGGGAATCTCCTGTTGT 
2461       G  W  E  G  I  K  Y  L  G  N  L  L  L   








Table 6.8: jpHMM subtyping results of NFLG’s fragments.  
Sample Subtype Results 
R84 B 
TV239 gag-pol A1 
TV239 env-nef A1 / C 
TV314 A1 
TV412 A1 / D 
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Figure 6.4: REGA subtyping results of NFLG’s fragments.  
 
 
 
 
 
 
 
 
 
